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ABSTRACT: Studies investigating the effect of 5-HT receptors mediating a response in the 
neonatal intestine have been limited.  There are evidences that the development of new neurones 
continues past postnatal term and this suggests that receptors expression may differ during 
maturation. Thus, ‘in vitro’ experiments were carried out to investigate the effects of ACh, 
atropine, 5-HT and its related drugs on intact intestinal segments taken from the ileum of adult and 
neonate rats.  The application of ACh (3nM-1mM) and 5-HT (3nM-1mM) induced contractions in 
a concentration dependent manner in all tissues examined. The 5-HT induced contractions were 
only sensitive to antagonism by atropine (1μM) in segments taken from the neonates but not adults. 
The pre-treatment with methysergide (5-HT1/2/5-7 receptor antagonist), ritanserin (5-HT2 receptor 
antagonist), granisetron (5-HT3 receptor antagonist) and RS 23597 (5-HT4 receptor antagonist) at 
1μM or a combination of ritanserin, granisetron, plus RS 23597 at 1μM significantly reduced or 
abolished contractile responses induced by 5-HT. SB 269970A (5-HT7 receptor antagonist) and 
WAY 100635 (5-HT1A receptor antagonist) at 1μM failed to influence contractile responses induced 
by 5-HT or the challenges to 5-HT receptor agonists, 5-CT (5-HT1A/7 receptor agonist) and 8-OH-
DPAT (5-HT1A receptor agonist) at a concentration range of 10nM-0.1mM, indicating the unlikely 
involvement of 5-HT1A and 5-HT7 receptors in the mediation of contractile responses in the 
neonatal rat ileum. Results indicate differences in cholinergic receptor involvement during 
postnatal maturation and suggest the involvement of 5-HT2, 5-HT3 and 5-HT4 receptors in the 
mediation of contractile responses to 5-HT in the neonatal rat ileum. 
There is a growing need to decrease animal usage in pharmacological experiments. This may be 
achieved by the development of ‘in vitro’ cell culture models. Thus attempts were also made to 
develop a cell culture model of neonatal intestine to further investigate the action of 
pharmacologically active agents. The isolation of individual cell populations from segments taken 
from the intestine of rat neonates were achieved by ligation of both ends of the intestine prior to 
incubation in trypsin so that a gradual dissociation could be monitored. This was supported by 
histological procedures, determining the time required to extract large numbers of cells from 
different intestinal layers. Differential adhesion and selective cytotoxicity techniques were used for 
further purification of intestinal smooth muscle cells (ISMC), neuronal cells, and a coculture of 
ISMC and neuronal cells, and these were characterised through immunostaining with antibodies to 
α-smooth muscle actin, α-actinin and the 5-HT3 receptor. A protocol for cryopreservation of ISMC 
was designed in order to protect cells against genetic instability, enhance cell availability and 
reduce animal usage. Results showed that cells extracted from the intestine are viable for up to 4-
months. ISMC functionality was analysed via the application of known pharmacologically active 
drugs on ISMC, which were plated onto glass and silicone elastomer substrate. The cultured ISMC 
responded to the application of drugs such as potassium chloride (KCl), carbachol, 5-HT and 
noradrenaline (NA). Large population of cocultures seeded onto silicone elastomers or cholesteric 
liquid crystal substrates (LC) were assessed for their ability to produce a collective response to KCl 
application. Attempts were made to detect any deformations of the substrate surface due to the 
exposure to KCl and NA. Cholesteric LC substrates seemed to be the most suitable material for 
investigating the cellular tensions.  
The availability of cell cultures allowed the development of an intestinal model of inflammation. 
This was achieved through the use of lipopolysaccharide (LPS)-induced inflammation and was 
confirmed by assessing the levels pro-inflammatory mediators interleukin (IL-8) and nitric oxide 
(NO), which were significantly elevated. Reduction of IL-8 ad NO was also examined using 
granisetron and L-NAME and Chaga mushroom extract. Granisetron and L-NAME reduced the 
NO production during short incubation times. However, an elevated level of NO was observed 
when longer treatment times were examined. The Chaga mushroom extract caused a significant 
reduction in NO production in the model of inflammation. This indicates that this model may be a 
valuable tool for the investigation of other pro-inflammatory mediators and may contribute for the 
investigation of more selective drugs in the management of intestinal inflammation in neonates. 
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CHAPTER ONE 
 
INTRODUCTION
 1
 
1.1 INTRODUCTION 
 
 
Globally it is estimated that 6-60 billion cases of gastrointestinal (GI) illness occur 
annually (Guandalini, 2004). Advances in pharmacological approaches have improved 
therapeutic options for the treatment of GI diseases. Such approaches focus on well-
identified cellular components of the GI tract including receptors and neuroendocrine 
substances. However, peadiatric pharmacology remains an area that does not provide 
adequate information about many drugs. The scientific interpretation of data for 
therapeutics prescribed for infants continues to be a challenge due to the difficulties in 
establishing a relationship between pharmacokinetics (what the body does with the drug) 
and pharmacodynamics (what the drug does to the body). Thus, it is necessary to test the 
efficacy and toxicity of these potential drug candidates in relation to the potential end user. 
Due to differences across species, animal data obtained from experimental pharmacology 
must be modeled appropriately and ma 
de relevant to specific mechanisms to improve drug dosing in infants. 
The complexity of the cell signal within the GI makes the interpretation of the cellular 
response to chemical agents very difficult. Thus, therapies based on the direct delivery of 
these chemical agents into single cells have become an area of focus.  This is based on 
isolation of specific cell populations from a primary tissue source with subsequent 
remodeling into suitable substrates to create functional templates that mimic the 
physiological aspects of the GI tract.  Development of such ‘in vitro’ models can be 
potentially used to improve our present understanding of the basic functions of the GI tract 
in health and disease. 
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 1.2 THE ANATOMY OF THE GASTROINTESTINAL TRACT 
 
 
The GI tract system consists of the digestive tract (Figure 1.2.1), whose functions are the 
ingestion and transport, and the digestion and absorption of nutrients along the GI tract. 
Food contents following ingestion are passed from the oral cavity to the esophagus, which 
connects to the stomach. The luminal contents are propelled along the length of the tract at 
a rate appropriate to the digestive and absorptive processes occurring at each part of the 
tract. This is achievable through the transit component of the GI tract, which is controlled 
and coordinated by the nerves and hormones originating the motility pattern of the GI tract 
(Kirszenbaum, 2002).  
The wall of the GI tract is composed of four main components (Figure 1.2.2). The mucosa 
is highly specialised in each of the regions of the GI tract, where it plays a role in 
absorbing a multitude of substances in the small intestine and absorbing specific quantities 
of water in the large intestine. In the small intestine the structure consists of a membrane of 
columnar epithelium folded into villi. The submucosa consists of irregular connective 
tissue with large blood vessels, lymphatic vessels and nerves branching into the mucosa 
and muscularis.  The muscularis externae consists of circular inner muscular layer and 
longitudinal outer muscular layer and between the two muscle layers are the myenteric 
plexus, collectively they are responsible for the gross movement of gut contents towards 
the distal end of the tract. Lastly, is the serosa, a thin membrane of connective tissue that 
encapsulates the gut (Kirszenbaum, 2002). 
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Figure 1.2.1: Diagrammatic illustration of the gastrointestinal tract (Murphy & Bloom, 
2006). 
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Figure 1.2.2: Diagrammatic representation of the GI tract layer’s distribution (Gray, 
1918). Additional illustration represents the extrinsic and intrinsic innervations controlling 
the digestive tract motility (Roman & Gonella, 1987). 
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1.3 GASTROINTESTINAL MOTILITY 
 
 
A complex network of nerves is embedded in the walls of the digestive tract.  This network 
extends from the pharynx to the anal sphincter and is composed of a large collection of 
intrinsic neurones (enteric neurones) and processes of both vagal afferents (sensory 
neurones) and efferents sympathetic and parasympathetic extrinsic neurones.  From these 
two ganglionated plexus, smaller bundles of nerves emerge from non-ganglionated plexus 
in the longitudinal muscle, the circular muscle, around the blood vessels, the submucosa, 
around the bases of the mucosal glands, and within the cores of the villi (Weisbrodt, 1987) 
(Figure 1.2.2). 
The intrinsic cycle, which derives from two patterns of electrical activity across the 
membrane referred as spikes, coordinates a rhythmic spontaneous depolarisation, which 
subsequently reaches threshold and generates an action potential (Axelsson, 1970, Somlyo 
& Somlyo, 1968, Yamazawa & Iono, 2002). In the smooth muscle this excitation-
contraction coupling (electrochemical) results in calcium permeating the membrane 
through the cell membrane from the extracellular space into the cytosol of the smooth 
muscle cells (Axelsson, 1970). 
In the small intestine, early dissection studies led to the conclusion that the spontaneous 
electrical activity was originated in the longitudinal muscle (Bortoff, 1965). Following 
studies suggested that the interstitial cells of Cajal (ICCs) generated electrical waves that 
paced rhythmic contractions through nerve-to-cell communication. These were reported to 
have a synaptic relationship to the nerve processes and form gap junctions with smooth 
muscle cells, thus giving rise to a pathway from the nerve to the muscle that paralleled to 
the pathway of direct innervations of the smooth muscle (Thuneberg, 1982, Thuneberg et 
al., 1995). More recent studies demonstrated that spontaneous electrical activity, intrinsic 
to smooth muscle tissue, is generated by the ICCs that are electrically coupled to the 
smooth muscle cells. In addition to this level of control, inputs from the enteric nervous 
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system and hormonal influences were shown to regulate normal activity during normal 
physiological responses (Sanders et al., 2006).   
The extrinsic innervations, on the other hand, are divided into sympathetic and 
parasympathetic branches. The parasympathetic branches innervates the GI tract via 
preganglionic nerves and the sympathetic branches innervates the gut via postganglionic 
nerves, both of which synapse mainly with cells of the enteric nervous system.  The enteric 
nerve stimulation originated from the extrinsic innervations, forms networks dispersed 
through the smooth muscle cells to influence GI motility.  Here pharmacochemical 
coupling takes place, in which receptors are activated by drugs or hormones leading to 
modulation of intrinsic patterns of GI smooth muscle contraction, through calcium release 
from an internal source – the endoplasmic reticulum (Somlyo & Somlyo, 1968, Chen & 
Breemen, 1992, Somlyo & Somlyo, 1994, Somlyo et al., 1999). 
Both extrinsic and intrinsic nerve pathways induces depolarisation and contribute to the 
increase in intracellular calcium, resulting in calcium associating with the calmodulin 
complex (CaM), which activates smooth muscle myosin light chain kinase (MLCK). This 
in turn creates a complex with actin filaments and the muscle contracts (Stull et al., 1996). 
The coordination of both intrinsic and extrinsic neuronal reflexes results in the appropriate 
GI motility through coordinated contractions of smooth muscle cells from the muscularis 
region of the GI tract (Figure 1.3.1). 
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Figure1.3.1: Diagrammatic representation of the signaling transduction pathways 
involved in smooth muscle contraction (Stull et al., 1996). 
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1.4 THE SMOOTH MUSCLE CELL 
 
 
Smooth muscle cell cytoskeleton is arranged into three classes of myofilaments: the thin 
filaments correspond to the actin (Hanson & Lowy, 1963, Shoenberg, 1965), the thick 
filaments are identified as myosin (Cooke & Fay, 1972, Devine & Somlyo, 1971, Lowy & 
Small, 1970), and the intermediate filaments (Lazarides, 1982) (Figure 1.4.1). 
With advent of high resolution electron microscopy, myofilaments were first found to 
constitute a single class of contractile proteins within the smooth muscle cell with a 
diameter of 60-80nm (Hanson & Lowy, 1963, Shoenberg, 1965). Further work, indicated 
that when smooth muscle cells were fixed under “physiological” conditions, they contained 
numerous thick myofilaments (170nm) and x-ray reflection characteristic of myosin 
filaments were found (Cooke & Fay, 1972, Devine & Somlyo, 1971, Lowy & Small, 
1970). More recent ultrastructural studies revealed the presence of three distinct classes of 
myofilaments in smooth muscle cells (Cooke & Fay, 1972, Fay & Cooke, 1973, Small & 
Squire, 1972). The third of which were identified as intermediate filaments with a circular 
cross-sectional profile around 100nm in diameter (Lazarides, 1982). 
Actin filaments are the most abundant, they are packed into bundles of filaments showing 
considerably regular center-to-center interfilaments spacing. They also appeared 
homogeneously distributed throughout the sarcoplasm (Cooke, 1976). There are at least six 
different actin isoforms, however, those that have been studied in greatest deal are the 
muscle α and y actin associated with contractile filaments and the cytoplasmic β and y 
actin associated with non-contractile filaments (North et al., 1994). 
Myosin filaments are consistently found in the smooth muscle, but their absolute 
abundance and distribution are highly variable (Cooke, 1976). Moreover, with the 
introduction of electron microscopy it became clear that both contractile proteins (actin and 
myosin) existed as organised filaments, which were obliquely orientated to the longitudinal 
axis of the cell (Bagby et al., 1971). Following numerous studies smooth muscle-myosin is 
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now a well-characterised marker of smooth muscle phenotype, which is exclusively 
expressed in smooth muscle cells (Miano et al., 1994, Owens, 1995). The known smooth 
muscle-myosin heavy chain isoforms are products of an alternative splicing of a single 
gene. This splicing has enabled the production of at least four heavy chain isoforms 
including smooth muscle myosin 1 (SM-1); smooth muscle-myosin 2 (SM-2); smooth 
muscle-myosin A (SMA) and smooth muscle-myosin B (SMB) (White et al., 1993).   
The molecular structure and organisation of the contractile apparatus in the smooth muscle 
cells enables force generation (contraction) through sliding of the adjacent α-actin and 
heavy chain myosin filaments. 
The intermediate filaments were first demonstrated through use of electron microscope and 
revealed that numerous connections were made between the dense bodies and bundles of 
intermediate filaments (Cooke, 1976). The direct structural connections between the 
intermediate filaments and the dense bodies suggested that these structures constituted a 
three-dimensional filamentous network within each smooth muscle cell (Cooke, 1976).  
Following various studies it is now accepted that intermediate filaments constitutes the 
major component of the smooth muscle cytoskeleton, serving a structural role in the cell 
body and supporting the contractile apparatus (Malmqvist et al., 1991). 
In smooth muscle, the intermediate filaments are mainly composed by two major proteins: 
desmin and vimentin (Berner et al., 1981, Osborn et al., 1981). Desmin intermediate 
filaments bind to the dense bodies (Small & Sobieszek, 1977, Small, 1995) and might 
provide an anchoring of the contractile units (Wede et al., 2002).  
As a result, smooth muscle cells possess a contractile apparatus of actin and myosin 
filaments and the cytoskeleton structurally supported by the intermediate filaments, which 
provides the interface between the contractile machinery on the inside of the cell and the 
extracellular matrix on the outside, to which force must be transmitted.  Force transmission 
between smooth muscle cells is achieved by gap junctions, which provide low-resistance 
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channels between cells allowing easy and rapid spread of electrical currents (Peracchia, 
1980, Spray & Bennett, 1985).  
Gap junctions of small intestine are found between the circular muscle cells (Henderson et 
al., 1971, Thuneberg, 1982), between the ICCs of the deep muscular plexus and adjacent 
outer circular muscle (Thuneberg, 1982, Horiguchi & Komuro, 1998). Gap junctions 
between longitudinal muscle layers or between cells of the inner circular muscle have not 
been reported (Daniel et al., 1998, Thuneberg et al., 1995). It is agreed that gap junctions 
provides transit between cells.  This was demonstrated through techniques using dye 
injection into one and its spread into adjacent cells (Farraway et al., 1995). Similarly, 
techniques using electrode systems provided evidence that gap junctions couple cells. In 
such experiments adjacent cells were impaled with potassium chloride filled glassed 
microelectrodes so that one cell could be depolarised by the injection of current and the 
corresponding depolarisation of the second cell could be monitored (Verheule et al., 1997).  
In addition to this level of control, studies have been reported on independent intestinal 
smooth muscle contraction in response to stretch. This stretch activation mechanisms, 
suggests that mechanosensitivity and mechanotransduction can occur at the level of muscle 
tissue. These studies went on to conclude that stretch activation pathway displayed an 
increase intracellular pressure leading to calcium release. Thus, stretch-activated calcium 
channels in the GI smooth muscle may also regulate smooth muscle tone and intestinal 
motility (Farrugia et al., 1999). 
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Figure 1.4.1: Diagrammatic representation of spindle-like smooth muscle cells composed 
of thick myosin and thin actin filaments, which constitutes the contractile proteins. The thin 
filaments anchored either from the plasma membrane or the structures known as dense 
bodies, which are attached to a network of intermediate filaments. The intermediate 
filaments form an internal cytoskeleton in which contractile filaments are anchored. 
Contraction of smooth muscle occurs due to the sliding filament mechanism with cross-
bridge formation occurring between the overlapping thin and thick filaments. The cells 
function as an effector unit because cells are functionally coupled to one another. Opposed 
cell membranes are fused to form gap junctions that allow the spread of excitation from 
one cell to another. 
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 1.5 THE ENTERIC NEURONES 
 
For several decades it was accepted that the autonomic nervous system consisted of the 
parasympathetic and sympathetic nervous system. In 1921 pioneering work carried out by 
Langley established the enteric nervous system as the third division of the autonomic 
nervous system containing two efferent pathways: the cholinergic and adrenergic neurones. 
The cholinergic pathway was assumed to act at the nicotinic/acetylcholine (ACh) receptors 
to cause excitation of the enteric nerves and muscarinic receptors to cause contraction of 
the GI function. Inhibition of the GI function was believed to take place through the action 
of norepinephrine released from the sympathetic nerves. At the time Langley also 
postulated the hypothesis that many of the neurones present in the enteric nervous system 
were not connected to the central nervous system (Langley, 1921).  Succeeding studies 
demonstrated that the enteric nerves could release non-cholinergic excitatory and non-
adrenergic inhibitory neurotransmitters (Burnstock et al., 1966, Ambache & Freeman, 
1968). 
Intensive studies over the last 20 years have led to identification of the major neuronal 
types in the enteric nervous system and it is now appreciated that the enteric nervous 
system possesses several neuronal mechanisms similar to the central nervous system, but 
has autonomic and physiological independence from the central nervous system (Bornstein 
et al., 1994). Further work continued into investigation of their mechanisms of action 
revealing that the muscle layers of the intestine are dually innervated by excitatory and 
inhibitory motor neurones located in the gut. With the introduction of selective antagonists, 
ACh was soon recognised as the primary transmitter of the excitatory motor neurones. 
However, it was also observed that cholinergic blockers did not completely abolish the 
excitatory transmission. This transmission was later found to be blocked by antagonism of 
tachykinin (TK) receptors (Burnstock et al., 1966, Ambache & Freeman, 1968). 
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Classification of the mechanisms of transmission from excitatory motor neurones was 
concluded through immunohistochemical studies, which demonstrated that smooth muscle 
is innervated by one class of excitatory neurones that is immunoreactive for both choline 
acetyl-transferase (through which ACh is synthesised) and tachykinin (Galligan et al., 
1986), thus confirming that both these components of transmission are derived from single 
neurons (Galligan et al., 1986). The main inhibitory neurotransmitters have been suggested 
to include nitric oxide (NO), adenosine triphosphate (ATP) and vasoactive intestinal 
peptide (VIP) (Mashimo & Goyal, 1999), however, the roles of these transmitters are not 
yet fully resolved. Additionally, inhibition of the GI function also takes place through the 
release of noradrenaline at most post-ganglionic sympathetic nerve endings causing muscle 
relaxation (Lungren, 2000). 
Evidence for the existence of interneurones in the enteric nerve network arose from 
structural studies, which revealed the existence of neurones with cell bodies in the 
myenteric ganglia and in the terminal ganglia. There are at least one class of ascending 
interneurones and three classes of descending interneurones. It is challenging to study 
interneurones physiologically, however, direct recording have shown that interneurones 
respond to reflex stimuli with fast excitatory postsynaptic potentials. Data obtained from 
organ bath pharmacology and the microelectrode recording studies indicated that in 
ascending pathways, transmission between interneurones and excitatory muscle motor 
neurones is cholinergic via the nicotinic receptors.  Therefore, ascending interneurones 
contain choline acetyl-transferase and tachykinins, and they transmit to each other via ACh 
at the nicotinic receptors, but to excitatory motor neurones via both ACh and tachykinins 
(Bornstein et al., 2004). 
To date three types of descending interneurones have been recognised and one transmits to 
the inhibitory motor neurones via adenosine triphosphate. The second one is thought to 
occur via NO synthase-containing interneurones and the third transmission to and from 
 14
 15
descending interneurones pathway is thought to occur either via choline acetyl-
transferase/serotonin and/or choline acetyl-transferase/somatostatin, but this is yet to be 
characterised (Bornstein et al., 2004) (Table 1.1). The neurones in the intrinsic nerve 
circuits are the intrinsic primary afferent neurones also known as sensory neurones. These 
nerve fibers were recognised through studies using intracellular electrodes, in which it was 
found that some neurones were excited by sensory stimuli. Extensive work in this area 
demonstrated that the sensory nerve fibers in the wall of the GI tract detect mucosal pH 
and osmolarity and can respond to temperature, tension and touch (Berthoud et al., 2004).  
On the basis of this information, when changes in the environment of the intestine are 
detected by a receptor cell, which synapses with a sensory neurone it carries the impulse 
from the site of stimulus to the central nervous system. Here it synapses with an 
interneurone, which in turn synapses with a motor neurone carrying the impulse out to an 
effector cell, thus restoring normal homeostasis (Berthoud et al., 2004) (Figure 1.5.1). 
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Figure 1.5.1: The organisation of the three types of enteric ganglia neurones (sensory, 
interneurone and motor neurones) and the circuit network from the triggered stimuli to the 
response elicited in the GI musculature. 
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Table 1.1: Summary of the types of neurones in the enteric nervous system and some of 
their defining characteristics in the gastrointestinal tract (Bornstein et al, 2004). 
 
Type of neurone Function 
Excitatory motor neurones Primary transmitter ACh, co-
transmitter TK 
 
Inhibitory motor neurones Several co-transmitters with varying 
prominence: ATP, NO and/or VIP 
 
Ascending interneurones Primary transmitter ACh 
Descending interneurones (excitatory 
secrotomotor effect) 
Primary transmitter ACh, co-
transmitter 5-HT or SOM  
 
Descending interneurones (inhibitory 
secrotomotor effect) 
Primary transmitter ATP and NO 
 
 
 
ACh, acetylcholine; ATP, adenosine triphosphate; NO, nitric oxide; 5-HT, 5-
Hydroxytrytamine; SOM, somatostatin; TK, tachykinin; VIP, vasoactive intestinal peptide. 
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1.6 HORMONAL REGULATION  
 
 
In the past it was widely accepted that the concept of GI endocrinology was that a few 
peptides were released to the circulation from the endocrine cells interspersed among other 
mucosal cells in upper GI tract (Starling, 1905, Edkins, 1905, Edkins, 1906). However, 
with the advances in cell and molecular biology it is now more complex to describe the 
effect of substances in response to bodily stimulus arising from within or outside the body 
(Rehfeld, 1998). This is because bodily stimulus may act directly on the responding cell or 
on a sensory cell that in turn sends a chemical messenger to the responding cell.  These 
chemicals messenger are transmitted by one of the three different mechanisms: neurocrine, 
endocrine, or paracrine (Figure 1.6.1). 
In neurocrine transmission the signalling molecules of the nervous system of the species 
are chemicals called neurotransmitters.  These are released at the axon end of one nerve 
cell referred as the synaptic cleft to target cells: receptor cells, nerves cells, and 
neuromuscular junctions. The paracrine transmission takes place as the signalling cells 
released by one cell travels through the extracellular environment and acts on the receptor 
molecule of the adjacent cells in close proximity.  These are normally growth regulators 
that react with the receptor cell and are removed from the environment. Lastly, the 
endocrine transmission signalling molecules act on target cells distant from their site of 
synthesis.  These are often specialised cells that release the hormones into vessels of the 
circulatory system, so that they can travel to the target cells in other parts of the body. 
However, endocrine transmission is more complex as there is evidence of scattered cells 
rather than discrete glands that act as organs and endocrine cells that affect themselves. 
This autocrine transmission suggests that endocrine cell activity may be modulated directly 
within that endocrine gland itself, without the need of hormones entering the blood stream 
(Sporn & Roberts, 1992). 
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Communication between cells via neurotransmitters or hormones can elicit a response 
within a cell if receptor is present.  This cascade is then amplified by interaction with a 
number of proteins embedded in the cell membrane referred as second messengers by 
which a ligand generate a specific intracellular event. However, in studies of release 
mechanisms it is difficult to distinguish material derived from the neurocrine or endocrine 
or paracrine cells, since the unifying links between these systems is that all three utilise 
amino acids, peptides, and amines as second messengers, just as some of the same peptides 
are found in both nerves and endocrine cells. Conversely, the responses evoked by 
exogenous applications of substances may reflect actions usually exerted in the paracrine, 
endocrine or neuroregulatory systems (Arimura et al., 1975). 
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Figure 1.6.1: Images adapted from Alberts et al, to illustrate the different signalling 
mechanisms (paracrine, endocrine, and neurocrine) used by chemical messengers to travel 
to target cell (Alberts et al., 1994). 
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1.7 THE GASTROINTESTINAL TRACT IN HEALTH AND 
DISEASE STATE 
 
Functional GI disorders comprise alterations in motor and secretory activity. The causes 
and mechanisms underlying most of functional GI disorders are still largely unknown, 
however, alterations seem to arise primarily in inflammation with consequent changes in 
localised neurotransmitters released locally, that induce pathological reflex mechanisms 
occurring in response to specific stimuli. Because the GI tract is the natural habitat to a 
large and dynamic population of bacteria, the continuous exposure to even normal 
physiological conditions such as food ingestion, displays an immunological state in 
response to the pathogens that is manifested by the abundance of pro-inflammatory agents.  
These agents constitute the GI immune system and their main function is to restore 
homeostasis by maintaining a delicate balance between the immune response to the 
microbial pathogens and tolerance to the dietary pathogens and the local microflora 
(Brandtzaeg et al., 1989). The initiation of the immune response against antigens within the 
intestine involves primarily the selective migration of T lymphocytes into the regions. Of 
these, the lymphocytes that play a significant role are T helper cells (Th), which are later 
divided into subsets of Th1, Th2, Th3, Th0, Thp, and Tr1 cells (Seder & Mosmann, 1999). 
These cells, when activated during the immune response, synthesise and release pro-
inflammatory cytokines such as tumour necrosis factor (TNF) α; interleukin (IL) 1β, IL-6, 
IL8, IL-12, IL18; metalloproteinases (collagenase, gelatinase), arachidonate metabolites 
(platelet-activating factor) reactive oxygen species and nitrogen metabolites (superoxide, 
hydrogen peroxide, nitric oxide) (Abbas et al., 2000). 
Conversely, gut flora might also be an essential factor in certain pathological conditions 
leading to chronic intestinal inflammation. The reasons for the breakdown in the regulation 
of the intestinal immune system are yet to be identified. However, there is evidence 
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suggesting the possible involvement of Th cells in attacking bacteria in the gut, hence, 
leading to intestinal inflammation. This has been shown in studies generated in genetically 
engineered rodent models of inflammatory bowel disease (IBD). This works by using 
vector systems that can efficiently transduce epithelial and sub-epithelial areas of the 
intestine to overproduce a pro-inflammatory mediator of interest inducing the disease state 
(Wirtz & Neurath, 2000). It has been found that a failure to regulate protective immune 
regulators resulted in uncontrolled overproduction of pro-inflammatory cytokines and 
mediators. This can cause severe and extended inflammation of the inner epithelial lining 
of the gut leading to the onset of fibrosis. It can subsequently lead to scarring, which 
reduces the width of the lumen known as strictures, giving rise to functional GI disorders. 
Although, intensive research has been carried out towards understanding the aetiology and 
specific pathogenic mechanisms, to date advances have been minimal.  
Despite the substantial new data that has been obtained in recent studies, it has been 
increasingly difficult to accommodate this into a unifying disease model. However, when 
looking at the exact mechanisms that trigger immune response breakdown in the intestine, 
it continues to be apparent that the immune system plays a crucial role in promoting 
chronic gut inflammation and that the antigens that initiates and cause the onset of the 
disease are part of the normal gut flora (Laroux et al., 2001). 
 
 
 
 
 
 
 
 
 21
1.8 THE ROLE OF 5-HT IN PHYSIOLOGICAL AND 
PATHOPHYSIOLOGICAL PROCESSES IN THE GI TRACT 
 
The pharmacological understanding of the nervous and endocrine controls of the GI tract 
and its importance for gut function in several states of disease has advanced greatly over 
recent years. Thus, opening doors into new therapeutic concepts based on the roles of key 
neurotransmitters and neuroendocrine substances.  
One clear example is 5-hydroxytryptamine (5-HT), one of the neurotransmitters in the GI 
tract, possessing complex actions within the gut. 5-HT is synthesised, stored and released 
by enterochromaffin cells and enteric neurones, and participates in sensory, motor, and 
mucosal sensory stimulation. The serotonergic myenteric interneurones project into the gut 
but not into the luminal area. The sensory stimulus by the enteric nervous system and the 
central nervous system is achieved by paracrine transmission, which activates specialised 
epithelial detectors, such as enterochromaffin cells underlying the intrinsic and extrinsic 
afferent nerves (Gershon, 2002). Thus, the main source of 5-HT in the gut is the 
enterochromaffin cells from which 5-HT is released in response to increased luminal 
contents and stimulus such as food; pathophysiological conditions such as bacteria or 
toxins; or pharmacologically in response to chemical agents. The released 5-HT exerts its 
effects through receptors that are located on intrinsic primary afferents and extrinsic 
afferents, ganglion cells, axonal membranes, nerve terminals, enterochromaffin cells, 
enterocytes, and immuno-related cells (Gershon, 1999).  
The effects of 5-HT and its pharmacological interaction with the serotonergic pathways on 
gut functions have proven over the years to be complex and unpredictable. This seems to 
be caused by the action of 5-HT and its multiple receptors.  
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1.9 5-HT RECEPTOR CLASSIFICATION 
 
The classification of 5-HT receptors began in 1957, when 5-HT was first found to affect 
the guinea pig ileum and that this action could be blocked by morphine (M) and partially 
by dibenzyline (D) (Gaddum & Picarelli, 1957). However, neither morphine nor 
dibenzyline were selective to the 5-HT receptors. In 1976 while performing radio-ligand 
binding studies, the presence of 5-HT was reported in the brain. A few years later it was 
reported that two distinct 5-HT binding sites existed (Peroutka & Snyder, 1979). The D 
receptor was found to correspond pharmacologically to the two receptors reported by 
Peroutoka and Snyder, and the M receptor was distinct. As a result, Bradley and colleagues 
proposed the existence of three groups of 5-HT receptors, named 5-HT1-like, 5-HT2, 5-
HT3, the latter corresponding to the M receptor type (Bradley et al., 1986). In the mid 
1980s due to the increased use of radioligands, followed by an increased understanding 
about the second messenger systems and the advances in genetic recombination techniques 
in the mid 90’s, a vast number of 5-HT receptor subtypes were identified. Currently seven 
5-HT receptor families have been recognised. The 5-HT1 receptor class comprises five 
receptors (5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F). These operate via ligand-gated 
ion channels and are negatively coupled by adenyl cyclase to inhibit cyclic AMP 
formation. In the GI tract, 5HT1A has been reported to act as inhibitory modulators of fast 
excitatory postsynaptic neurones (Hannon & Hoyer, 2002).   
The 5-HT2 receptor class is divided into 5-HT2A. 5-HT2B, 5-HT2C and operate via ligand-
gated ion channels and are thought to increase in inositol phosphates and cytosolic calcium 
concentration by positive coupling to phospholipase C. 5-HT2A is widely distributed in the 
periphery including ileal and urinary smooth muscle. 5-HT2B receptors contract 
longitudinal muscle in human small intestine (Hannon & Hoyer, 2002). 
5-HT3 receptors (M receptors of Gaddun and Picarelli 1957) are unique in that they couple 
to ions channels, which gate sodium, potassium, and calcium (Hannon & Hoyer, 2002). In 
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the GI tract the 5-HT3 receptors are believed to be involved in motility and intestinal 
secretion. 
The 5-HT4, 5-HT6, 5-HT7 receptors are positively coupled to phospholipase C and thus 
generate inositol phosphates and mobilise intracellular calcium when activated to mediate 
effects of 5-HT. The 5-HT4 receptor activation has been reported to trigger ACh release in 
the guinea-pig ileum, it also stimulates secretory responses to 5-HT in the intestinal 
mucosa (Bockaert et al., 1992). The 5-HT5 receptors are believed to stimulate cyclic 
adenosine monophosphate (AMP) production, however, a physiological functional 
response or specific 5-HT5 binding are still missing (Bockaert et al., 1992). The 5-HT6 
receptors are found in the striatum, amygdala, nucleus accumbens, hippocampus, cortex 
and olfactory tubercle, but have not been found in the peripheral organs (Hannon & Hoyer, 
2002). 
The 5-HT7 receptor is the previously proposed ‘5-HT1A-like’ receptor and it has been 
shown to mediate relaxation in the guinea-pig ileum (Hannon & Hoyer, 2002) (Figure 
1.9.1).  
5-HT acts on cell membranes, which have specific 5-HT receptors, furthermore, the sub-
types of these receptors are present in different cells associated with different actions of 5-
HT. This is further compounded with the ability of 5-HT to act indirectly either by 
stimulating or inhibiting the release other neurotransmitters. For instance increased 5-HT 
release causes stimulation of the ACh release from the myenteric neurones increasing 
intestinal contractions and secretions, however, 5-HT also directly activates smooth muscle 
cells causing contraction (Costall & Naylor, 1990, Gershon et al., 1990) . Therefore, it is 
not surprising that when there is dysfunction of the enteric nervous system several of the 
recognised functional GI disorders are related to alterations in 5-HT levels (Thompson, 
2002). 5-HT has been suggested to play an important role in controlling both inhibition and 
facilitation of motor functions of the oesophagus, stomach, small intestine, ileocaecal 
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sphincter and colon, as well as modulating small intestine and colon secretion (Jule, 1980, 
Goldberg et al., 1986, Costa & furness, 1976, Bulbring & Gershon, 1967, Beubler & 
Horina, 1990). 
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Figure 1.9.1: Graphical representation of the current classification of 5-HT receptors. 
Receptor subtypes represented by lower cases designates receptors that have not been 
demonstrated to completely function in the native systems. Abbreviations: 3’-5’ cyclic 
adenosine monophosphate (cAMP); phospholipase C (PLC); negative (-ve); positive (+ve). 
Adapted from (Hannon & Hoyer, 2002). 
 
On the basis of this information, the 5-HT receptor family has become a target of intense 
research with the identification of more potent and selective ligands for the different 
receptor subtypes as a major goal. Such selective markers should assist in better defining 
the functions of these receptors, furthermore, leading to potential drug treatments.  
However, when seeking to determine the ‘identity of action’, it is essential to know not 
only the mechanisms of action interconnecting the muscular layers to the neuronal 
plexuses but all the co-existing effects exerted by neurotransmitters, hormones, and other 
peptides in the gut. Thereby the urge to create models representative of individual 
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intestinal layers in order to investigate the mechanisms of action of selective agonists and 
antagonists and attempt to relate these to the unifying links in communication among the 
different intestinal layers and the hormones and neurotransmitters produced. 
Studies of stimulus-contraction coupling of smooth muscle cells have been largely 
performed on intact tissues, considerable information about the function of these tissues 
have been acquired. However, results obtained from the intact tissue normally emerge from 
the complex network of organised smooth muscle cells into a multicellular unit rather than 
from the individual properties of cells themselves. 
 More recently, attention has been directed to the use of cells isolated from the intact tissue 
as a source for studies of some basic physiology and biochemical properties of muscle cells 
(Lieberman et al., 1987). 
 
 
 
1.10 PRIMARY CELL CULTURE 
 
 
Cell culture was first devised at the beginning of the century (Harrison, 1907, Carrel, 1912) 
as a method for studying the behaviour of animal cells free from systemic variations that 
might arise both during normal homeostasis and under stress caused by external stimulus 
during an experiment. In cell culture, when specific cells are extracted from primary 
tissues and cultured, they usually propagate, expand and divide into identical replicates 
assuming a uniform constitution (Freshney, 2005). Cell culture refers to culture derived 
from dispersed cells taken from the original tissue, by enzymatic, mechanical or chemical 
disaggregation. Since this provides the accessibility to study particular cell populations 
within the tissue or organ, this has created a new wave of interest based in the cultivation 
of tissue ‘in vitro’ (Freshney, 1994) and subsequently became a valuable technique for 
studies of physiological properties of cells (Lieberman et al., 1987). Moreover, due to the 
requirement of animals for continuation of preclinical trials of new pharmaceuticals, there 
is a widespread concern about the extensive use of animals in drug development. Hence, 
there is an ever-increasing need for more ‘in vitro’ assays, which can subsequently at later 
stages of evaluation be validated with data from animal experiments (Freshney, 1994). 
 
 
1.11  INTESTINAL CELL CULTURE 
 
The culture of different cell populations extracted from the small intestine has proven 
challenging. For intestinal smooth muscle cells (ISMC) this is primarily related to the loss 
in phenotypic characteristics (Thyberg et al., 1983). Muscle cells ‘in vitro’ are highly 
differentiated which is evident from the large proportion of contractile filaments within the 
cell and thus must undergo a process referred as “phenotypic modulation” before mitosis 
so an increase in the cell number may occur (Chamley-Campbell et al., 1979). There is 
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evidence that such proliferation processes lead to a decrease in the number of contractile 
proteins, hence changes in the phenotypic properties of cells, resulting in a loss of 
contractility (Chamley-Campbell et al., 1979). Furthermore, the complex layered nature of 
the GI tract makes it difficult to acquire pure preparations of individual cell types. These 
difficulties are further compounded by the limited availability of adult animal species from 
which successful ISMC cultures can be established (Bitar & Makahlouf, 1986, Benham et 
al., 1986, Oishi et al., 2000).  
 
 
1.12  COMPARISON OF NEONATAL AND ADULT INTESTINAL 
CELL CULTURE MODELS 
 
In establishing primary culture models, the major concerns are obtaining sufficient number 
of cells, obtaining a population with a high degree of purity, and, most importantly, having 
a cell population that will survive the culture. The increasing difficulty in obtaining viable 
proliferating cells with increasing age is mainly due to the onset of differentiation, the 
increase fibrous connective tissue and the decrease in undifferentiated proliferating cells 
(Freshney, 2005). Conversely, embryonic or neonatal tissue disperses more readily and 
gives higher number of proliferating cells compared to the adult tissue (Freshney, 2005). It 
has been reported that the phenotype of cultured neonatal smooth muscle cells are very 
stable in terms of their contractile profile (Yamashita et al., 1994) and that they are less 
susceptible to damaged by the dissociation process than ISMC obtained from adult tissue 
(Chlocikova et al., 2001). 
However, when dealing with neonatal tissue, techniques for cellular dissociation requires 
the support of advanced optical equipment due to the small size of the tissues (Smirnov et 
al., 1992, Frings et al., 2000). Although, enzymatic and mechanical techniques of 
disaggregation usually gives a high yield in the neonatal tissue due to its softness compared 
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to the adult tissue (Schaffer et al., 1997), it can be disadvantageous since cell cultures 
yielded via this technique are more representative of the whole tissue (Freshney, 2005). 
Nevertheless, such limitations in the disaggregation of cells from neonatal tissue can be 
minimised if methods are employed to monitor the gradual dissociation from a specific 
region of the intestine. This technique, combined with cell sorting techniques and 
morphological monitoring may provide the parameters necessary for acquisition of highly 
pure cell preparations from neonatal tissue. 
 
 
1.13 PURIFICATION TECHNIQUES FOR INTESTINAL CELLS 
 
Preparations of homogenous samples of cells from tissues are considered to be an 
obligatory step, not only in the study of physiological processes, they are also required for 
modern methods in molecular biology, drug screening, diagnosis and cell replacement 
therapy. It has been estimated that 90% of the cost and 95% of the time needed to obtain 
molecular diagnostic data today are associated with sample collection and preparation. The 
inadequacy of effective sample preparations may be one of the major shortcomings in past 
cell based and molecular analysis systems (Gascoyne & Vykoukal, 2004).  
Although, there have been improvements in the instrumentation and techniques used for 
separating specific target cells from a mixed preparation, challenges in this area are still 
encountered due to the relatively high cost in the separation of large cell populations.  
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1.13.1   SUBSTRATUM ADHESIVENESS  
 
 
Some methods exploited the differences in substratum adhesiveness between the cells to be 
separated (Yaffe, 1968). This method has been successful in the past enabling separation of 
myogenic cells from fibroblasts (Richler & Yafee, 1970, Gareth et al., 1990, Rando & 
Blau, 1994, Qu et al., 1998). This is because the method implies that when cells of 
differing affinities are mixed, differences in cell adhesion can drive cell sorting.  If two 
different cell populations are mixed they will re-arrange on basis of strength of cell-cell 
interaction. If cells have equivalent adhesions, they will mix randomly, however, if their 
adhesion molecules are more expressed in one cell population that the other, they will sort 
to the surface separately (McNeill, 2000) (Figure 1.13.1). Thus, this is performed by 
continuous monitoring of the rate of cell attachment for different populations, which 
subsequently provides estimation of the time required for a specific cell population to 
attach to the surface.  
 
 
Rate of cell adhesion 
to the surface 
1 hour 
Mixed cell 
populations 
6 hours 
 
Figure 1.13.1: Schematic diagram of the cell separation system: substratum adhesiveness. 
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1.13.2   PERCOLL GRADIENT 
 
 
Other methods exploited the differences in cell density when separated in a Percoll 
gradient (Price et al., 1978). This conventional method comprises a cell suspension that is 
layered over a polymer gradient column in a centrifuge tube. The cell populations are then 
separated by centrifugation based on the cell density and shape (Figure 1.13.2). Although 
clean cell population can be isolated using this method, depending on conditions, isolation 
times can be lengthy causing cell viability to decrease. Density gradient fractionation can 
also pose risk to the cells in two distinct ways: primarily, if solution of gradient material is 
viscous at high density, and secondly if it exerts high osmotic effects at low concentration. 
As a result it may cause cells to band at a different density from their physiological 
density. In separate occasions it can also lead to the solution of the gradient material with 
low molecular weight penetrating the cells (Pertoft, 2000). 
 
 Mixed cell 
population 
 
Centrifugation 1.050 
 
1.100 
 
1.150 
Separated cell 
populations 
Density 
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Figure 1.13.2: Schematic diagram of the cell separation system: density gradient cell 
separation. 
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1.13.3   PANNING METHOD 
 
Those early methods, however, failed to produce an entirely pure population of cells. 
More selective techniques involve the panning method, which was developed for the 
separation cells in mixed populations. This technique requires the use of a specific 
antibody, which binds to the target cells’ specific isotope. The unbound fraction is then 
removed simply by pouring the supernatant from the dish (Figure 1.13.3). Although this 
technique results in the production of an enriched homogenous fraction of cells with a high 
recovery of approximately 90%-95% of the original population (Jones et al., 1990) its 
limitations is that it cannot be applied universally because of the lack of antibodies and 
known surface markers for some cell types.  
 
 
 
Target 
cells Selective 
Antibodies 
Supernatant 
removed 
Cell + complex 
in suspension 
Mixed cell 
population   
 
 
Figure 1.13.3: Schematic diagram of the cell separation system: panning method. 
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1.13.4   MAGNETIC AND FLUORESCENCE ACTIVATED CELL 
SORTING METHODS  
                   
 
The most recently devised method for separating cells centers on the use of cell sorting 
machinery. Fluorescence-activated cell sorter and magnetic-activated cell sorter are both 
typically used for separating specific target cells and like the panning method they require 
immunolabelling to separate target cells. Additionally, magnetic-activated method 
combines the antibodies used to tag cells of interest with small magnetic microbeads. 
Magnetic-activated method is favoured over fluorescence-activated method, primarily 
because a larger cell population yield was attained with magnetic cell sorting (Blau et al., 
1983) (Figure 1.13.4). 
Both these cell separation systems provide convenient pre-enriched cell suspensions before 
they run downstream sorting through flow cytometry. The use of flow cytometry has been 
developed to improve the specificity of the cell separation. As samples are processed 
through a column and placed within the separator instrument, the cells retained are 
subsequently analysed and separated, one cell at a time, thus determining the purity of the 
cells sorted. The enrichment of samples through magnetic or fluorescence separation 
provides an essential step that isolate cells of interest in a specific manner, which can 
subsequently ensure an accurate separation through flow cytometry. The data is then 
analysed by computer and can be plotted in several ways. Cell separation through these 
methods can lead to extremely pure preparations and can subsequently ensure an accurate 
cell separation. Nonetheless, this technique requires specialised and expensive equipment 
and is not employed within standard cell culture facilities. Although sophisticated, this 
technique presents drawbacks associated with sterility and cost. 
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 Labeling of cells with 
the selective antibody 
Addition of Microbeads 
Application into 
the column 
Remove unbound material 
by stringent washing 
Elution of target cells while the rest of 
the isolated complex (antibody + 
microbeads) remains on the column 
 
 
Figure 1.13.4: Schematic diagram of cell separation technique adapted from Biomagnetic 
research and technology Reviews (Zaiyed et al., 2003): Magnetic activated cell sorting. 
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1.13.5 SELECTIVE CYTOTOXICITY 
 
 
In the foregoing procedures, cells are isolated and purified before culture. In some 
instances this is not feasible. Instead, cultures can be enriched in specific cell types by 
culture conditions. Selective cytotoxicity is a method that allows selection by favouring the 
proliferation of one of the cell types in the mixture (Ham, 1984). The technique has been 
adopted from developmental neurotoxicity. Studies of the central and peripheral nervous 
systems have benefited greatly from the systematic application of the systems toxicology 
approach. The ability of certain compounds to have an adverse effect on structure or 
function, or physical agent that diminishes the ability of an organism to survive, reproduce 
or adapt to its environment creates a useful tool for studies of structure and function of the 
specific organ systems. Thus, as adapted for toxicology and referred to as systems 
toxicology, it involves the perturbation by chemicals and stressors by monitoring 
alterations in the culture environment (Figure 1.13.5).  
   
    
Incubation with mixed cell 
population in culture 
Target cells undergo apoptosis 
or deactivation while other cell 
types remain intact 
Selective drug 
 
 
Figure 1.13.5: Schematic diagram of cell separation technique adapted from Nano Letter 
articles (Quinti et al., 2006): selective cytotoxicity. 
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Hence, this approach requires the understanding of functional interactions between key 
components of cells and how they change with toxicant exposure (Waters et al., 2003).   
In tissue culture it has been demonstrated that specific use of toxicology systems resulted 
in apoptotic cell death of targeted cell populations. Some of the studies include those by 
Blennerhassett and Lourenssen, where scorpion venom was used to target neuronal cells in 
a mixed cell culture. This led to targeted neurotoxicity without disturbing neighboring cells 
(Blennerhassett & Lourenssen, 2000). Additionally, some toxicants are yet more specific to 
molecular components of the cell. One example is the antimitotic cytosine arabinoside that 
targets non-neuronal cells. Treatment with this toxicant has been shown to incorporate 
efficiently into the RNA-primed DNA fragments to discontinue DNA synthesis in cells 
(Harrington & Perrino, 1995). Limitations for this technique are that drug specifications 
must be accurate so that it specifically targets the proposed cell population. Furthermore, it 
only allows separation of one cell population at a time and like immunolabeling due to the 
drug specification required it is not available to all cell types.  
 
 
1.14 TECHNIQUES FOR INVESTIGATING THE SIGNALLING 
TRANSDUCTION PATHWAYS IN THE GASTROINTESTINAL 
TRACT 
 
1.14.1  BATH PERFUSED PREPARATIONS 
 
A variety of ‘in vitro’ methods are available for studying the signalling pathways 
mechanisms of intestinal motility. The most commonly used method for qualitative 
pharmacological studies ‘in vitro’ are the conventional bath-perfused preparations to study 
contractility of smooth muscle through identification of specific nerve firing during 
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contraction, their projections, their mediators and the transduction mechanisms used by 
their mediators (Furness, 2000).  The preparations are normally strips containing the whole 
musculature that are set up in an organ bath and connected to a strain gauge. The 
contraction is then recorded and contractile responses measured as agonists are added in 
increasing concentrations to obtain a complete concentration-effect curve. This can 
subsequently be used to normalise the responses recorded as a percentage of the maximal 
response to a full agonists, thus, giving information about the ability of various agonists to 
attain maximal responses. It also provides quantitative information about the affinity of the 
antagonist and the nature of its interaction with the receptor (Schild, 1969, Schild, 1975, 
Schild, 1997, Arunlakshana & Schild, 1997). The GI tissue strips, however, have a large 
population of intrinsic nerves, some of which may contribute in hidden modulation of 
responses, thus agonists may act in part by a releasing mediator either increasing or 
decreasing the potency of the response (Daniel et al., 2001). On the basis of this 
information, the relation of structure to function of smooth muscle cells within 
multicellular preparations has proven difficult to analyse owing to the variable interactions, 
electrical and mechanical between neighbouring cells and the intracellular matrix. 
As a result, new approaches investigating the force generated by single cells have been 
introduced (Bitar et al., 1984). 
 
1.14.2 COMPUTERISED CELL COUNTER  
 
The first methods reported for measurement of contraction and relaxation of isolated 
muscle cells were achieved through an estimate in the average of cell dimension of large 
population of cells. These included methods reported by Singer and Fay in which a 
computerised cell counter technique was used to obtain an estimate of change in cell width. 
The technique required the measurement of large numbers of cells in order to generate 
histograms on cell dimensions (Singer & Fay, 1977).  
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1.14.3 IMAGE-SPLITTING MICROMETRY  
 
Methods that followed computerised cell counter involved the use of image splitting 
micrometry to obtain estimates of change in length of cells in successive microscope fields 
in response to different drug. The cell suspension incubated with the test agent is measured 
for cell length by looking at initial and successive microscopic images and relative 
percentage decrease in cell length (Bitar & Makhlouf, 1982a). Both these methods were 
supported by micrographs and were proven to be accurate. However, it is important to note 
that validation of such methods implied measurement of large population of fixed cells. 
Furthermore, it limits the characterisation of specific kinetics and reversibility of response 
since only one concentration can be tested at a time.    
 
1.14.4 ELECTROPHYSIOLOGICAL STUDIES  
 
With the introduction of single cell electrophysiological studies of smooth muscle, this 
permitted the measurement of the kinetics and study of single and multiple ion channels in 
cells.  
These include the patch clamping technique that is used to measure ion current across the 
cell membrane. Current patch-clamp recording allows the detection and measurement of 
action potential in excitable cells. For these events to be captured the technique requires 
the use of an extremely fine hollow glass pipette held against the cell membrane by suction  
to achieve a seal between the glass pipette and the cell membrane. Recording of cell 
electrophysiology are then acquired by filling the interior of the pipette with solution to 
match the ionic salts in the bath solution. In this system pipette electrode measures changes 
in current in relation to a chloride coated earthing/reference wire (Benham et al., 1982, 
Benham et al., 1983) (Figure 1.14.1). Although this technique is very powerful and allows 
measurement of the current flowing through a single ion channel, if cells are perforated the 
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cell contents may be diluted, hence, producing recordings that do not reflect the entire cell 
activity (Hamil et al., 1981).  
 
 
Cells 
Micropipette 
Amplifier  
Earth/reference 
wire 
 
 
 Figure 1.14.1: Diagram illustrating the single cell patch-clamping procedure. Adapted 
from Addison Wesley Longman Inc. 
 
 
1.14.5 INTRACELLULAR CALCIUM MEASUREMENTS 
 
The introduction of calcium sensitive dyes was a result of intensive research into 
membrane depolarisation and its correlation with calcium release. Calcium was taken as an 
indicator to cells in response to a trigger, after it was established that calcium is released as 
long as the membrane depolarisation is maintained during contraction. In essence, cells are 
loaded with a stipulated dye concentration for a pre-determined time period. The cell 
preparation is subsequently loaded onto the coverslip on a set microscope stage and 
allowed to attach to the surface. Commercial instrumentation such as dynamic fluorescence 
digital imaging and laser confocal fluorescent microscope are then used for spatial 
mapping of calcium mobilisation in the different regions of single smooth muscle cells 
(Drummond et al., 2000).  The calibration of the fluorescence signals can be transformed 
into pseudocolour for easy mapping and visualisation of the concentration gradient across 
the entire area of the cell or in a focal area of interest. When a stimulus is induced the 
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contractile events can be monitored simultaneously in real time with a change in 
fluorescence ratio such that the changes of cytosolic calcium concentration can be related 
to the contractile events (Figure 1.14.2). 
Limitations to the technique may arise in data interpretation, as baseline of fluorescence 
signal tends to decrease with time due to photo-bleaching and other conditions (Daniel et 
al., 2001). 
 
 Low intensity High intensity 
 
Figure 1.14.2:  Diagrammatic illustration of intracellular calcium response of isolated rat 
glomerulus to selective agonist using fluorescence video microscopy and calcium indicator 
dye (Nitschke et al., 2000) 
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1.15 INTESTINAL RESTITUTION: PROGRESSION IN THE 
FABRICATION OF RESPONSIVE CELL CULTURE SURFACES 
 
Methods for studying the intrinsic properties of muscle in the GI tract has led to the 
dissociation and purification of smooth muscle from the intact intestine so that they could 
be easily manipulated ‘in vitro’. However, disengagement of cells from the extracellular 
architecture leads to phenotypic changes in culture and therefore impairs the ability of 
muscle cells to contract. 
As a result, it was observed that when attempting to create a representative model to 
investigate mechanical and biochemical controls of smooth muscle physiology as well as 
pathophysiology it is necessary to recreate the appropriate conditions.  Since most common 
attachment sites for mammalian cell is another similar cell or extracellular matrix, this 
indicates that normal tissue cells probe elasticity as they anchor and pull on their 
surroundings. These are materials that have elastic moduli unlike the commonly used glass 
or plastic surfaces. Thus, there is a need to develop cell culture substrates with mechanical 
properties mimicking those of the ‘in vivo’ environment. However, there have been 
enormous challenges over the selection of an appropriate substrate to embody the cell 
surroundings, mainly due to the dynamic relationship that exists between cells and the 
extracellular matrix. While many tools exist to manipulate the biochemical adhesiveness of 
experimental substrates, for example, the culturing of cells using laminin and collagen 
allow them to express muscle-specific contractile proteins (Thyberg & Hultgardh-Nilsson, 
1994). Fewer approaches have been successful towards the development of suitable 
substrates to study the mechanical forces of contraction. More recently with the 
introduction of soft materials such as polymerised hydrogels or silicone elastomers, this 
has allowed the study of force exerted by cells. Since these materials allow the control of 
mechanical compliance (Harris et al., 1980) when cells are seeded and attach appropriately 
to a compliant substrate, this creates local deformations to the substrate, which can 
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subsequently be used to calculate the force created by cells (Dembo & Wang, 1999). Thus, 
it is apparent that to develop functional models of muscle cells, substrates should be 
sufficiently strong to resist damage from the contracting cell population. Conversely, cell 
adhesion should be sufficient to permit attachment and generate tractional force for 
movement, yet not so adhesive as to inhibit capture of the contractile signals induced in 
response to selective drugs. 
Accomplishing both these criteria has proven challenging over the years because cells on 
soft substrates are not able to generate sufficient tractional force, conversely stiff substrates 
are less compliant to cytoskeleton-generated contractile forces (Peyton & Putnam, 2005).  
However, with the recent advances in understanding how the extracellular matrix affects 
cell function, it is clear that matrix compliance is an important controllable variable 
(Georges & Janmey, 2005). 
Thus, optimising the polymer substrate to mimic the extracellular matrix flexibility of the 
tissue appears to be the primary goal in establishing a responsive model of contractile cells.  
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1.16 THE AIM OF THE PRESENT STUDY  
 
The first aim of the present study was to pharmacologically investigate the role of 5-HT in 
the regulation of motility in the neonatal rat small intestine. The study focused on the “in 
vitro” measurement of changes in the tension following the exogenous addition of drugs 
using the traditional organ bath set ups.  
  
Secondly, the study aimed at developing cell culture models representative of the intact 
intestine. Such studies were designed to culture different layers of the intestine separately 
and/or in combination. This was sought to have cells disengaged from extracellular 
architecture of the intact intestine and into an environment that enabled an easy assess, 
control, and manipulation of the cells. Additionally, the study intended to assess the 
functionality of isolated single cells and compare the patterns of contraction to those 
observed in the intact intestinal preparations using the organ bath set up. Furthermore, the 
study also focused on the culturing of cells on different substrates to create a reproducible 
responsive model of contractile cells. 
 
 Having established a model of primary cell culture, the final aim was to exploit the model 
for investigation of the inflammatory response. The study focused on establishing the 
inflammatory response and then exploring the characteristics associated with smooth 
muscle phenotype, cell adhesion, proliferation, and immunological regulators. 
Furthermore, the effects of granisetron, a 5-HT3 receptor antagonist, L-NAME, a NO 
synthase inhibitor, and Chaga mushroom extract on inflammatory response were 
investigated.
 
 
 
 
 
 
 
 
 
 
 
CHAPTER TWO 
PHARMACOLOGICAL CHARACTERISATION OF 5-HT 
RECEPTORS IN THE RAT NEONATAL ILEUM 
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2.1 INTRODUCTION 
 
 
Since the discovery of 5-hydroxytryptamine (5-HT) in the 1930s, and subsequent 
extraction of 5-HT from the intestine in 1937 (Erspamer & Vialli, 1937), it has became 
clear that 5-HT is implicated in various GI physiological functions via interactions with 
multiple 5-HT receptors (Barnes & Sharp, 1999, Hoyer, 2002). Presently, fourteen 5-HT 
receptors including 5-HT1A-AF, 5-HT2A-2C, 5-HT3A-3C, 5-HT4, 5-HT5, 5-HT6, and 5-HT7 
have been identified (Hoyer et al., 1994, Hoyer et al., 2002).  Extensive research into the 5-
HT receptor families and their subtypes has led to the development of selective agonists 
and antagonist that are now used as valuable tools to study the role of each 5-HT receptor 
in GI function. Most importantly, 5-HT has also been associated with more complex 
pathophysiological activities in the GI tract such as emesis and diarrhoea. Preclinical 
studies also indicate therapeutic potentials for drugs acting on 5-HT receptors in the 
treatment of emesis (Sanger & Andrews, 2006), diarrhoea and visceral pain (Meerveld, 
2007). For instance, the application of 5-HT3 receptor antagonists such as ondansetron, 
granisetron, tropisetron, ramosetron, and alosetron have been shown to increase whole gut, 
small intestine, or colonic transit time in mice, rats, and guinea pigs, presumably by 
attenuating endogenous 5-HT through 5-HT3 receptors-mediated prokinetic activity 
(Clayton et al., 1999, Brown et al., 1993). Thus, 5-HT3 receptor antagonists have 
considerable value, not only as pharmacological tools but also as clinically potential 
therapeutics for nausea and vomiting (Sanger & Andrews, 2006), and diarrhoea 
predominant irritable bowel disease (IBS) sufferers (Camilleri et al., 2000).  However, it 
remains to determine which of the many actions of 5-HT might be of physiological 
significance to the neonates. One could argue that results obtained in the physiological 
studies of adults might be used to interpret those in the neonates. However, it has been well 
documented in the past that there may be great variations in the way the gut muscles from 
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different species respond to drugs (Gaddum & Picarelli, 1957). Variations were also 
reported in different GI regions from the same animal (Bennett & Fleshler, 1969). These 
variations are further compounded by the possibilities that responses to GI muscle might 
be influenced by the age of the animal.  
In the adults, GI motility is regulated by the enteric nervous system, which controls muscle 
contraction. Neurones in the gut can be directly coupled to smooth muscle or may affect 
the muscle cells via ICCs, which generate synchronised electrical slow waves that are 
thought to be the driving force of spontaneous motor activity in the smooth muscle 
(Thuneberg et al., 1982). In the embryos and neonates, the enteric neurones migrate 
principally from the vagal neural crest and colonise the gut (Epperlein et al., 1996). 
Smooth muscle maturation follows with the formation of circular and longitudinal muscles. 
Finally the ICCs network develop (Wallace & Burns, 2005). GI motility in the human 
neonate develops from a weak and disorganised motor activity into an organised cyclic 
pattern.  Thus, there is a clear pattern of maturation with the gestational age. The pattern is 
characterised by an increase in the contractility and frequency of contraction of intestinal 
smooth muscle cells associated with an increase in the degree of propagative activity. This 
eventual development of a cyclic pattern characterises intestinal motility in older infants 
and adults (Bisset et al., 1988, Vantrappen et al., 1977). 
In terms of enteric nervous system activity, it is apparent that although the gut and the 
enteric nerves must be functioning at the time of birth to cope with feeding, both the gut 
and the enteric nervous system enlarge as a function of postnatal maturation (Phillips & 
Powley, 2001). In mice it has been demonstrated that the development of new neurones 
continues at least through to postnatal day 21 (Pharm et al, 1991). The corresponding age 
has not been fully documented in humans, although, it has been recently demonstrated that 
the postnatal gut contains stem cells (Kruger et al., 2002). This evidence suggests that there 
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is a possibility of new neurones being added to the enteric nervous system during postnatal 
life. 
Although, many studies have been reported on the role of 5-HT receptor family in the adult 
intestine of various species, little is known about 5-HT receptor distribution and activity in 
neonatal models. Moreover, due to the relative immaturity of the motor function in 
neonates and the scant understanding about the relationship between gestational age and 
motor development, one should investigate the participation of 5-HT in the modulation of 
GI motility in the neonates. A better understanding of the role of 5-HT and its associated 
receptors in the physiology of the GI tract in neonates will certainly help to identify the 5-
HT selective compounds that target specific 5-HT receptors in the neonatal preparations. 
The correct analysis of drug actions provides insight into normal and pathological systems 
that control motility in the GI tract and may provide therapeutic candidates that in the 
future may prove useful in the treatment of functional GI diseases in neonates.  
 
2.2 AIM 
 
 
The present study aimed at the pharmacological characterisation of the 5-HT receptors that 
may be involved in the regulation of motility in the neonatal rat small intestine. The study 
focused on the ‘in vitro’ measurement of changes in the tension of the intact intestinal 
segments taken from rats to exogenously added acetylcholine (ACh), 5-HT, and 5-HT 
receptor agonists in the absence and presence of different antagonists such as atropine or 5-
HT related antagonists. 
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2.3 METHODS  
 
 
2.3.1 ANIMAL AND HOUSING CONDITIONS  
 
 
 
The experiments were carried out on adult (4 months old) and neonatal (5-8 days old) 
Sprague-Dawley rats (Bradford University strain). Adult rats were housed in cages 
(385Wx590Lx200HMM) supplied with food and water ad libitum and maintained at 
humidity between 45-50% at 24°C and illuminated between 21.00 and 07.00. The cage 
floors were covered with sawdust and cleaned twice a week and food and water checked 
every day. Female rats were mated and delivered pups. After delivery the necessary 
number of pups was separated and experiments were carried out within 30-60 minutes 
following separation from the mother.  
 
2.3.2 PREPARATION OF ISOLATED TISSUES 
 
Rats were killed by dislocation of the neck. The whole intestine was removed and 
immediately placed in freshly prepared Krebs solution (composition mM: NaCl 118, KCl 
4.7, KH2PO4 1.2, MgSO4 1.2, CaCl2 2.5, NaHCO3 25 and glucose 10) and gassed with 
95% O2 and 5% CO2 at room temperature. The mesentery fatty tissue was removed and 
intestine emptied of its contents by flushing Krebs solution gently through the intestine 
using a 10ml syringe. The length of the intestine was approximately 15cm in the neonatal 
rats and 70cm in the adult rat in its contracted form. A segment of approximately 6cm was 
taken 1-7cm proximal to the Ileocaecal junction. The segment was then cut into four pieces 
of approximately 1.5cm each segment. The preparations were alternated between their use 
as a control or treatment in paired experiments. Each segment was connected in a 20ml 
water-jacketed organ bath (Figure 2.1). The Krebs solution was maintained at a 
temperature of 37°C ± 0.5°C and gassed continuously with a mixture of 95% O2 and 5% 
CO2. The free end of the isolated tissue was connected to an isometric transducer 
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(Dynamometer UFI) and the tension adjusted to 0.40g. Each tissue was left to equilibrate 
in the presence or absence of antagonist for 1h, and washed every 20 min. The resting 
tension was readjusted to 0.40g when required. Changes in the tension were recorded by 
using Power Lab Chart V4.0.4. 
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Figure 2.3.1: Photograph of the equipment used to measure the tension changes in the 
tissues obtained from the intestine of rat neonates. 
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B. Grass force displacement transducer 
C. Tissue holder 
D. Water-jacket bath 
E. Computer connected to Power Lab recording system 
F. Power Lab recording system 
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2.3.3 APPLICATION OF DRUGS 
 
 
Drugs were added to the organ bath in single doses rather than cumulatively (Figure 2.3.2). 
The volumes of the drugs did not exceed 1.5% of the bath volume. The contact time 
between tissue and the agonist was 1 min, which was followed by two washings with 1 
min in between. Agonists were injected every 15 min and when the influence of 
antagonists on the responses to an agonist was studied, tissues were bathed in the constant 
presence of the antagonist. 
 
 
Isometric tension 
transducer 
Hook connecting free 
end of tissue preparation 
to the transducer 
Cotton thread 
Krebs’ solution at 37°C 
Doses of the drug 
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automatic pipette 
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Isolated intestinal 
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95%O2/5%CO2 
gas mixture line  
 
Figure 2.3.2: Image illustration of a single tissue bath apparatus, showing on attachment 
of an intestinal preparation isolated from the rat neonate. 
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Drugs were used freshly or prepared from their frozen stock solution every day. 
Throughout the present work concentrations of the drug refers to the final bath 
concentration (FBC). The effects of the agonists in the presence or absence of antagonists 
was expressed as the absolute value in grams tension, which were obtained after each dose 
application. In each comparison ‘n’ represents the number of animals used for the 
particular experiment. Only one concentration of the antagonist was used in any one tissue 
unless otherwise stated. 
 
2.3.4 EXPERIMENTAL DESIGN ‘PAIRED DESIGNED’ 
 
 
Segments were taken from the ileum of rat neonates and were set up as described in section 
2.3.2. After 1h equilibrium time, non-cumulative dose response curves to ACh at 
concentration range of 3nM to 1mM and 5-HT at the concentration range of 3nM to 
0.1mM were constructed. In such experiments, two adjacent segments from each region of 
the intestine were taken 1-7cm proximal to the ileocaecal junction, one served as the 
control and the other as the test tissue. Results in paired tissues were comparable. 
Therefore, a paired experimental design was used for subsequent experiments (Figure 
2.4.1a-b). 
 
 
 2.3.5 ESTABLISHMENT OF CONCENTRATION – RESPONSE CURVES 
TO ACh AND 5-HT IN TISSUES TAKEN FROM THE ILEUM OF RAT 
NEONATES  
 
Tissues were set up and separate non-cumulative dose response curves to ACh (3nM - 
1mM) and 5-HT (3nM – 0.1mM) were constructed.  
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2.3.6 THE AFFECTS OF 5-HT, 5-CT AND 8-OH-DPAT IN TISSUES TAKEN 
FROM THE ILEUM OF RAT NEONATES 
 
Experiments were carried out to compare the responses induced by exogenous applications 
of 5-HT and 5-HT receptor agonists. In such experiments, concentration response curves to 
5-HT (10nM – 0.1mM), 5-HT1A receptor agonist, 8-OH-DPAT (10nM – 0.1mM), and 5-
HT1A/7 receptors agonist, 5-CT (10nM – 0.1mM) were established in segments taken from 
the neonatal rat ileum. 
 
2.3.7 THE EFFECT OF ATROPINE ON 5-HT INDUCED CONTRACTILE 
RESPONSES IN THE ADULT AND NEONATAL RAT SMALL INTESTINE 
 
Experiments were carried out to investigate the effect of 5-HT (3nM – 1mM) in the 
absence and presence of atropine (0.1μM) in the neonatal rat ileum.  
In separate experiments, using the adult rat ileum, segments were exposed to 5-HT (3nM – 
1mM) in the absence and presence of atropine  (0.1μM). 
 
 
2.3.8 THE EFFECTS OF 5-HT RECEPTOR ANTAGONISTS ON 5-HT-
INDUCED CONTRACTILE RESPONSES IN THE ISOLATED NEONATAL 
RAT ILEUM 
 
Using the paired experimental design, tissues were set up and the concentration-response 
curves to 5-HT (30nM – 1mM) in the absence and presence of a 5-HT2 receptor antagonist, 
ritanserin (0.1μM), a 5-HT3 receptor antagonist, granisetron (0.1μM), a 5-HT1/2/5-7 
receptors antagonist, methysergide (0.1μM), a 5-HT4 receptor antagonist, RS 23597-190 
Hydrochloride (0.1μM), a 5-HT7 receptor antagonist, SB269970A (0.1μM), and a 
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combination of ritanserin (0.1μM), granisetron (0.1μM), RS 23597-190 hydrochloride 
(0.1μM), plus SB269970A (0.1μM) were investigated.  
 
2.3.9 THE AFFECTS OF WAY 100635 AND SB269970A ON RESPONSES 
TO 5-HT, 8-OH-DPAT, 5-CT IN TISSUES TAKEN FROM ILEUM OF RAT 
NEONATES 
 
Segments were set up and the effects of 5-HT (30nM – 1mM) in the absence and presence 
of a selective 5-HT1A receptor antagonists, WAY 100635 (0.1μM) was investigated in the 
segments taken from the neonatal rat ileum. 
In separate experiments, segments were set up and the effects of 8-OH-DPAT, a 5-HT1A 
receptor agonist (10nM – 0.1mM) in the absence and presence of WAY 100635 (0.1μM) 
were investigated. 
In another series of experiments the effects of 5-CT, a 5-HT receptor agonist (10nM –
0.1mM) were investigated in the absence and presence of WAY 100635 (0.1μM) and 
SB269970A, a selective 5-HT7 receptor antagonists (0.1μM). 
 
2.3.10 ANALYSIS OF RESULTS 
 
 
Changes in g tension were expressed as a mean of the absolute values and their standard 
error of the mean (mean ± s.e.mean). The potency of the agonists were expressed as the 
absolute value  (g) of the tension originated. 
The significance in differences between control and the test responses were determined 
using the Student’s paired t-test, where *p<0.05, **p<0.01, ***p<0.001 were taken as 
significant.  
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Table 2.1 Drugs used in the present study, their solvent and suppliers. 
Drugs 
 
 
Solvents Suppliers 
Acetylcholine 
 
Distilled water Sigma 
Atropine sulphate 
 
Distilled water Sigma 
Granisetron HCL 2H20 
 
Distilled water Glaxo smithkline 
Methysergide hydrogen maleate 
 
Distilled water Sigma 
Ritanserin 
 
Methanol Sigma 
RS 23597-190 Hydrochloride 
 
Distilled water Tocris 
SB 269970 (R)-3-[2-(2-(4-methyl-1-piperidinyl) 
ethyl] pyrolidine-1-sulphonyl) phenol) 
 
Distilled water Glaxo Smithkline 
WAY-100365 maleate  
(N-[2-[4-(2-methoxyphenyl)-1- 
piperaziny] ethyl]-N- (2-pyridinyl) 
cyclohexanecarboxamiidetrihydrochloride) 
 
Distilled water Sigma 
5-CT (5-Carboxamidotryptamine) 
 
Distilled water Tocris 
5-Hydroxytryptamine 
 
Distilled water Sigma 
8-HO-DPAT 
 
Distilled water Tocris 
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2.4 RESULTS 
 
 
2.4.1 GENERAL OBSERVATIONS 
 
The isolated intestine of the adult rat showed spontaneous activity under a basal 1g tension 
and for the neonatal rat this was achieved under a basal 0.40g tension. The magnitude of 
contraction oscillated between the 0.1-0.8g in the adult rat and 0.01-0.05g in the neonatal 
rat. The rate of spontaneous activity was approximately 24-38 cycles per min in the adult 
intestine and 27-31 cycles in the neonatal intestine. 
 
2.4.2 ESTABLISHING THE EXPERIMENTAL DESIGN 
 
 
Four segments were taken 1-7cm proximal to the ileocaecal junction. The concentration-
response curves to 5-HT and ACh separately overlapped in all four segments (Figure 
2.4.1a-b). It was decided to use the paired experimental design for the subsequent 
experiments. In such experiments two segments were taken as control and the other two as 
test tissues.  
 
2.4.3 THE EFFECTS OF ACh AND 5-HT INDUCED CONTRACTION IN 
THE NEONATAL RAT SMALL INTESTINE 
 
The non-cumulative addition of ACh at concentration range of 3nM-1mM and 5-HT at 
concentration range of 3nM-0.1mM produced concentration dependent contractions in all 
segments taken from the ileum of the neonatal rat intestine. The administration of ACh 
induced a rapid sustained contraction. A representative tracing is shown in Figure 2.4.2. 
The maximum tension of 0.26g±0.004 induced by ACh was observed at 10 μM. The EC50 
values for ACh was 1.3μM ±0.21. 
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The contraction induced by 5-HT developed slowly and was followed by a contraction 
maintained at a slightly lower level. A representative tracing is shown in Figure 2.4.3. The 
maximum tension of 0.185g±0.004 induced by 5-HT was observed at 10μM. The EC50 
values for 5-HT was 1.8μM ±0.4. 
No relaxation response occurred following the administration of ACh or 5-HT, in all 
tissues examined. 
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Figure 2.4.1: The contractile responses induced by ACh (A) and 5-HT (B) in segments taken 
from the neonatal rat ileum. Segments 1, 2, 3, 4 were taken from 6-4.5cm; 4.5-3.0cm; 3.0-
1.5cm; and 1.5-0cm proximal to the ileocaeal junction, respectively. Each point represents 
the mean±s.e.mean; n=4.  
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Figure 2.4.2: Representative tracings showing the contractile responses induced by increasing 
concentrations of ACh in the isolated ileum of the rat neonates. 
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Figure 2.4.3: Representative tracings showing the contractile responses induced by 
increasing concentrations of 5-HT in the isolated ileum of the rat neonates. 
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2.4.4 COMPARISON OF THE EFFECT OF 5-HT ON THE ILEAL TISSUES 
TAKEN FROM ADULT AND NEONATAL RAT SMALL INTESTINE 
 
The non-cumulative addition of 5-HT (3nM –1mM) in segments taken from the rat 
neonatal intestine and (3nM-1mM) in the rat adult intestine induced a concentration-
dependent contraction response in all segments examined. The maximum tension produced 
by 5-HT in the adult intestine was in the range of 1.2-4.4g. However, in segments taken 
from the neonatal intestine, application of 5-HT induced contractile responses ranged from 
0.11-0.23g. The EC50 values for 5-HT in the adult intestine was 7.9μM±0.96 and 1.8μM 
±0.4 in the neonatal intestine (Figure 2.4.4a-b). 
 
2.4.5 THE EFFECTS OF 5-HT, 5-CT, AND 8-OH-DPAT ON SEGMENTS 
TAKEN FROM THE NEONATAL RAT INTESTINE 
 
Non-cumulative application of 5-HT and 5-CT at concentration ranges of 10nM to 0.1mM 
produced concentration dependent contractions in segments taken from the ileum of the 
neonatal rat intestine. The contractile responses induced by 5-CT were significantly 
(p<0.05-0.01) smaller compared to contractile responses induced by the exogenous 
application of 5-HT (Figure 2.4.5a). The non-cumulative application of 8-OH-DPAT at 
concentrations range of 10nM to 0.1mM produced hardly any contractile responses in the 
segments taken from the ileum of the neonatal rat intestine (Figure 2.4.5b). 
The maximum tension of 0.074g±0.010 induced by 5-CT was observed at 30μM compared 
to 0.19g±0.024 induced by 5-HT at 10μM. 
No relaxation response occurred following the administration of 5-CT.  
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Figure 2.2.4: The contractile responses induced by 5-HT (3nM-1mM) in segments taken from 
the adult (A) and neonatal (B) rat ileum. Each point represents the mean±s.e.mean; n=4. 
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Figure 2.4.5: Comparison between the contractile responses induced by 5-HT (10nM-
0.1mM) and to 5-HT1A/7 receptor agonists 5-CT (10nM - 0.1mM) (A) and 5-HT1A receptor 
agonist 8-OH-DPAT (10nM - 0.1Mm) (B) in segments taken from the ileum of rat neonates. 
Each point represents the mean±s.e.mean; n=4. *p<0.05, **p<0.01, ***p<0.001 taken as a 
significant difference compared to the control values. 
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2.4.6 THE ABILITY OF ATROPINE TO MODIFY 5-HT INDUCED 
CONTRACTION IN THE ADULT AND NEONATAL RAT SMALL 
INTESTINE 
 
Tissues were set up as previously described in section 2.1.2 and contraction response 
curves to the non-cumulative addition of 5-HT (3nM-1Mm) were constructed in the 
absence and presence of atropine (0.1μM). In all experiments tissues were exposed to a 
single concentration of the antagonist. Previous experiments revealed that the 
concentrations chosen for the antagonists were effective in blocking related receptors 
(Obreshkove, 1941). Results presented in Figure 2.4.6 show that, in tissues taken from 
ileum of adult rats, atropine at 0.1μM reduced the contraction induced by 5-HT at 
concentrations higher than 10μM, however, these observations were not significantly 
different as compared to the control tissues. However, in tissues taken from the ileum of rat 
neonates, atropine (0.1μM) significantly (p<0.05-p<0.001) reduced the contraction induced 
by 5-HT at ≥ 10nM concentrations. Representative tracings are shown in Figures 2.4.7 and 
2.4.8. 
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Figure 2.4.6: The contractile responses induced by 5-HT (3nM-1mM) in segments 
taken from the adult (A) and neonate (B) rat ileum in the absence and presence of a 
selective muscarinic receptor antagonist, atropine at 0.1μM. Each point represents the 
mean±s.e.mean; n=4. *p<0.05, **p<0.01, ***p<0.001 taken as a significant 
difference compared to the control values. 
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Figure 2.4.7: Representative tracings showing the contractile responses induced by 
increasing concentrations of 5-HT in the adult ileum in the absence (A) and in presence of 
0.1μM atropine (B). 
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Figure 2.4.8: Representative tracings showing the contractile responses induced by 
increasing concentrations of 5-HT in segments taken from the ileum of rat neonates in the 
absence (A) and in presence of 0.1μM atropine (B). 
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2.2.7 THE ABILITY OF METHYSERGIDE, RITANSERIN, GRANISETRON 
AND RS 23597 190 TO MODIFY 5HT-INDUCED CONTRACTION IN 
NEONATAL RAT SMALL INTESTINE 
 
In segments taken from the ileum of rat neonates, separate application of methysergide at 
0.1μM and ritanserin at 0.1μM significantly (p<0.05-p<0.01) reduced the contraction 
induced by 5-HT at concentrations lower than 3μM (Figure 2.4.9a-b). The application of 
the selective 5-HT4 receptor antagonist, RS 23597 190 at 0.1μM significantly (p<0.05-
p<0.01) reduced the contraction induced by 5-HT at concentrations lower than 1μM, and 
also at a concentration of 100μM 5-HT (p<0.05) (Figure 2.4.9d). In the presence of 
methysergide (0.1μM), ritanserin (0.1μM), or RS 23597 190 hydrochloride (0.1μM), 
higher doses of 5-HT induced contractions, where the maximum responses were 
comparable to those obtained in the absence of the antagonists. The administration of 
granisetron at 0.1μM significantly (p<0.01-p<0.001) reduced the contraction induced by 5-
HT at concentrations higher than 10μM (Figure 2.4.9c).  
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Figure 2.4.9: The contractile responses induced by 5-HT (30nM-1mM) in the neonatal rat 
small intestine in absence (control) and presence of selective 5-HT receptor antagonists 
0.1μM methysergide (A), 0.1μM ritanserin (B), 0.1μM granisetron (C), 0.1μM RS 23597 190 
hydrochloride (D).  Each point represents the mean±s.e.mean; n=4. *p<0.05, **p<0.01, 
***p<0.001 taken as a significant difference compared to the control values. 
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2.2.8 THE ABILITY OF SB269970A ALONE AND IN THE PRESENCE OF 
A COMBINATION OF RITANSERIN, AND GRANISETRON, PLUS RS 
23597 190 TO MODIFY 5HT-INDUCED CONTRACTIONS IN THE 
NEONATAL RAT SMALL INTESTINE 
 
The administration of a combination of ritanserin, and granisetron, plus RS 23597 190 at 
0.1μM significantly (p<0.01-p<0.001) reduced the contractions induced by 5-HT at 
concentrations higher than 1μM. The contractile responses were nearly abolished, with 
some possible spontaneous activity remaining. 
 The administration of a 5-HT7 receptor antagonist, SB267790A alone at 0.1μM failed to 
significantly modify contractions induced by 5-HT in all segments taken from the terminal 
regions of the ileum. The contractions to 5-HT were comparable to those in control tissues 
(Figure 2.4.10). Furthermore, addition of SB267790A at 0.1μM to a combination of 
ritanserin, and granisetron, plus RS 23597 190 at 0.1μM did not further antagonise 5-HT 
induced responses in the segments taken from the neonatal rat ileum (Figure 2.4.10). 
 
2.2.9 THE ABILITY OF WAY 100635 AND SB269970A TO MODIFY 5-HT, 
8-OH-DPAT, 5-CT-INDUCED RESPONSES IN TISSUES TAKEN FROM 
ILEUM OF RAT NEONATES 
 
In segments taken from the ileum of rat neonates, separate application of WAY 100635 at 
0.1μM failed to reduce the contractile responses induced by 5-HT (Figure 2.4.11a) 
Similarly, the separate application of WAY 100635 and SB267790A at 0.1μM failed to 
influence the contractile responses induced by 5-CT (Figure 2.4.11b). Applications of 8-
OH-DPAT in the presence of WAY 100635 (1μM) induced responses comparable to those 
of 8-OH-DPAT when applied alone (Figure 2.4.11c). 
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 Figure 2.4.10: The contractile responses induced by 5-HT (30nM-1mM) alone 
and in presence of 0.1μM SB269970A, a combination of 0.1μM 
ritanserin/granisetron/RS23597 190, and a combination of 0.1μM 
ritanserin/granisetron/RS23597 plus SB267790A in the segments taken from the 
ileum of rat neonates. Each point represents the mean±s.e.mean; n=4. *p<0.05, 
**p<0.01, ***p<0.001 taken as a significant difference compared to the control 
values. 
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Figure 2.4.11: Contractile responses induced by 5-HT (30nM-1Mm) in the absence and 
presence of WAY 100635 0.1μM (A). Contractile responses induced by 5-HT (10nM-0.1Mm) 
and the comparison between contractile responses induced by 5-CT (10nM - 0.1mM), and 8-
OH-DPAT (10nM - 0.1mM) in the absence and presence of WAY 100635 and SB 267790A 
0.1μM (B, C) in segments taken from the ileum of rat neonates. Each point represents the 
mean±s.e.mean; n=4. *p<0.05, **p<0.01, ***p<0.001 taken as a significant difference 
compared to the control values.
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2.5 DISCUSSION 
 
In the present studies attempts were made to investigate the involvement of 5-HT receptor 
subtypes mediating contractile responses in the neonatal rat small intestine.  
The GI tract is a complex and highly organised system that regulates and coordinates the 
absorption, secretion, sensation, and motility of gut contents. This is achievable through a 
network of nerves embedded into the walls of the digestive tube (Gershon & Tack, 2007). 
The ENS consists of the myenteric and submucosal plexus and a complex network of 
intrinsic and extrinsic afferent neurones, ascending and descending interneurones, 
excitatory and inhibitory motor neurones, which interact with the longitudinal and circular 
smooth muscle and mucosal endocrine cells. Additionally, the myenteric motor neurones 
innervate smooth muscle via the ICCs and regulate mechanical activity (Gershon, 2004, 
Gershon & Tack, 2007). 
It has been well reported that the main source of 5-HT is in the gut, more precisely in the 
enterochromaffin cells, where it is synthesised and stored. 5-HT can be released into the 
gut lumen as a reaction to pressure and nervous or alimentary stimuli. As a result it acts on 
5-HT receptors located on smooth muscle, enterocytes, nerves, ICCs through their distinct 
receptor subtypes to induce muscle contraction or relaxation (Hannon & Hoyer, 2002, 
Gershon & Tack, 2007). Enterocytes, in turn express the serotonin reuptake transporter 
(SERT), which plays a critical role in terminating 5-HT (Ramamoorthy et al., 1993) and 
ensuring that 5-HT mediated toxicity and receptor desensitisation that are usually observed 
as consequences of maintained agonist exposure, are avoided (Chen et al., 1998, Camilleri 
et al., 2007).  
Therefore, the coordinated movement of food along the GI tract is dependent on 5-HT-
mediated regulation of smooth muscle tone, peristalsis, mucosal secretion, and visceral 
perception (Baker, 2005, Hansen, 1997, Jin et al., 1999) via regulated signalling with the 
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intrinsic enteric and the extrinsic afferent neurones, the ICCs, smooth muscle cells, and 
enterocytes (Gershon & Tack, 2007, Read & Gwee, 1994, Wouters et al., 2007). 
The involvement of 5-HT-receptor subtypes in 5-HT-induced intestinal contraction has 
been well examined in the adult guinea pigs (Costa & Furness, 1979, Woollard et al., 
1994). This involvement has been less extensively investigated in the adult rat isolated 
intestine. There is evidence, however, that species difference exists in the involvement of 
5-HT-receptor subtypes in intestinal motility. Experimental evidence demonstrated that the 
5-HT induced contraction in the ferret, piglet and rat ileum were mediated by the activation 
of different 5-HT receptors. 5-HT-induced contraction in the ferret ileum was mediated by 
the activation of 5-HT1 on smooth muscle cells and ACh release through the activation of 
5-HT3 receptors. Previous studies have also shown that, in the piglet ileum, the 5-HT-
induced contractions were mediated by the release of neurotransmitters other than ACh via 
5-HT1 receptors. The 5-HT induced contraction in the rat ileum was evoked by the 
activation of 5-HT1 and 5-HT2 receptors located on the muscle cells (Yamano et al., 1997). 
Recent studies have indicated significant differences in the 5-HT-induced contraction 
amongst adult and neonates (Bian et al., 2007). Evidence supporting these arose in studies 
comparing 5-HT disposition in the intestinal mucosa of neonatal and adult guinea pigs. The 
results revealed that although there were no differences in 5-HT content between neonates 
and adults, the enterochromaffin cells where 5-HT is stored, were found in the crypts in 
neonatal and along the villi in adults intestinal segments. As a result 5-HT expression is 
low in neonates, and this is associated with high levels of free mucosal 5-HT and reduced 
metabolism (Bian et al., 2007). Therefore, due to clear physiological differences related to 
5-HT distribution during GI tract postnatal maturation, the importance of experimental 
pharmacology is fundamental to identify the site and mode of action of 5-HT signalling in 
the control of intestinal motor reflexes in neonates.  
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Initial experiments focused on the comparative investigation of the involvement of 
cholinergic pathways in the 5-HT-induced contraction in the adult and neonatal rat 
intestine. In the present study the administration of 5-HT induced contractile responses, 
which were sensitive to antagonism by atropine in segments taken from the neonatal rat 
intestine. However, the application of atropine failed to significantly modify the contractile 
response to 5-HT in the adult rat small intestine. This finding correlates with previous 
studies that demonstrated that contractile response to 5-HT is insensitive to antagonism by 
atropine in the isolated rat ileum and colon (Sakai, 1979, Lu et al., 1995). However, pre-
treatment with atropine of the neonatal rat ileum preparations significantly reduced the 
contractile response induced by 5-HT. The antagonistic action of atropine was 
insurmountable, depressing the maximum response to 5-HT. Therefore, the effect of 
atropine on neonatal preparations implies that intestinal contraction induced by 
exogenously applied 5-HT is partially cholinergically mediated since atropine is a highly 
selective cholinergic receptor antagonist (Ambache, 1955 ). The present data is in line with 
human studies by Prins et al., where it was demonstrated that 5-HT4 receptors on 
cholinergic neurones facilitate contractility, partially through the release of ACh (Prins et 
al., 2000). Moreover, studies examining 5-HT receptors mediating contractile responses 
and ACh release in the guinea-pig ileum, have clearly demonstrated that evoked 
contraction through ACh release are mediated via 5-HT3 receptor activation (Fox & 
Morton, 1990).  
In more recent studies investigating the physiological role of 5-HT3 receptors, it was 
confirmed that 5-HT3 receptors activation followed by rapid depolarisation causes a rapid 
rise in cytosolic calcium concentration, as well as, modulation of various neurotransmitters 
including ACh leading to muscle contraction (Greenshow & Silverstone, 1997).  Thus, 
there is evidence that 5-HT receptor activation produce an ACh-mediated contraction. In 
the present study, atropine caused significant reduction of the 5-HT-induced contractions 
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in segments taken from the ileum of rat neonates, however, in adult preparations atropine 
only caused a slight reduction to 5-HT-induced contractions, which did not achieve 
significance. This was an interesting observation and raised questions as to why the ileum 
loses its sensitivity to atropine as the animal ages. It is possible that other systems 
dominate and may mask the cholinergic involvement in mediating a response to 5-HT. It is 
also possible that the involvements of some systems or receptors are diminished as the 
animal ages. Indeed recent studies have shown the involvement of 5-HT4 in the enteric 
neuronal survival to be age-dependent (Gershon & Liu, 2007). Such studies showed that 
the number of enteric neurones in the gut increase in the postnatal life, reaching a peak and 
then stabilising. Aging subsequently is associated with a postpeak decline, hence, fewer 
neurones than in the young mature GI tract. These findings revealed that 5-HT4 receptor 
partial agonists such as tagaserod increase the number of neurones in cultured populations, 
therefore enhancing cell survival or increasing differentiation of neurones from precursors, 
or both. The ability of 5-HT4 agonists to promote enteric neurogenesis from precursors ‘in 
vitro’ supports that 5-HT4 receptors when activated may also promote the development of 
new enteric neurones from the stem cells that have been reported to be present in the young 
gut (Gershon & Liu, 2007). This may suggest the nomination of other mechanisms in 
mediating the responses to 5-HT as animals mature.  
Following the above observations, experiments were designed to characterise the 5-HT 
receptors present in the 5-HT-induced contraction in the intestine of rat neonates. In the 
presence of methysergide the contractile responses to 5-HT were significantly reduced.  
The antagonistic action of methysergide (pA2 8.12±0.14) in the neonatal isolated intestine 
was surmountable, with no alteration of the maximum response induced by exogenously 
applied 5-HT. Methysergide has been shown to be an antagonist of 5-HT2A (pA2 7.1), 5-
HT2B (7.1-8.2) and 5-HT2C receptors (pA2 8.9), but also believed to act as a weak agonist at 
5-HT1D receptors (pEC50 7.0). It also has a moderate affinity at 5-HT1F  (pA2 7.5), and 5-
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HT5–7 receptors (pA2~7.0) (Briejer et al., 1997, Routsalainen, 2003). In previous 
experiments performed in the isolated adult rat ileum, the contractile responses to 5-HT 
were sensitive to methysergide (Yamano et al., 1997, Javid & Naylor, 1998) and the 
surmountable antagonistic action correlated to those observed in the neonatal intestine in 
the present studies.   
In separate experiments the effect of ritanserin, a potent 5-HT2 receptors antagonist were 
performed. Ritanserin (pA2 7.99±0.32) demonstrated similar patterns of the antagonistic 
action compared to those of methysergide (pA2 8.12.±0.14). Ritanserin displayed 
surmountable antagonistic activity, with no significant difference of the maximum 
response induced by 5-HT as compared to control values.  In line with these observations, 
studies investigating the effect of ketanserin (5-HT2A receptor antagonist) in the adult rat 
distal ileum (Yamano et al., 1997) equally showed inhibitory effects of ketanserin on the 5-
HT-induced contractions. The 5-HT2 receptor family comprises of the 5-HT2A, 5-HT2B and 
5-HT2C receptor subtypes. There is no evidence for a functional role of 5-HT2C in the GI 
tract physiology, whereas 5-HT2A (Leysen, 2004) and 5-HT2B (Borman et al., 2002) 
receptor subtypes have been localised in longitudinal smooth muscle cells and to a lesser 
extent in the myenteric neurones and circular smooth muscle cells. Moreover, 5-HT2B is 
also expressed on ICCs in the human and mouse intestine (Wouters et al., 2007). 
 In the present study, the antagonism afforded by methysergide and ritanserin to the 
contractile responses, suggests the involvement of 5-HT2 receptors in mediating 5-HT 
responses in the segments taken from the neonatal rat ileum. 
 
 
The involvement of 5-HT3 receptors in the 5-HT induced contraction was investigated in 
presence of the selective 5-HT3 receptors antagonist granisetron (Tamura et al., 1996). The 
antagonist action of granisetron on the neonatal isolated intestine was insurmountable, with 
a significant depression of the maximum response to 5-HT. Previous studies investigating 
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the effect of 5HT3 receptors in the 5-HT-induced contraction in the adult rat ileum reported 
no influence of 5-HT3 receptors (Yamano et al., 1997). 5-HT3 receptors are believed to be 
located in the enteric neurones of the GI tract and are implicated in the control of motility 
and secretion throughout the entire GI tract (Hoyer et al., 1994, DePonti & Tonini, 2001). 
The pharmacology data acquired from the present study on the isolated neonatal intestine 
suggests the involvement of 5-HT3 receptors in the contractile response elicited by higher 
concentrations of 5-HT. 
 
Further experiments using RS 23597 190 hydrochloride, a selective 5-HT4 receptor 
antagonist (Bonhaus et al., 1994) revealed a surmountable antagonistic action (pA2 
7.9±0.35) in the neonatal isolated intestine, with no alteration of the maximum response 
induced by exogenously applied 5-HT. However, previous studies revealed that the pre-
treatment with 5-HT4 receptor antagonists (GR113808) in the adult rat ileum failed to 
influence the 5-HT-induded contractions. In fact, GR113808 enhanced contractile response 
elicited by 5-HT (Yamano et al., 1997).  In the GI tract, 5-HT receptors are located on the 
myenteric neurones and also on smooth muscle cells. In the enteric nervous system, the 
presence of 5-HT4 receptors has been demonstrated on several functionally distinct types 
of neurones, including intrinsic primary afferent neurones, ascending 
cholinergic/tachykinergic excitatory pathways and descending non-adrenergic and, non-
cholinergic inhibitory pathways (Foxx-Orenstein et al., 1996). Activation of the 5-HT4 
receptors is associated with the release of transmitters, where the excitatory responses 
appear to be mediated indirectly via facilitatory cholinergic or non-cholinergic 
transmission, whereas the inhibitory responses are caused by direct smooth muscle 
relaxation (Wouters et al., 2007). Thus, it is apparent that 5-HT4 receptors mediate both 
inhibition and activation of smooth muscle involve myogenic as well as neuronal 
mechanisms. In the present studies, pre-treatment with RS 23597 190, significantly 
reduced the contraction induced by 5-HT. The present results suggest the likely 
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involvement of 5-HT4-receptors in mediating contraction induced by 5-HT in the ileum 
taken from neonatal GI tract.  
In summary, there is apparent involvement of 5-HT2 and 5-HT4 receptors being activated 
at lower concentrations and 5-HT3 being activated at higher concentrations of 5-HT-
induced contraction in ileal segments taken from rat neonates.  Therefore, subsequent 
experiments were designed to investigate whether the combined antagonism of all three 
receptors on the isolated neonatal intestine would result in complete abolition of the 
contraction elicited by exogenously added 5-HT. The results revealed that the combination 
of methysergide and granisetron plus RS 23597 190 greatly diminished the contractile 
responses elicited 5-HT administration on the neonatal isolated intestine, with hardly any 
responses remaining. These observations provide strong evidence that the 5-HT induced 
contractions in the ileum of rat neonates are mediated through 5-HT2, 5-HT3, and 5-HT4 
receptor subtypes.  
 
Nonetheless, additional experiments were designed to investigate the possible involvement 
of additional 5-HT receptor subtypes known to be present in the GI tract. These include 5-
HT1A and 5-HT7.  
5-HT1A has been localised in the smooth muscle of the GI tract where it is expected to 
induce an excitatory contractile response, when coupled with adenylate cyclase, which is 
the primary coupling mechanism of this receptor (Raymond et al., 1999). Analysis of 5-
HT1A receptors involvement was performed in the presence of a selective 5-HT1A receptor 
antagonist, WAY 100635 (Corradetti et al., 1998), which failed to influence 5-HT induced 
contractions in the neonatal rat ileum. Preclinical studies using isolated GI smooth muscle 
preparations have demonstrated 5-HT1A receptor-mediated activities. 5-HT1A receptors 
activation is associated with inhibition of electrically evoked contractions in the guinea pig 
stomach (Buchheit & Buhl, 1994) and relaxation of the dog proximal stomach (Janssen et 
al., 2003). 
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The involvement of 5-HT7 receptors in the 5-HT induced contraction was primarily 
investigated in the presence of the selective 5-HT7 receptors antagonist, SB 269970A and 
separately in combination with previously described methysergide, granisetron and of RS 
23597 190 hydrochloride. In both instances, SB 269970A failed to influence the 5-HT 
induced contraction in the rat neonatal intestine. 5-HT7 receptors involvement has been 
demonstrated in the ENS where it is postulated to play a role in GI physiology (Hemedah 
et al., 1999). Stimulation of 5-HT7 receptors in the smooth muscle of the ileum and colon 
produces relaxation (Carter et al., 1995) and in the rat jejunum it induces contractile 
responses (McLean & Coupar, 1996). 
Further experiments of 5-HT1A and 5-HT7 receptors involvement in mediating a response 
in the neonatal intestine were performed by primarily establishing concentration response 
curves to 5-HT1A/7 receptor agonist, 5-CT (Christ & Surprenant, 1987, Lucchelli et al., 
2000) and 5-HT1A receptor agonist, 8-OH-DPAT (Christ & Surprenant, 1987). This was 
followed by the investigation of the effect of SB 267790A and WAY 100635 antagonists 
on the 5-CT and 8-OH-DPAT induced responses. Although the dose response curve to 5-
CT induced measureable contractions in a concentration-dependent manner, there were of 
less potency and efficacy compared to those elicited by 5-HT. The application of 8-OH-
DPAT did not induce contractile responses in the neonatal rat ileum.  Moreover, WAY 
100635 and SB 267790A failed to influence 5-CT induced contractions. Since the 
application of 8-OH-DPAT did not induce a measurable response, further experiments 
were carried out to investigate if in the presence a highly selective 5-HT1A receptor 
antagonist, WAY 100635, 8-OH-DPAT would induce a measurable response. However, 
the application of 8-OH-DPAT in the presence of WAY 100635 induced responses 
comparable to those of 8-OH-DPAT when applied alone. 
5-CT has been extensively used in the central nervous system and enteric nervous system 
to localise 5-HT7 receptors (Lucchelli et al., 2000). 8-OH-DPAT has been shown to 
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preferentially bind to 5-HT1A receptors than other 5-HT receptor subtypes (Galligan et al., 
1988). WAY 100635, is a highly selective 5-HT1A receptor antagonist and a valuable tool 
to characterise these receptors (Hannon & Hoyer, 2002). SB267790A, is a highly selective 
5-HT7 receptor (Tonini et al., 2005). The failure of WAY100635 and SB267790A to 
modify the responses to 5-HT and 5-CT indicates the unlikely involvement of 5-HT1A and 
5-HT7 in mediating contractile responses in the neonatal rat ileum.  
 
Further experiments are required to investigate a possible relaxation response induced by 
8-OH-DPAT on pre-contracted tissues. Such approach would also be useful for the 
characterisation of 5-HT receptors involvement in the relaxation responses to 5-HT in the 
intestine from rat neonates.  
Additionally, it would also be very interesting to establish a methodology to investigate the 
reduction of 5-HT4 receptors in adults as compared to those in neonates. 
 
In summary, data obtained from the present experiments suggest that there are significant 
differences in the receptor responsiveness between the adult and neonate intestinal tissues. 
This strongly supports the view that the generation of pharmacological data is necessary 
for the development of treatments in infants.  
Nonetheless, alternative methods that reduced, refine, or replace the traditional animal 
methods for generation of pharmacological data has indeed been an area of significant 
interest. Such methods involve ‘in vitro’ systems, which aim at the development and 
validation of individual cell culture models for use in early stages of pharmacological, 
biochemical and immunological analyses. Data obtained from ‘in vitro’ methods can then 
be validated at a later stage using data from animal experiments. 
  
 
 
CHAPTER THREE 
DEVELOPMENT OF CELL CULTURE MODEL TO 
OBTAIN INTESTINAL SMOOTH MUSCLE CELLS AND 
ENTERIC NEURONES 
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3.1 INTRODUCTION 
 
 
Cell isolation techniques have been employed to obtain a variety of different cell types 
from different organs such as the heart, stomach, gallbladder, and intestinal tissues (Bitar 
& Makhlouf, 1982a, Collins & Gardner, 1982, Seidel & Johnson, 1983). Cells in 
suspension have proven useful in characterising the mechanical, biochemical and 
physiological properties of cells.  
In the intestine the availability of individual cell types in culture has led to characterisation 
of receptors for neuropeptides using immunochemical techniques such as radioligand 
binding assay (Seidel & Johnson, 1983) and pharmacological techniques such as the 
measurement of single cell contraction and relaxation responses using specific agonists and 
antagonist for a particular receptor  (Bitar & Makhlouf, 1982a, Souquet et al., 1984) . Such 
information is important since the functional data obtained from the intact intestine 
normally emerges from a complex network of organised smooth muscle cells in a 
multicellular unit rather that from individual properties of contractile cells themselves. 
When cell culture techniques became available, specific cell types were extracted from the 
primary source and kept in culture under controlled environment. This allowed them to 
propagate, expand, and divide into identical replicates, assuming a uniform constitution.  
Experiments in the cultures of different cell population from the small intestine, however, 
have proven difficult.  This is primarily because of the complex layered nature of the GI 
tract making it difficult to acquire pure preparations of individual cell types.  
Nevertheless, such limitations in the disaggregation of cells from the intestine can be 
minimised when methods are employed to monitor the gradual dissociation from specific 
regions of the intestine. The cell extracts can be further monitored for purity through 
observations of morphological features or the use of cell sorting techniques including 
differential adhesion and selective cytotoxicity.  
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Although, the combination of cell sorting techniques may create the required parameters 
for the acquisition of highly purified cell populations from the intestine, further challenges 
remain on the continuity of primary cultures. This is due to the limited growth potential of 
the cells and the limited access to healthy cell lines. As a result there is increasing interest 
in the development of cryopreservation techniques of organs and tissues enabling constant 
availability. A well-established cryopreservation technique for use in the storage of 
intestinal cell population would allow storage, whilst enhancing availability and decreasing 
animal usage.  
The functional assessment of smooth muscle cell contractility is an essential part of 
determining the phenotypic status of smooth muscle cells in culture and it is an important 
aspect of hypothesis testing the validity of ‘in vitro’ cell culture models. This type of 
functional measurement complements the ability to assess cell responses to different 
conditions, particularly when this measurement is limited in the intact intestine. 
 
3.2 AIM 
 
 
The aims of this study were firstly to develop a cell culture model to establish and 
characterise the following cell populations from the intestine: intestinal smooth muscle 
cells (ISMC), myenteric neurones, and a coculture of ISMC and myenteric neurones. This 
was achieved through cell viability tests, cell confluence tests, histological techniques, and 
cell purification techniques to determine the optimum parameters for cell dissociation of 
different cell types originated from the primary tissues. Secondly, the study focused on the 
development of selective purification techniques to obtain specific cell populations from 
different intestinal layers and to characterise fully the individual cell types via 
immunocytochemistry methods. Thirdly, attempts were made to develop a suitable 
cryopreservation technique for long-term storage of ISMC. Lastly, the functionality of 
single cells was assessed using different agonists capable of activating specific receptors or 
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systems to induce a contraction or relaxation responses. Further experiments were carried 
out to assess the cell functionality in larger population of cells. This was achieved by 
seeding the cells onto substrates with different stiffness prior to monitoring their response 
to specific agonists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 METHODS 
 
3.3.1 INTESTINAL DISSECTION 
 
 
Animal housing and conditions were kept as described in section 2.3.1. Rat neonates were 
killed by dislocation of the neck. Bodies were subsequently transferred to a flow hood 
under sterile conditions and the whole intestine was removed and immediately placed in 
Hanks balanced salt solution (HBSS). The mesentery fatty tissue was removed and the 
intestine emptied of its content by flushing HBSS gently through the intestine using a 1ml 
syringe. The length of the intestine was approximately 15cm in its contracted form. In 
order to create a reproducible dissection of the different parts of the small intestine, one 
segment (1.5cm length) was taken from each region of the intestine (2-4cm, 7-9cm, 12-
14cm distal to the pyloric region) and were considered as the duodenum, jejunum and 
ileum, respectively. 
 
 
3.3.2 CELL CULTURE TECHNIQUE 
 
 
Each respective segment was ligated in both ends using sterile cotton thread. Subsequently, 
each segment was transferred to a 15ml centrifuge tube containing 1ml of 0.25% porcine 
trypsin and 0.1% EDTA (Ethylene diamine tetraacetic acid) and incubated at 37°C at 
varying dissociation times of 30, 45, 60, 75, 90 min.  
Preparations were removed respectively from the incubation and triturated by gently 
pipetting the preparation up and down for approximately 5 min. The supernatant was 
carefully transferred to a clean centrifuge tube and 1ml of media added: Dulbecco 
modified eagle’s medium (DMEM) with HEPES modification (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) and supplemented with 10% fetal calf serum (FCS), 100U 
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ml-1 penicillin and 100μg mL-1 streptomycin solution, 2mM L-glutamine, 2.5% rat serum 
(RS), and 0.2% amphotericin B.  
The preparations were centrifuged for 5 min at 450xg. Supernatant was discarded and 5ml 
media was added. The cell suspensions were pipetted up and down so as to obtain a 
uniform suspension of single cells and then transferred to 25cm2 cell culture flasks and 
incubated at 37°C (Figure 3.3.1). Cells were routinely monitored and medium was changed 
at 48h intervals.  
Once cultures reached approximately 70-80% confluence (Log-phase), cells were further 
dissociated in 0.05% trypsin/EDTA for approximately 2 min at 37°C and cell detachment 
monitored under the microscope. When cells had detached, 5ml of media was added in 
order to stop trypsin action. Medium was flushed through the cell culture flask to wash 
remaining cells that were still attached to the surface. Cell suspensions were subsequently 
transferred to a 15ml centrifuge tube and centrifuged for 5 min at 450xg. Supernatant was 
discarded and pellets were re-suspended in 5ml of medium. Cell suspensions were gently 
triturated as to obtain a suspension of single cells, and extra media was added accordingly 
to make up desirable dilution for proceeding passages. In most occasions 2ml of cell 
suspension was added to 4ml of media, hence, resulting in a 1:3 dilution (approximately 
5x104 cells/ml). 
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Step 1 
Incubation in 0.25% trypsin/EDTA 
 
 
 
 
 
 
Step 2 
Mechanical disaggregation through 
gentle pipetting 
 
 
 
 
 
 
Step 3 
Suspension of single cells in media  
 
 
 
Step 4 
Plating of cells in culture 
 
 
 
 
Figure 3.3.1: Schematic illustration of the cell culture technique. 
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3.3.3 OPTIMISATION OF CELL CULTURE PARAMETERS 
 
 
 
Preliminary experiments were designed in order to investigate and optimise the main 
parameters for a successful cell culture. These included dissociation time, source of tissue 
and age of the animal on primary acquired intestinal cells. Cells were isolated from the 
different intestinal regions (duodenum, jejunum, and ileum, n=16), and the optimal 
dissociation time per intestinal region was determined by varying the trypsinisation times 
(30, 45, 60, 75, 90 min, n=4). The experiments were repeated for tissues derived from 
animals that were 1, 2, 3, 4 days old (n=4). For each preparation, isolated cells were 
monitored for cell growth, and cultures were assessed for their ability to reach confluence 
within a 7-day period. In this study a cell culture was considered confluent when the entire 
cell culture surface was completely covered by well spread cells. 
 
3.3.4 CELL VIABILITY EXPERIMENTS 
 
 
Cells were extracted from segments taken from the different intestinal regions of the rat 
neonates (1-4 days old) and exposed to the varying dissociation times. Subsequently, cells 
were centrifuged for 5 min at 450xg, the pellet was re-suspended in 5ml of medium and 
cell suspension was gently triturated to obtain a uniform suspension. Once re-suspended an 
accurate cell count was performed by diluting 50μl of 0.4% trypan blue into 100μl of the 
cell suspension making a dilution of 1:2. The preparation was mixed several times and 
allowed to stabilise at room temperature for 2 min. A cover slip was placed over the cell 
counting chamber (haemocytometer) and 20μl of the mix (0.4% trypan blue + cell 
suspension) was loaded into the chamber by allowing fluid to run into the chamber to the 
edges of the grooves only. The counting chamber was then placed under the microscope 
using x10 objective and the grid lines on the chamber were brought to focus. Only the cells 
laying within the areas bound by parallel lines were counted (4 x 1mm2 per preparation). 
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Total number of stained and unstained cells were counted (dead cells take up the dye and 
appear blue under the microscope and living cells exclude the trypan blue and appear 
white). The haemocytometer was then washed with water first, followed by 70% alcohol, 
and allowed to air dry.  
 
3.3.5 HISTOLOGY 
 
 
Intestinal segments taken from the duodenum, jejunum and ileum of rat neonates (1-4 days 
old) were incubated in 0.25% trypsin for 15, 30, 45, 60, 75, 90 min. Segments were then 
rinsed in HBSS and fixed in 10% buferred formaldehyde and left overnight. Preparations 
were processed by dehydration in serial alcohols (70%, 80%, 90% each for 3 h and in 
100% three times each for 2h). This was followed by impregnation in Histoclear I (1h) 
Histoclear II and Histoclear III (for 2h each). Segments were then infiltrated by pure wax 
(2 changes of wax, each 2h) and embedded in fresh wax with melting point of 61°C when 
transferred to the mold cassestes. Blocks were then labelled and stored at 4°C. For 
sectioning, wax blocks were removed individually from the refrigerator and immediately 
attached to a pre-cooled microtome.  Sections were cut at thickness of 5-7µm, these were 
floated in a preheated water-bath (30°C) and picked up singly on slides pre-coated with 
poly-L-lysine. The slides were left to air dry at room temperature until stained. 
After deparaffination (2 changes of Histoclear each for 5 min) and hydration in descending 
grades of alcohols (2 changes of 100%, 70%, and tap water each for 5 min), slides were 
stained with Herovici’s picropolychrome (Herovici, 1963). Tissue sections were stained 
progressively from the nucleus (black) by incubation for 5 min each in two solutions, A 
and B.  Solution A consisted of 0.25g celestine blue, 2.5g iron alum, dissolved and boiled 
for 3 min in 50ml of distilled water. Subsequent to this solution A was supplemented with 
10ml of cold glycerol. Solution B consisted of 100ml 5% aqueous solution of aluminum 
sulphate heated to boiling point to which a further 50ml of 1% of alcoholic solution of 
 89
haematoxylin was added over 5 min and the resultant solution was boiled for a further 3 
min. After cooling, 100ml of distilled water, 10ml 4% aqueous FeCl3 and 1ml HCL was 
added. Subsequently, the cytoplasmic stain (yellow-green) was performed by incubation of 
the sections for 2 min in solution C, where solution C consisted of a mixture of 0.25g 
metanil yellow, 60ml distilled water, and 5 drops acetic acid. This was followed by 
incubation for 2 min in solution D (mixture of 60ml distilled water and 5 drops of acetic 
acid) and a further 2 min incubation in solution E (a mixture of 60ml distilled water and 2 
drops of saturated aqueous LiCO3). The sections were finally stained for connective tissue 
stain (red and blue) by incubation for 2 min in solution F (a mixture of a solution 1: 0.05g 
methyl blue in 50ml distilled water and solution 2: 0.1g of acid fuchsin in 50ml of 
saturated aqueous picric acid). After mixing these two solutions, the resultant solution was 
supplemented with 10ml of glycerol and 0.5ml of saturated aqueous LiCO3. Between 
applications of solutions A-F the sections were washed for 2 min in running water. After 
the final incubation in solution F the sections were incubated for a further 2 min in 1% 
acetic acid. Lastly, tissue sections were dehydrated in serial alcohol solutions of 100%, 
90%, and 70% (1 min each), incubated in Histoclear for 2 min each, mounted on glass 
slides using Histomount and examined using a Nikon Eclipse 80i bright field microscope. 
 
 
 
3.3.6 ISOLATION OF INTESTINAL SMOOTH MUSCLE CELLS AND 
MYENTERIC NEURONES 
 
Following cell confluence, cell viability and histological procedures, results revealed that 
intestinal segments taken from the ileum and a trypsinisation time of 30 min were the most 
suitable parameters for all the subsequent experiments. These parameters were selected 
based on the segments that gave the best cell yield and the shortest trypsin contact time 
necessary for the dissociation of a considerable number of smooth muscle cells and 
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myenteric neurones. Thus, the cells extracted from the ileum and trypsinised for 30 min 
produced viable cells, which were plated onto cell culture flasks and medium changed after 
48h. The obtained cultures consisted predominantly of ISMC, neuronal cells and 
fibroblasts.  
In subsequent experiments these cells were purified through differential adhesion 
technique to reduce the number of fibroblasts and produce a coculture consisting mainly of 
ISMC and neurones. The differential adhesion is a commonly utilised procedure to 
minimise the number of fibroblasts in culture since they characteristically adhere to the 
surface faster in a cell culture monolayer than other cell types (Yaffe, 1968).  The 
differential adhesion technique was carried out by plating suspensions of mixed cell 
population (ISMC, neuronal cells and fibroblasts) into plastic cell culture flasks and 
incubating at 37ºC. Following 10 min incubation, flasks were monitored for cell adhesion 
under the microscope. This procedure was repeated for every 10 min until not only 
fibroblasts but also characteristic spindle-like shape ISMC were observed adhering to the 
cell culture flask. This was observed after 30 min of continuous monitoring. At this point 
the remaining non-adherent presumably consisting of ISMC and neurones were removed 
from the cell culture flask and transferred to a centrifuge tube and centrifuged for 5 min at 
450xg. Cells were then re-suspended in 5ml of media by gentle trituration, plated onto a 
second cell culture flask and incubated at 37ºC until reaching confluence. By this stage the 
cell population consisted of a coculture of mostly ISMC and myenteric neurones with a 
significantly reduced number of fibroblasts.  
In separate series of experiments attempts were made to purify the myenteric neurones 
through selective cytotoxicity technique. This procedure enables the cell purification by 
favouring the proliferation of one of the cell types in the mixture (Ham, 1984). For 
instance, for removal of non-neuronal cells, preparations were pre-treated with cytosine 
arabinoside, an anti-mitotic drug that inhibits non-neuronal DNA synthesis. After seeding 
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of the isolated cell mixture containing fibroblasts, ISMC and neurones in cell culture flasks 
for 24h, the cell culture media was replaced with media containing 6μM of cytosine 
arabinoside and incubated for 72h at 37ºC. Treatment with cytosine arabinoside containing 
media was replaced with normal medium and cells were allowed to proliferate for another 
96h by incubating at 37ºC. Single dose treatment with cytosine arabinoside caused a 
significant reduction of non-neuronal cells including ISMC and fibroblasts with cultures 
displaying an approximate 80-90% neuronal cell population.   
In another series of experiments attempts were made to purify ISMC. This was performed 
primarily through differential adhesion technique for 30 min to minimise the number of 
fibroblasts in culture. The remaining non-adherent cells consisting of ISMC and neurones 
were removed with the medium into a second flask. The cells were allowed to adhere to 
the cell culture flask for 5h. This procedure was carried out as an attempt to reduce the 
number of neurones in culture. By monitoring cell adhesion, it was observed that neurones 
took the longest to adhere to the surface compared to other cell types present in the 
mixture. It was also found that neurones displayed a distinct morphology as they formed 
clusters during cell adhesion to the surface. Hence, cell morphology monitoring revealed 
that neurones start to adhere to the surface after 5h elapsed. At this point, the media with 
the non-adherent cells were aspirated from the cell culture flask, replaced by fresh medium 
and cells were incubated at 37ºC and allowed to proliferate for 24h. A substantial reduction 
in neurones was observed following this procedure, however, a small number of neurones 
were still present in the culture.   Subsequently, selective cytotoxicity technique was again 
applied for the removal of the remaining neurones. This was enabled by using scorpion 
venom maurus palmatus, an effective neurotoxin that disrupts neuronal activity without 
disturbing ISMC (Blennerhassett & Lourenssen, 2000). After cells were purified via the 
two-step differential adhesion procedure explained above and allowed to proliferate for 
24h, cell culture media was replaced with media containing 30μg/ml maurus palmatus and 
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incubated at 37°C for 24h before being replaced with normal media. At confluence, the cell 
population in culture consisted mainly of ISMC, however, some neurones were still 
visible. Hence, cells were passaged as described in section 3.3.2, plated at a 1:2 dilution 
and allowed to proliferate for 24h before they were again exposed to a second treatment 
with scorpion venom maurus palmatus (30μg/ml) for 24h at 37°C. Following this 
treatment, cell cultures displayed a uniform distribution of ISMC with purity levels of 
approximately 80- 90%.   
 
3.3.7 IMMUNOCYTOCHEMISTRY 
 
Intestinal segments obtained from the ileum of rat neonates (1-4 days old) were exposed to 
30 min trypsinisation as described in section 3.3.2. Three different cell cultures were 
prepared: the first culture consisted of a combination of ISMC and neurones, the second 
culture consisted of purified neuronal cells, and the third culture consisted of purified 
ISMC cells as explained in section 3.3.6.  
Immunocytochemistry procedures were subsequently used to confirm the nature of the 
cells in each preparation following the purification protocols. At confluence cocultures and 
purified cell populations of neurones and ISMC were seeded on glass cover slides 
overnight using a 1:5 dilution and then they were fixed in 2% formaldehyde for 5 min and 
kept in PBS until used for immunostaining experiments. This dilution was selected, as 
lower cell numbers promote better cell dispersion in the cover slides and subsequently 
better images of cell morphology and immunoreactivity.   
Dual-label immunocytochemistry with mouse anti-α-smooth muscle actin and anti-rabbit 
5HT3 receptors antibodies were carried out to verify the nature of cells growing in the 
cocultures and moreover to confirm the purity of newly obtained ISMC and myenteric 
neurones in culture. Briefly, cell were exposed to PBS containing 0.1% Triton X-100 for 
15 min. Slides were then bathed in PBS containing 2% goat serum for 30 min before 
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incubation for 60 min with mouse anti-α-smooth muscle actin (1:100 in PBS-1%BSA) at 
room temperature. This was followed by incubation with mouse TRITC-labeled secondary 
antibody (1:30 in PBS-1%BSA) for 60 min at room temperature. Slides were subsequently 
incubated with the neuronal marker rabbit anti-5HT3 receptors antibody (5μg/ml) for 120 
min at room temperature followed by incubation with rabbit FITC-labeled secondary 
antibody (1:80 in PBS-1%BSA) for 60 min room temperature.  Incubations were preceded 
by 3 washes with PBS.  
Antibodies to α-actinin were also used to confirm the nature of the purified ISMC in 
culture. Slides were incubated with mouse anti-α-actinin antibodies (1:400 PBS-1%BSA) 
for 60 min at room temperature followed by incubation in mouse secondary antibody 
labeled with Alexo fluor (1:400 PBS-1%BSA) for 60 min at room temperature. Both 
incubations were preceded through by 3 washes with PBS. 
Negative controls were carried out, in which primary antibodies were replaced with PBS. 
Preparations were mounted using DAPI, this forms fluorescent complexes with natural 
double stranded DNA, hence is useful for marking the cell nucleus (Sulston et al., 1983). 
Stained samples were observed with Nikon Eclipse 80i Fluorescence, and images were 
digitally captured with SOP (ACT-2U) software. Digital recombination of images using 
Adobe Photoshop was applied for the dual labeling of neurones and ISMC. 
 
 
3.3.8 CRYOPRESERVATION 
 
 
In an attempt to develop a method for long-term ISMC storage, cryopreservation 
techniques were examined. Cells were prepared from ileum segments taken from rat 
neonates (1-4 days old) by exposing to 30 min trypsinisation as explained in section 3.3.2 
and ISMC were purified as explained in section 3.3.6. Cell suspensions were plated onto 
cell culture flasks and medium changed after 48h until cells reached confluence. Cells were 
 94
subsequently passaged once as described in section 3.3.2. The cell suspensions were 
centrifuged for 5 min at 450xg and the pellet was re-suspended in 4 ml of media (dimethyl 
sulfoxide + 10% FCS) that was previously warmed up to 37°C, making up a suspension of 
1-2x106cells/ml. Dimethyl sulfoxide is a commonly used cryoprotectant agent, which 
protects cells during cryopreservation. By warming the freezing media this promotes a 
balance between the cells and the surrounding environment and reduces the changes of 
disturbing the cell membrane. 
Subsequently, different protocols for cell freezing were applied: In protocol 1 after the 
pellet containing the dispersed cells from the ileum were re-suspended in 4ml of freezing 
media, 1ml at a time were transferred into 1ml cryovials. The 4 cryovials were directly 
plunged into a –80°C freezer followed by liquid nitrogen (-196°C). In protocol 2, the cell 
pellet was again re-suspended in 4ml of freezing media and transferred into 1ml cryovials. 
However, this time the freezing protocol involved several steps, commencing with 
incubation of cryovials for 15 min at room temperature to allow cooling of samples (37°C 
to 21°C) and promote the diffusion of the freezing media across the cell membrane. These 
vials were then placed on ice for 20 min to help bring the samples to subzero conditions 
(21°C to -1°C). Subsequently, cryovials were rapidly transferred to a polystyrene container 
wrapped with thermo isolators and stored at -80°C freezer for 12h. This enables a slow 
cooling of samples from –1°C to –80°C before storage in liquid nitrogen (-196°C). This 
gradual decrease of the temperature was employed in order to try and reproduce a simple 
technique, which would allow controlled-rate freezing without the use of expensive 
equipment. The samples were stored for periods of 1-week, 1-month and 4-months. 
Thawing was achieved by immersing the vials into a water bath (39°C) until the contents 
thawed completely. The cells were then suspended in 10ml of the culture medium and 
centrifuged for 5 min at 450xg. Pellet was re-suspended in 5ml of media, plated into cell 
culture flasks and monitored daily to assess morphological changes.   
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3.3.9 COMET ASSAY 
 
To qualitatively assess the viability of the cells in response to freezing, the percentage of 
viable cells for each of these preparations were measured by the trypan blue exclusion 
assay as explained in section 3.3.4. In Separate experiments, 100µl of the cell suspension 
were collected and used to quantitatively assess DNA damage using comet assay. 
The comet assay is a sensitive method for analysing and quantifying DNA damage in 
individual cells. Briefly, a mixture of cell suspension (50μl) and a 1% low melting-point 
agarose (50μl) were dipped onto regular microscope slides coated with 1% normal 
melting-point agarose. A coverslip was then placed on the mixture and the slides were then 
placed on ice for 5 min. Next, the coverslips were removed and a final layer of 0.5% of 
low melting point agarose (100μl) was placed on the slide. The coverslip was replaced and 
the slide kept on ice for 5 min. Coverslips were then removed and slides were lysed in 
detergent overnight [178ml lysing solution (2.5 M NaCl + 100 mM EDTA + 10 mM Tris 
making up the volume to 890ml, PH adjusted to 10 with NaOH) + 2ml TritonX-100 + 20 
ml of Mg2SO]. Slides were transferred to an electrophoresis unit and incubated for 15 min 
with electrophoresis buffer (60ml of 60M NaOH + 10ml of 200 mM EDTA + 1930ml 
distilled water). The final step promotes the disruption of cell membrane such that the 
chromatin can be assessed and fragmentated DNA can migrate from the nucleus towards 
the anode during electrophoresis at 25V and 300mA (electrical field strength 
corresponding to 0.7 V/cm) for 30 min. After electrophoresis, the slides were rinsed 3 
times with 400mM Tris, pH 7.5, stained with ethidium bromide (20µg/ml) and coverslip 
placed (Figure 3.3.2).  
From each slide, 50 cells were randomly selected, nuclei were analysed using a 
fluorescence microscope. Comet length measurements were taken starting from the left 
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margin of the fluorescence constituting the head of the comet, to the furthest visible pixel 
in the tail via a computerised image analysis system (Komet version 3.1).  
 
Cells on agarose 
coated slides  
 
 
 
 
 
Figure 3.3.2: Schematic illustration of  comet assay analysis. Cells in suspension are 
cryopreserved and subsequently thawed. Each sample preparations is smeared onto a agar 
treated-coverslip and lysed to release cell chromatin. Samples are finally ran in an 
electrophoresis system allowing the identification and quatification of the degree of DNA 
damage elicited by different treatments. 
 
3.3.10 FUNCTIONALITY STUDIES (PLASTIC SURFACE) 
 
 
 
In subsequent experiments attempts were made to investigate the functionality of single 
ISMC isolated from segments taken from the ileum of rat neonates. This was performed to 
verify if single ISMC responses to known agonists were comparable to those in the intact 
tissue.  In such experiments cells were taken from the ileum and trypsinised for 30 min, 
centrifuged, re-suspended, and plated as explained in section 3.3.2. Once cultures reached 
confluence, they were passaged as explained in section 3.3.2.  Cell suspensions were 
centrifuged for 5 min at 450xg and pellet re-suspended with 5 ml of media. Cells 
suspensions were subsequently plated into cell culture flasks using a 1:6 dilution and 
incubated overnight at 37°C. This dilution was chosen to promote low cell proliferation 
and enable clear morphological selection of ISMC for the functionality studies.  
An inverted microscope with fitted Camera and heating stage kept at 37°C was used 
collectively with image processing software NIH Scion Image software for live capture of 
Freezing Electrophoresis 
Cell suspension Fragmented DNA 
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cell responses to varying drug concentrations such as potassium chloride (KCl) (0.03, 0.1, 
1, 6, 10, and 30mM), carbachol (0.003, 0.01, 0.03, 0.1, 0.3, 1, and 3μM), and 5-HT (0.03, 
0.1, 0.3, 1, 3, 10, 30, and 100nM). Drugs were applied and images were captured for 5 min 
in each administration. Preparations were washed twice with fresh medium kept at 37°C 
and allowed to settle for 10 min before the subsequent dose was added.  
For every different concentration of the drugs, 10-point pixels were carefully selected 
around the inner border of the cell and the responses were assessed as a measure of 
variation in gray-scale intensities as cell dimensions changed in response to each drug 
applications. The 10-pixel points were selected before drug application (0 sec) and were 
kept fixed throughout the 5 min of drug exposure. The measurements of the contrast 
differences were subsequently taken for 0, 15, 60, 120, 180, 240, and 300 sec.  Therefore, 
as cell displacement occurred in response to drug application, gray-scale measurements 
were accurately captured over a 5 min period. This reflected the ISMC contractile 
responses to any drug application (Figure 3.3.3a).  
The cells displayed a spread appearance after plating on the plastic surface. The application 
of any drug caused the cells to slightly narrow in width without any observable shortening 
of the length.  In response to these observations, pixel points were placed on one side of 
the cell to maximise the capture of cell movement in response to drug application. At each 
given concentration of a drug seven contact times of 0, 15, 60, 120, 180, 240, and 300 sec 
were measured per pixel point. This was repeated for all 10-pixel points (n=10). A 
complete concentration response curve to each drug was repeated 4 times (n=4).   
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3.3.11 FUNCTIONALITY STUDIES USING SILICONE ELASTOMER 
SUBSTRATES (SYLGARD SURFACE) 
 
As ISMC demonstrated the ability to respond to drugs on the plastic surfaces, attempts 
were made to amplify these responses by plating ISMC into a softer surface.   
Cells obtained from segments taken from the ileum of rat neonates were trypsinised for 30 
min, centrifuged, re-suspended, and plated as explained in section 3.3.2. Once cultures 
reached confluence, they were passaged as explained in section 3.3.2.  Cell suspensions 
were centrifuged for 5 min at 450xg and pellet re-suspended with 5 ml of media. Cell 
suspensions were subsequently plated onto cover slides previously coated with silicon 
elastomer using a 1:6 dilution and incubated overnight at 37°C. The silicone elastomer 
mixture (9 base: 1 curing agent) was coated onto the cover slides using a spin coater. A 
drop of the mixture was applied to the centre of the cover slide and gradually the rotation 
was increased up to 12V until the mixture had spread evenly across the entire surface. 
Subsequently, the coated cover slides were allowed to set for 12h before transferring into 
petri-dishes, where cells were seeded onto the coated substrates and incubated overnight at 
37°C. Preparations were used to establish concentration response curves to non-cumulative 
addition of KCl  (1, 10, 100μM, 1 and 3 mM), 5-HT (0.03, 0.1, 0.3, 1, 3, 10 and 30 nM), 
carbachol (0.1, 0.3, 1, 3, 10, 30, and 100 nM) in the absence and presence of atropine 
(0.1μM), and cumulative administration of carbachol (0.3, 1, 3, 10, 30, and 100 nM). In 
separate experiments, noradrenaline (1, 3, 10, 100nM, 1, 3, 10μM) was applied to 
investigate relaxation properties of single ISMC on the silicone elastomer substrates. 
Parameters of measurements were kept the same as in section 3.3.10 with two exceptions. 
ISMC when plated on silicone elastomer surfaces displayed a different morphology 
compared to ISMC plated on plastic surfaces. The flexibility of the material enabled ISMC 
to attach to the silicone substrates and display a shorten appearance. As a result, responses 
to drug application caused not only changes in cell width but also in cell length. Therefore, 
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the 10-pixel points were placed all around the cell inner border to maximise the capture of 
changes in cell dimension following drug application. The other exception was applied on 
the measurement of ISMC responses to noradrenaline, in which the 10-pixel points were 
selected on the outer border of the cell. The reason for this change in the protocol was 
because noradrenaline is a known relaxant at the ISMC. Thus, if methods used to measure 
contraction were applied to measure cell relaxation, the variation in gray scale intensities 
would not be captured since relaxation induced by noradrenaline would be expected to 
produce flattened and expanded appearance of the cells and these changes would not be 
captured by pixel points placement at the inner border of the cells (Figure 3.3.3b).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gray-scale 
A B 
Pixel 
point 
Cell 
relaxation 
Cell 
contraction 
 
Figure 3.3.3: Image illustrating method of measurement of cell contraction (A) and 
relaxation (B). When ISMC were exposed to contractile drugs, pixel points were placed at 
the inner border of the cell where the higher intensities of gray are present. As cell 
dimension changed in response to drug application, the selected pixel points captured the 
variations in gray intensities. When ISMC were exposed to relaxant drugs pixel points 
were placed at the outer border of the cell where the lower intensities of gray are present. 
Thus, as cells flatten in response to drug application, the selected pixel points captured the 
variations in gray scale intensities.  The differences in gray–scale values before and after 
drug application were proportional to cell responses to drug application. 
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 3.3.12 MICROPATTERNING - CELL ALIGNMENT STUDIES  
 
Experiments were carried out to investigate the ability of isolated intestinal cells taken 
from the neonatal rat ileum to respond to guidance cues. Such a technique is important 
controlling the organisation of cells in culture and in re-instituting the architecture 
attributed to cells in the intact intestine. The most commonly used method for promoting 
cell organisation and alignment is by patterning surfaces with extracellular matrix proteins 
such as fibronectin. This was achieved by casting silicone elastomer 
(polydimethylsiloxane, PDMS) in the desired patterns and subsequently coating the PDMS 
with fibronectin to be transferred to the substrate surface.  The masterstamps of 3.8, 5, 12.5 
and 25 micron were pre-fabricated at the University of Glasgow. The silicone elastomer 
was thoroughly mixed with the curing agent in a 9:1 ratio. The masterstamps were placed 
into a petri dish with the patterned grooves facing up. Subsequently, enough silicone 
elastomer mixture was poured into the petri dish covering the master stamps. The petri dish 
was placed for 30 min under a partial vacuum to remove bubbles from the elastomer and 
cured for 72h at room temperature. The stamps were carefully removed from the master 
stamps, washed in ethanol and distilled water to remove residuals from the surface and 
allowed to air dry.  
Initially, cover slides were washed in distilled water followed by ethanol and allowed to 
dry in sterile conditions. Consequently, a mixture of 20µl fibronectin plus 80µl sterile 
water (1μg/ml) was prepared to use as ink in the stamping of the different pattern sizes. 
The different stamp sizes were dipped in the ink for 1 min and subsequently the excess was 
wiped off from the edges and allowed to air dry prior to stamping. Stamping was then 
performed by firmly pressing the inked stamp onto the cover slide for approximately 1min. 
The stamped cover slides were transferred to small petri dishes and a coculture of purified 
ISMC and neurones taken from segments of the ileum as described in section 3.3.2 and 
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purified as described in section 3.3.6 were plated at cell densities of 1:7 onto the cover 
slides patterned with 3.8, 5.0, 12.5, and 25 micron wide fibronectin repeat grating. A low 
cell density of 1:7 was selected to ease cell movement and promote their ability to follow 
the stamped patterns. The petri dishes were then sealed with parafilm and incubated at 
37°C overnight. 
Following incubation the cell preparations were fixed in 2% formaldehyde for 5 min and 
washed three times with HBSS.  Cell alignment to the different sized patterns was then 
determined by measuring the angle between the long axis of the cells and the stamp-
patterned proteins repeat grating using image processing software NIH scion image. In 
these measurements a mean angle of 0˚ represents 100% alignment and a mean angle of 
approximately 45˚ represents random alignment. 
 
3.3.13 SYLGARD PATTERNED THIN SUBSTRATES 
 
 
Following determination of the optimal fibronectin grating for the alignment of ISMC and 
neurones, attempts were made to create thin sylgard patterned substrates casted from the 
12.5 micron masterstamp and coated with fibronectin. The use of topographical cues 
derived from the 12.5 micron grating enabled the surface area micropatterned with 
fibronectin at dimensions optimal for cell alignment to be doubled. Such substrates were 
designed to grow large numbers of intestinal cell population with organised orientation, 
which would collectively increase the ability of coculture preparations to respond to the 
stimulus applied. Moreover, it was believed that with the substrate flexibility, the traction 
force originated by cells on the soft surface and the availability of large number of cells in 
the substrate, these would create the optimum parameters for detecting cellular contractile 
tension induced by intestinal cell population in response to the application of drug.  
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Primarily, silicone elastomer mixture was prepared at a dilution of (9.75 base: 0.25 curing 
agent) and allowed to set for approximately 24h into a glass petri dish.  Such mixture 
dilution was selected to further increase the flexibility of the substrate. Subsequently, the 
12.5micron masterstamp was inverted onto the silicone elastomer mixture and allowed to 
set for an additional 24h. The 12.5 pattern size was chosen as it revealed to promote the 
best alignment for the coculture of ISMC and neurones (Figure 3.4.26f).   The masterstamp 
was gently peeled from the silicone mixture and the set silicone mixture consequently 
peeled from the petri dish. The latter was cut within the areas where patterns were visible, 
creating small patterned constructs of approximately 0.5 x 1.0cm (Figure 3.4.28). The 
constructs were dipped onto a mixture of 20µl fribronectin plus 80µl sterile water 
(1μg/ml), the excess was wiped off, and allowed to air dry. Coculture of ISMC and 
neurones taken from segments of the ileum as described in section 3.3.2 and purified as 
described in section 3.3.6 were plated on the sylgard substrates using a 1:2 dilution (cell 
suspension: medium) and incubated overnight in a sealed petri dish at 37°C. High cell 
density was chosen to promote a high cell number attaching to silicone pattern substrates. 
Subsequently, when cells spread and displayed a satisfactory degree of alignment, 
preparations were exposed to a sub-maximal dose of KCl (6mM). The changes in tension 
of the cells were measured using the optical microscope images elaborated with image 
processing software (NIH scion image). The data was then used to construct profile plot 
and surface plot. The surface profile displays a 3-dimensional imitation of the selected 
image’s surface, whereas the profile plot allows summing up and averaging all the pixels 
data along the row or column parallel to the shorter axis, which can then be used to plot all 
the averaged intensities against the longer axis. This will allow accessing the surface 
deformations induced by cells in response to the application of the drug. 
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3.3.14 INTESTINAL CELLS SEEDING ONTO LIQUID CRYSTAL 
COATED SURFACES 
 
In additional attempts to develop a flexible matrix able to display surface deformation in 
response to contractile activity exerted by the cells, shear sensitive cholesteric liquid 
crystal was used.  Shear sensitive cholesteric liquid crystal was produced from a mixture of 
three components: cholesteryl chloride (0.25g), cholesteryl pelargonate (0.38g), and 
cholesteryl oleyl carbonate (0.38g). The melting points for these liquid crystal compounds 
are 94°C-96°C, 74°C-77°C, and 113°C respectively. The mixed compounds were 
transferred into a vial and heated up on a hot plate to their highest melting point of 113°C. 
As the temperature increased, the solid material gradually melted into a more turbid liquid-
crystalline phase at 70°C and subsequently to a clear isotropic phase at the highest melting 
point of 113°C. When the mixtures reached this liquid phase, 20μl were transferred onto 
one cover slide and another cover slide was used to gently spread the liquid crystal 
material into a smooth layer and allowed to set for 5 min under sterile conditions. 
Coculture of ISMC and neurones taken from segments of the ileum as described in section 
3.3.2 and purified as described in section 3.3.6 were plated onto the cholesteric liquid 
crystal coating using a 1:2 dilution (cell suspension: medium) and incubated overnight in a 
sealed petri dish at 37°C. Intestinal cells were primarily assessed for their viability on 
liquid crystal using the dye exclusion assay. In separate experiments, cells were plated on 
liquid crystal and monitored for 12-24h until they displayed satisfactory proliferation. The 
preparations were then exposed to a single application of KCl (6mM). In another series of 
experiments, cells were plated in the liquid crystal for 12-24h and preparations were pre-
contracted with a single application of KCl (6mM) before the application of a single dose 
of noradrenaline (40μM). The responses were measured using Scion Image software as 
explained in section 3.2.13. 
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3.3.15 STATISTICAL ANALYSIS 
 
 
Comparative results were given as means ± standard error of the mean. Following tests for 
normality, all the significance of the differences were tested by one-way ANOVA followed 
by the Bonferroni adjustment test with the exception of single cell contractility studies 
where significance of the differences was tested using paired t-test. 
 
 
 
Table 3.1 Chemicals/drugs used in the present study, their solvent and suppliers. 
 
Chemicals/drugs 
 
Solvents Suppliers 
Agarose Distilled water Agar Scientific 
Anti mouse α-smooth muscle actin antibody BSA Sigma 
Anti mouse α-actinin antibody BSA Sigma 
Anti rabbit 5-HT3 receptor antibody BSA Sigma 
Anti mouse TRITC conjugated labeled secondary 
antibody 
BSA Sigma 
Anti rabbit FITC conjugated labeled secondary 
antibody 
BSA Sigma 
Atropine sulphate Distilled water Sigma 
Bovine albumin serum (BSA) HBSS Sigma 
Carbachol Distilled water Sigma 
Cholesteryl chloride Distilled water Sigma 
Cholesteryl pelargonate Distilled water Sigma 
Cholesteryl oleyl carbonate Distilled water Sigma 
Cytosine Arabinoside Distilled water Sigma 
DAPI (4’, 6-Diamidino-2-phenylindole 
dihydrochloride) 
HBSS Sigma 
EDTA (Ethylene diamine tetraacetic acid) Distilled water Sigma 
Ethidium Bromide  Distilled water Sigma 
Fibronectin  Distilled water Sigma 
Hanks balanced salt solution (HBSS) - Sigma 
Noradrenaline Distilled water Sigma 
KCl (Potassium Chloride) Distilled water Sigma 
Scorpion venom (maurus palmatus) Distilled water Sigma 
Sodium chloride Distilled water Sigma 
Sodium hydroxide Distilled water Sigma 
Tris (hydroxymethyl) aminomethane Distilled water Sigma 
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3.4 RESULTS 
 
 
3.4.1 ENZYME TREATMENTS AND DISSOCIATION 
 
 
Intestinal cell preparations harvested from segments of both the jejunum and the ileum 
yielded significantly (p<0.05 and p<0.001 respectively) higher number of cultures reaching 
confluence compared to the duodenum (Figure 3.4.1a). Lower trypsinisation times of 30, 
45 and 60 min yielded higher number of confluent cultures in segments of the duodenum, 
jejunum and ileum as compared to the longer trypsinisation times of 75 and 90 min (Figure 
3.4.1b). The cell viability assay also demonstrated that segments taken from both the 
jejunum and the ileum yielded a significantly (p<0.05 and p<0.01, respectively) higher 
percentage of viable cells compared to the duodenum (Figure 3.4.2a). Similarly, Lower 
trypsin incubation times of 30, 45, and 60 min resulted in a higher percentage of viable 
cells.  Further dissociations at 75 and 90 min led to a significant (p<0.05 and p<0.001 
respectively) reduction in the percentage of viable cells in the segments taken from the 
jejunum, and significant (p=0.001 and p<0.001 respectively) reduction in viability of cells 
harvested from the ileum (Figure 3.4.2b). However, there were no significant differences in 
cell viability or number of cultures reaching confluence in relation to the age range of 
neonates (Figure 3.4.1c and 3.4.2c). Results obtained in the different intestinal regions at 
varying trypsin dissociation times and age range of neonates, clearly demonstrate that 
extraction of cells from the ileum gives better yields and higher viabilities compared to cell 
preparations isolated from both the jejunum and the duodenum. 
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Figure 3.4.1: Intestinal cell cultures obtained from segments taken from the duodenum, 
jejunum, and ileum reaching confluence (A). Intestinal cell cultures harvested at varying 
trypsin dissociation times taken from different intestinal regions (B). Intestinal cell 
cultures taken from the intestine of different age range of neonates (C). Each point 
represents the mean ± s. e. mean; n=16 (A) n= 4 (B, C).*p<0.05, **p<0.01 and 
***p<0.001 taken as significant differences in the group. 
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Figure 3.4.2: Percentage of viable cells obtained from the duodenum, jejunum, and ileum 
(A). Percentage of viable cells harvested at varying trypsin dissociation times taken from 
different intestinal regions (B). Percentage of viable cells taken from different age range 
of neonates (C). Each point represents the mean ± s. e. mean; n=16 (A; B) n= 4 (C). 
*p<0.05, **p<0.01 and ***p<0.001 taken as significant differences in the group. 
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3.4.2 HISTOLOGY 
 
 
Histological experiments were carried out on the intestinal segments (Figure 3.4.3) to 
investigate which layer of intestine have been removed following progressive exposure 
time to the dissociation enzyme trypsin (15, 30, 45, 60, 75, and 90 min). Segments from 
different regions of the intestine were taken and 15 min incubation in trypsin the intestinal 
segments of the duodenum, the jejunum, and the ileum revealed very minor cell 
dissociation from the longitudinal muscle layer (Figure 3.4.4a1-3).  After 30 min exposure 
to trypsin part of the muscularis externae including the muscle layers together with the 
myenteric plexus were removed in segments taken from the jejunum and the ileum, but not 
in segments taken from the duodenum (Figure 3.4.4b1-3). A major part of the muscularis 
externae was dissociated following a 45 min exposure to trypsin in segments taken from 
the duodenum, jejunum and the ileum (Figure 3.4.4c1-3).  Following 60 min exposure to 
trypsin, the muscularis externae was completely removed in all intestinal segments (Figure 
3.4.4d1-3). Further exposure to trypsin for 75 and 90 min led to complete dissociation of 
the intestine submucosal layers in all segments taken from the intestine (Figure 3.4.4e1-3 
and 3.4.4f1-3). Thus, for subsequent experiments a trypsinisation time of 30 min were 
chosen for cell isolation from segments taken from the ileum as it was the shortest of the 
trypsinisation times that enabled the maximum acquisition of viable ISMC and myenteric 
neurones from the muscularis externae. 
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Figure 3.4.3: Representative micrographs illustrating histological observations of 
intestinal segments taken from the intact duodenum, jejunum and ileum. Nuclei, cytoplasm, 
and connective tissues as stained in black, yellow-green, and red-blue, respectively (scale 
bar=100 µm). 
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Figure 3.4.4: Representative micrographs illustrating histological images in different 
intestinal segments taken from the duodenum (1), the jejunum (2), and the ileum (3), 
following incubation with trypsin for 15 min (A), 30 min (B), 45 min (C), 60 min (D), 75 
min (E), and 90 min (F). Scale bar = 100 µm. 
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3.4.3 DIFFERENTIAL ADHESION – MORPHOLOGICAL DESCRIPTION 
OF CELL TYPES 
 
Morphologically, the cell population isolated from segments taken from the ileum of the 
neonates as described in section 3.3.2 consisted of ISMC, neurones and fibroblasts. Thus, 
techniques for purifying cells were adopted in order to separate different cell types and 
yield pure cultures of individual cell types.  
The differential adhesion technique was primarily applied to minimise the number of 
fibroblasts in culture as explained in section 3.3.6. Cell attachment times were determined 
via time-lapse video microscopy, in which a frame was captured every 10 min. Monitoring 
of these cultures showed that fibroblasts attached first to the surface (after approximately 
30 min), followed by smooth muscle cells (1-5h), and lastly, a major number of clusters of 
neurones started adhering after 5 h. Differential adhesion technique for separation of 
fibroblasts resulted in cocultures consisting of ISMC and neurones with uniform 
distribution of myenteric neurones among the ISMC (Figure 3.4.5a-c).   
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Figure 3.4.5: Representative micrographs illustrating the coculture of intestinal cells 
isolated from segments taken from the ileum of rat neonates. At day 1, after the separation 
of fibroblasts (A) through differential adhesion ISMC-like cells and rounded clusters of 
neurones (B) were observed. By day 2, ISMC developed into a relatively uniform layer 
throughout culture with intervening areas of characteristically developed myenteric 
neurones (C). By day 5, ISMC were arranged in multilayered regions with intervening 
neurones showing extending neurites (D). Scale bar=100μm. 
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3.4.4 PURIFIED ISMC 
 
 
In the experiments that followed attempts were made to obtain pure ISMC preparations. 
Cells were obtained from segments taken from regions of the ileum and exposed to trypsin 
for 30 min. To obtain pure ISMC cultures, differential adhesion technique was employed 
primarily for removing fibroblasts. This was followed by incubation for 5h allowing 
attachment of sufficient numbers of ISMC to the surface of the flask (Figure 3.4.6a). The 
differential adhesion technique considerably decreased numbers of neurones in culture, 
although sparse clusters of neurones were observed throughout the culture of ISMC 
(Figure 3.4.6b). Morphological monitoring clearly demonstrated that treatment with 
scorpion venom (30 μg/ml) for 24h resulted in an increase in the proportion of ISMC in 
cultures (Figure 3.4.6c) compared to untreated cultures.  Furthermore, treatment with 
scorpion venom (30 μg/ml) induced a selective neurotoxicity without affecting the ISMC.  
It was also observed that single dose treatment following the first cell cultivation was not 
sufficient to completely abolish the presence of neurones. It was hypothesised that the 
presence of neurones in cultures obtained from neonatal intestine is inevitable, since 
neuronal replication rates are extremely high at this stage of tissue development. Thus, 
upon confluence, cells were passaged and exposed to a second dose of scorpion venom (30 
μg/ml) for 24h, which subsequently led to multilayered regions of spindle shaped ISMC 
with no apparent presence of neurones (Figure 3.4.6d). 
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Figure 3.4.6: Representative micrographs showing cells isolated from segments taken from 
the ileum of rat neonates at day 1 (A) and following differential adhesion to minimise 
numbers of neurones and fibroblasts resulted in cultures of ISMC-like and few clusters of 
neurones (B). At day 2, following pre-treatment with scorpion venom (30 μg/ml) there was 
reduction in the number of neurones and increased proliferation of ISMC (C). Incubation 
with second dose of scorpion venom resulted in cultures displaying multilayered spindle-
shaped cells, which were uniform throughout the culture (D). Scale bar=100μm. 
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3.4.5 PURIFIED MYENTERIC NEURONES 
 
 
 
Attempts were made to obtain pure cultures consisting of neurones. Segments were taken 
from the ileum of rat neonates and trypsinised for 30 min. For purified neuronal cultures, 
remaining cells in culture (accessory cells) were significantly removed by a single 
treatment with antimitotic cytosine arabinoside (6 μM) for 72h resulting in the formation 
of complex network of neurones by day 7 (Figure 3.4.7a-c). 
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Figure 3.4.7: Representative micrographs showing mixed population of cells isolated 
segments taken from the ileum of rat neonates at day (A).  Following a single treatment 
with cytosine arabinoside (6 μM) non-neuronal cells growth was significantly reduced and 
neurones start to develop processes (B). By day 7, the neuronal cells had enlarged cell 
bodies with processes that extended throughout the culture (C). Scale bar=100μm. 
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3.4.6 IMMUNOCYTOCHEMISTRY 
 
 
Experiments were carried out to further validate the purity of the cultured cells. Dual-label 
immunocytochemistry on cocultures showed clusters of myenteric neurones adjacent to 
ISMC, which were identified by positive staining with antibodies to serotonin-5HT3 
receptors and α-smooth muscle actin, respectively (Figure 3.4.8a). Purified ISMC cultures 
stained positive to α-smooth muscle actin displaying multilayered regions of actin 
filaments and negative to antibodies raised against 5HT3 receptors confirming the absence 
of neurones (Figure 3.4.9a-b). Similarly, purified myenteric neurones stained positively to 
anti 5HT3 receptors antibodies in the large cell bodies and extended neurites, but 
negatively to α-smooth muscle actin (Figure 3.4.10a). Additional immunocytochemistry 
included staining with anti α-actinin antibodies, which also stained positive on the ISMC 
cultures, equally showing multilayered regions of actinin filaments (Figure 3.4.11a-b). 
 
 
 
 
Figure 3.4.8: Representative micrographs of coculture preparations isolated from 
segments taken from the ileum of rat neonates with dual-label staining directed to 5HT3 
receptors (green) and α-smooth muscle actin (red) antibodies for characterization of 
neurones and ISMC respectively. DAPI mount was used for labeling cell nucleus (blue). 
Positive diffusion of the 5HT3 receptors antibody within the neuronal cell bodies opposed 
by neighbouring cells identified as ISMC (A). Negative controls showed no staining to both 
primary antibodies (B). Scale bar=25μm. 
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Figure 3.4.9: Representative micrographs of ISMC preparations isolated from segments 
taken from the ileum of rat neonates with dual-label staining directed to 5HT3 receptors 
green) and α-smooth muscle actin (red) antibodies for confirmation of the nature of the
purified ISMC. DAPI mount was used for labeling cell nucleus (blue).  Uniform ISMC 
tin filaments stained positive throughout the culture (A, B). Negative labeling to 5HT
receptors antibody confirmed the absence of the neurones in the preparation (A, B). 
(  
ac 3 
both primary antibodies (C, D). Scale bar=25μm 
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Figure 3.4.10: Representative micrographs of neuronal preparations isolated from 
segments taken from the ileum of rat neonates with dual-label staining directed to 5HT3 
receptors (green) and α-smooth muscle actin (red) antibodies for confirmation of the 
nature of the purified neurones. DAPI mount was used for labeling cell nucleus (blue). 
Neuronal cell bodies and extended neurites stained positive to 5HT3 receptors antibody 
(A). Negative immunoreactivity to α-smooth muscle actin antibody confirms the absence of 
the ISMC in the preparation (A). Negative controls showed no staining to both primary 
antibodies (B). Scale bar=25μm. 
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Figure 3.4.11: Representative micrographs of ISMC preparations isolated from segments 
taken from the ileum of rat neonates stained with smooth muscle actinin antibodies (green) 
for confirmation of the nature of the purified ISMC. DAPI mount was used for labeling of 
cell nucleus (blue).  Uniform ISMC actinin filaments stained positive throughout the 
culture (A, B). Negative controls showed no staining to primary antibodies (C, D). Scale 
bar=25μm. 
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3.4.7 CRYOPRESERVATION 
 
 
The aim of these experiments was to investigate cell viability following different 
cryopreservation procedures. The trypan Blue dye exclusion assay indicated that cell 
viability in all different groups was >70%. However, although cells are viable after 
freezing, this does not guarantee the genomic functionality, which was subsequently 
assessed by determining the degree of genomic damage induced by freezing using the 
comet assay. The comet assay revealed that some cells displayed a uniform rounded shape 
with no apparent genomic damage since no migration of DNA fragments from the nucleus 
was visible (Figure 3.4.12a). These observations were made in fresh cell preparations 
(control) and cells cryopreserved using a slow cooling protocol. However, when cells were 
rapidly frozen, upon thawing the comet assay revealed cells resembling a ‘comet’ with a 
distinct head and tail. The head was composed of intact DNA, while the long comet tails 
were indicative of significant genomic damage, which migrated from the nucleus following 
electrophoresis (Figure 3.4.12b). The percentage of damaged DNA was calculated by 
comparing the tail moment of migrated DNA tail in those controls and cryopreserved 
samples.  
 
 
 
 
 
 
 
Figure 3.4.12: Micrographs representing images obtained from the comet assay. Unfrozen 
cell preparations (control) isolated from segments taken from the ileum of rat neonates 
revealed intact cell nuclei with no evidence of DNA damage (A). Images obtained from 
cryopreserved ISMC via rapid cooling are clear evidence of a comet with a head 
composed by intact DNA, while the extent of DNA liberated referred as the ‘tail’ (arrows) 
demonstrates the degree of DNA damage displayed by cells (B). Scale bar = 25 µm. 
3A 
3B 
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In the unfrozen fresh samples (control), the degree of DNA damaged assessed in the ISMC 
was 2.34±0.35 (mean olive tail moment for DNA damage±s.e.mean). This was 
significantly (p<0.001) less than the extent of damage in the groups that underwent 
cryopreservation using protocol 1, where vials containing the cells were directly placed in 
a -80ºC freezer followed by liquid nitrogen storage, which showed an overall mean of 
10.15±0.72 damaged cells. However, ISMC that were cryopreserved via protocol 2, where 
cells were gradually cooled by incubations at room temperature (15 min), on ice (20 min), 
-80 freezer (overnight) and liquid nitrogen showed a degree of DNA damage (2.62±0.36), 
which was not significantly different compared to the controls (2.34±0.35) (Figure 
3.4.13a).  Thus, protocol 2 was subsequently used to evaluate the effect of long-term 
freezing on ISMC and revealed that cryopreservation for 1 week (2.62±0.36) and 1 month 
(3.81±0.72) results in minimal DNA damage compared to the control (2.34±0.35). 
Moreover, cryopreservation for 4 months (5.1±0.9) induced a significant (p<0.05) increase 
in the degree of DNA damage exhibited by ISMC as compared to the control (2.34±0.35) 
(Figure 3.4.13b).    
These observations demonstrated a strong positive linear correlation (R=0.977) between 
the time length of cryopreservation and the genomic damage exhibited by cells. Thus, as 
length of cryopreservation increases a very slow but gradual genomic damage is imposed 
on ISMC.  
Qualitative analysis of the effects of freezing on ISMC in culture was generated by 
micrographs comparing the morphology of cultured ISMC from controls (Figure 3.4.14a) 
and cultured ISMC following cryopreservation (Figure 3.4.14b). Both cultures showed 
distinctive ISMC characteristics of spindle-like cells, which grew on top of each other to 
form multiple layers throughout the culture. No apparent morphological differences were 
observed. 
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Figure 3.4.13: Mean average tail moment correspondent to the genomic damage 
exhibited by freshly isolated ISMC from segments taken from the ileum of rat 
neonates (control) and ISMC exposed to different cooling rates via protocol 1 and 2 
(A). The genomic damage induced by long-term cryopreservation on ISMC (0 weeks, 
1 week, 1-month, and 4-months). The intercept indicating a linear relationship 
between length of cryopreservation and genomic damage exhibited (B). Each point 
represents the mean±s.e.mean; n=4. *p<0.05, **p<0.01, and p***<0.001 taken as 
significant differences in the group. 
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Figure 3.4.14: Micrographs showing comparative images of unfrozen cultured ISMC 
isolated from segments taken from the ileum of rat neonates (A) and cultured ISMC 
following cryopreservation procedure for 1-week (B). Both cultures displayed spindle 
shaped cells characteristic of ISMC, with no apparent morphological changes. Scale bar = 
25μm. 
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3.4.8 THE EFFECT OF KCl, 5-HT, AND CARBACHOL ON THE ISMC 
PREPARATIONS CULTURED ON PLASTIC SURFACE  
 
Experiments were carried out to investigate functionality of the ISMC cultured models. 
The non-cumulative addition of KCl (0.03-30mM), 5-HT (0.03-100nM) and carbachol 
(0.003-3μM) induced concentration dependent contractions at the varying contact times of 
0-300 sec (Figure 3.4.16a, 3.4.17a, 3.4.18a). The contractile responses or changes in 
tension of the cells were characterised as changes in the cell dimensions and were 
quantified via gray-scale measurements captured by the ten-pixel points distributed around 
the inner border of the cell over the different time frames (Figure 3.4.15).    Maximum 
contractions were observed at 10mM, 100nM, 1μM for KCl, 5-HT, and carbachol 
respectively. The maximum contraction observed in single ISMC in response to KCl, 5-
HT, and carbachol produced responses in the range of 14±2.0 (gray-scale units±s.e.mean), 
7.0±1.0, and 3.0±1.0 respectively. 
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Figure 3.4.15: Representative micrographs illustrating responses induced by (carbachol 
(300nM) on ISMC isolated from segments taken from the intestine of rat neonates. The 
response was measured from before, 15, 60, 120, 180, 240, and 300 sec respectively, after 
application of the drug. Scale bar = 50µm. 
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Figure 3.4.16: Contraction responses induced by KCl (0.03mM - 30mM) in the single 
ISMC preparations isolated from segments taken from the ileum of rat neonates. 
ISMC were exposed to KCl at different contact times (A). The concentration-response 
curve to KCl (0.03mM - 30mM) at 180 sec contact time (B). Each point represents 
the mean ± s. e. mean; n=4. 
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Figure 3.4.17: Contraction responses induced by 5-HT (0.03nM - 100nM) in the ISMC 
preparations isolated from segments taken from the intestine of rat neonates. ISMC were 
exposed to 5-HT at different contact times (A). The concentration-response curve to 5-HT 
(0.03nM - 100nM) at 180 sec contact time (B). Each point represents the mean ± s. e. mean; 
n=4. 
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Figure 3.4.18: Contraction responses induced by carbachol (0.003μM- 3μM) in 
the ISMC preparations isolated from segments taken from the ileum of rat 
neonates. ISMC were exposed to carbachol at different contact times (A). 
Concentration- response curve to carbachol (0.003μM- 3μM) at 180 sec contact 
time (B). Each point represents the mean ± s. e. mean; n=4. 
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3.4.9 THE EFFECTS OF KCL, 5-HT, AND CARBACHOL ON THE ISMC 
PREPARATIONS CULTURED ON SYLGARD SURFACE. 
 
Experiments were carried out to investigate functionality of IMSC on softer substrates. 
Results illustrated that in the silicone elastomer surface single ISMC were able to attach 
and proliferate in a similar manner as in the plastic surface. The flexibility of the silicone 
elastomer substrate caused cells to display a slightly shorter and rounded appearance 
compared to those seeded on plastic surfaces (Figure 3.4.19). Cells were isolated from 
segments taken from the ileum of rat neonates according to section 3.3.2 and non-
cumulative concentration-response curves to KCl (1μM-3mM), 5-HT (0.03nM-30nM), and 
carbachol (0.1nM-100nM) were established. (Figure 3.4.20a, 3.4.21a, and 3.4.22a). In 
these experiments 120 sec was chosen for the representation of each drug dose cycle as it 
was repetitively the lowest contact time at which significant changes in cell responses was 
observed (Figure 3.4.20b, 3.4.21b, 3.4.22b).  Maximum contractions were observed at 
1mM, 100nM, 0.1μM for KCl, 5-HT, and carbachol respectively. The maximum 
contraction changes produced responses in the range of 10±2.0 (gray-scale 
units±s.e.mean), 4.0±1.0, and 13.0±5.0 respectively. 
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Figure 3.4.19: Representative micrographs illustrating responses induced by KCl (500µM) 
on ISMC isolated from segments taken from the intestine of rat neonates. The response was 
measured from before, 15, 60, 120, 180, 240, and 300 sec respectively, after application of 
the drug. Scale bar = 50µm. 
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Figure 3.4.20: Contraction responses induced by KCl (1μM - 3mM) in the single 
ISMC preparations isolated from segments taken from the ileum of rat neonates. 
ISMC were exposed to KCl at different contact times (A). The concentration-response 
curve to KCl (1μM - 3mM) at 120 sec contact time (B). Each point represents the 
mean ± s. e. mean; n=4. 
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Figure 3.4.21: Contraction responses induced by 5-HT (0.03nM - 30 nM) in the ISMC 
preparations isolated from segments take from the ileum of rat neonates. ISMC were 
exposed to 5-HT at different contact times (A). The concentration-response curve to 5-HT 
curve to 5-HT (0.03nM - 30nM) at 120 sec contact time (B). Each point represents the 
mean ± s. e. mean; n=4. 
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Figure 3.4.22: Contraction responses induced by carbachol (0.1nM- 100nM) in the 
ISMC preparations isolated from segments taken from the ileum of rat neonates. 
ISMC were exposed to carbachol at different contact times (A). The concentration-
response curve to carbachol (0.1nM- 100nM) at 120 sec contact time (B). Each point 
represents the mean ± s. e. mean; n=4. 
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3.4.10 THE EFFECT OF NORADRENALINE ON THE RELAXATION OF 
ISMC CULTURED ON SYLGARD SURFACES 
 
Separate experiments were carried out to investigate the relaxation effects of noradrenaline 
(1nM-10μM) on single ISMC isolated from segments of the ileum of rat neonates. The 
administration of noradrenaline caused the cells to display an ‘expanded and swollen’ 
appearance (Figure 3.4.23). The response to non-cumulative doses of noradrenaline 
produced concentration dependent relaxations  (Figure 3.4.24a) that were equally visible 
following 120 sec contact time with the cell (Figure 3.4.24b).  
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Figure 3.4.23: Representative micrographs illustrating responses induced by 
noradrenaline (300nM) on ISMC isolated from segments taken from the intestine of rat 
neonates. The response was measured from before, 15, 60, 120, 180, 240, and 300 sec 
respectively, after application of the drug. Scale bar = 50µm. 
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Figure 3.4.24: Relaxation responses induced by noradrenaline (1nM- 10μM) in the 
ISMC preparations isolated from segments taken from the ileum of rat neonates. 
ISMC were exposed to noradrenaline at different contact times (A) varying drug 
contact time during the cycle (A). The concentration-response curve to 
noradrenaline (1nM- 10μM) at 120 sec contact time (B).Each point represents the 
mean ± s.e. mean; n=4. 
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3.4.11 THE ABILITY OF ATROPINE TO MODIFY CARBACHOL 
INDUCED CONTRACTION ON ISMC PREPARATIONS CULTURED ON 
SYLGARD SURFACE 
 
Experiments were carried out to investigate the ability of the cholinergic antagonist, 
atropine to modify the contractile responses induced by carbachol on ISMC. The 
contractile responses to carbachol (0.1nM-100nM) were constructed in the absence and 
presence of atropine (0.1μM). Results demonstrated that atropine (0.1μM) significantly 
(p<0.05) reduced the contraction induced by carbachol on ISMC at concentrations of 
0.3nM and 3nM. Higher concentrations of carbachol in the presence of atropine induced 
maximal contractile responses that were comparable to those induced by carbachol alone 
(Figure 3.4.25a). 
 
 
3.4.12 COMPARISON BETWEEN CUMULATIVE AND NON-
CUMULATIVE DOSE-RESPONSE CURVES TO CARBACHOL IN ISMC 
PREPARATIONS CULTURED ON SYLGARD SURFACE 
 
Non-cumulative doses of carbachol produced dose-related responses to carbachol (0.3nM-
100nM). Maximum contractions of 13.0±5.0 were observed at a concentration 0.1 μM. 
However, cumulative addition of carbachol produced a rapid response, where the 
maximum contraction of 10.5±5.0 was observed at a concentration of 3nM (Figure 
3.4.25b).  
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Figure 3.4.25: Contraction responses induced by carbachol (0. nM- 100nM) in absence and 
presence of cholinergic antagonist atropine (0.1μM) in the ISMC preparations isolated from 
segments taken from the ileum of rat neonates at 120 sec contact time (A). Contraction responses 
induced by cumulative and non-cumulative carbachol applications on ISMC preparations at 120 
sec contact time (B). Each point represents the mean ± s.e. mean; n=4.*p<0.05, **p<0.01, 
***p<0.001were taken as significant differences in the group. 
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3.4.13 INTESTINAL CELLS RESPONSE TO GUIDANCE CUES ON GLASS 
AND THIN SYLGARD PATTERNED CONSTRUCTS 
 
Cultured ISMC and enteric neurones, normally results in layers of spindle- like shaped 
cells, which grow continuously on top of each other topped by projections of nerve 
processes. Thus, attempts were made to assess if the use of micro-contact printing aimed to 
re-orientate cells in culture, would allow these cells to align in an organised manner as in 
the intact tissue. 
The guidance ques assay, in which cells isolated from segments taken from the ileum of rat 
neonates were exposed to different size patterns of 3.8, 5, 12.5, and 25 micron (Figure 
3.4.26a-d) revealed that the intestinal cells aligned more precisely to the 12.5 micron 
fibronectin pattern producing an angle alignment of 10.81±4.17 (mean cell alignment angle 
to patterns ± s.e.mean). Additional stamp sizes of 5 micron and 25 micron also produced a 
satisfactory degree of cell alignment of 13.31±2.8 and 12.91±4.73 respectively. 3.8 micron 
patterned produced a less aligned re-orientation of intestinal cells (17.9±2.9). (Figure 
3.4.27). In all instance, the fibronectin patterns promoted cell spreading and caused a 
marked alignment (Figure 3.4.26f). Additionally, the fibronectin patterns resembled natural 
components of the extracellular matrix indicating that they may be suitable for the 
orientation of large number of cells on patterned constructs.  
When the intestinal cells were plated onto the thin sylgard patterned constructs with a 
pattern size of 12.5 micron (established from preceding experiments), the cell population 
displayed an aligned and organised distribution, which resembled the nature of the 
sectioned intact intestine (Figure: 3.4.28-30).   
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Figure 3.4.26: Intestinal cells isolated from segments taken from the ileum of rat neonates’ 
response to different sized patterns of 3.8 micron (A); 5.0 micron (B); 12.5 micron (C); 
and 25 micron (D) stamped with fibronectin.  Scale bar = 50 µm. The differences in 
morphology and cell orientation in the control (E) and fibronectin patterned surface at 
12.5 micron (F). Scale bar = 100 µm. 
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Figure: 3.4.27: The degree of alignment of cocultures of ISMC and neurones 
exposed to varying patterns of 3.8, 5, 12.5, 25micron. Each point represents the 
mean ± s.e.mean; n=7. 
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Figure 3.4.28: Micrograph representation of the thin sylgard constructs with 12.5micron 
patterned surface and fibronectin coated. Scale bar=50μm. 
 
 
 
Figure 3.4.29: Micrographs representing the cell seeding onto the thin sylgard substrates. 
The combination of ISMC and neuronal cell population isolated from segments of the 
ileum of rat neonates were plated onto the thin sylgard substrates previously coated with 
fibronectin. Scale bar=50μm. 
 
            
A B 
                                         
Figure 3.4.30: Micrographs representing the cell proliferation and reorientation in the 
thin sylgard patterned constructs (A) as opposed to cells seeded on unpatterned sylgard 
constructs (B) following 24 hours incubation at 37°C. Scale bar=50μm. 
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3.4.14 THE ABILITY OF INTESTINAL CELL POPULATION TO 
RESPOND TO KCl-INDUCED CONTRACTIONS ON THIN PATTERNED 
SYLGARD SUBSTRATES 
 
The population of aligned intestinal cells when exposed to KCl (6mM) failed to induce 
contractions with sufficient force to cause visible deformation of the sylgard substrates. 
The plot profile (Figure 3.4.31a) and surface plot (Figure 3.4.33b) analysis revealed no 
significant changes to the sylgard surface prior and subsequent to the KCl applications. 
 
3.4.15 THE ABILITY OF INTESTINAL CELL POPULATION TO 
RESPOND TO KCl-INDUCED CONTRACTIONS ON SHEAR SENSITIVE 
LIQUID CRYSTAL COATED SURFACES 
 
The failure of ISMC and neurones to respond to KCl-induced contractions on the thin 
sylgard pattern substrates, prompt the investigation of ISMC and neurones functionality on 
other materials with additional elasticity, namely cholesteric liquid crystals. The 
percentage viability of cells exposed to the liquid crystal material relative to the control 
was higher than 98%. Cocultures isolated from segments taken from the ileum of rat 
neonates and grown on the liquid crystal coating displayed firm attachment to the 
substrate, which generated distinct traction forces on the liquid crystal coating resembling 
those of a wrinkled surface. Furthermore, cells appeared round in shape and re-arranged 
themselves into clusters. The cell clusters on liquid crystal when exposed to KCl (6mM) 
induced contractions with sufficient force to cause visible deformation of the liquid crystal 
substrate. This was monitored for varying contact times of 0-180 sec. The surface profile 
analysis revealed displacements on the liquid crystal surface subsequent to the KCl 
application (Figure 3.4.32). Similarly, the plot profile analysis indicated sustained surface 
deformations with increased contact time in KCl (Figure 3.4.33b). 
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3.4.15 THE ABILITY OF INTESTINAL CELL POPULATION TO 
RESPOND TO NORADRENALINE-INDUCED RELAXATION ON SHEAR 
SENSITIVE LIQUID CRYSTAL COATED SURFACES 
 
The ability of intestinal cell population seeded on liquid crystal to produce contractile 
responses to KCl prompt the investigation of the suitability of the liquid crystal material   
for studies of relaxation of intestinal cell population. This was achieved by pre-contracting 
the cells with KCl (6mM) and subsequently analysing the relaxation responses induced by 
noradrenaline (40μΜ). The cell seeded on liquid crystal when exposed to KCl induced 
contractions with sufficient force to cause visible deformation of the liquid crystal 
substrate. On its contracted form cells were subsequently exposed to noradrenaline. The 
effect on noradrenaline on pre-contracted cells displayed a flatten appearance, which was 
sufficient to loosen the deformations caused by pre-contraction with KCl (Figure 3.4.34). 
When analysing the plot profile analysis, the deformations to the surface induced by cells 
in response to KCl displayed an increase in the mean contrast intensities compared to the 
control. The mean contrast intensity was reduced once cells were exposed to noradrenaline 
and gradually returned to values observed during KCl application (Figure 3.4.35). 
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30 sec 
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Figure 3.4.31:  Micrographs representing intestinal cell population isolated from segments 
taken from the ileum of rat neonates embedded on patterned sylgard constructs (A) and 
their respective surface profiles (B). Following applications of KCL (30 sec) the organised 
cell population of ISMC and neurones failed to respond since no changes in cell shape or 
substrate displacement were observed on the micrographs or surface profiles. 
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Figure 3.4.32:  Micrographs representing intestinal cell population embedded on 
cholesteric liquid crystals coating (A) and their respective surface profiles (B). Following 
applications of KCL (30 sec) the aggregate of cells contracted consequently pulling the 
substrate. By 120-180 sec there is clear displacement of cell aggregates on the liquid 
crystal substrate in response to the drug application. 
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Figure 3.4.33: Graphs comparing the plot profile on the effect induced by KCL on the 
coculture of ISMC and neurones seeded on sylgard patterned substrates (A) and 
cholesteric liquid crystals coated substrates (B). The profile plot was measured and 
average gray-scale intensities displayed were analysed. Combined cell population 
response to KCL application on  cells seeded on the sylgard patterned substrates 
induced little effect as there was a continuous overlap of the averaged intensities along 
the different time frames of 0, 30, 60, 120, and 180 sec (A). In the liquid crystals 
substrates, the cell population response to KCl application was translated into 
deformations to the substrate surface displaying clear differences in the profile plots 
from 0-180 sec (B).
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A      B 
    
0 sec (control) 
     
60 sec (KCl 6mM) 
    
15 sec (NA 40μM) 
 
30 sec (NA 40μM) 
    
60 sec (NA 40μM)  
 
Figure 3.4.34: Micrographs representing intestinal cell population embedded on 
cholesteric liquid crystals coating (A) and their respective surface profiles (B).  Cells were 
pre-contracted with KCl 6mM (60 sec) and subsequently a single dose of NA (40μM) was 
applied. The effects of KCl application caused the cells to contract and pull the substrate.  
Subsequently, the application of NA on the pre-contracted cells induced a relaxation 
response resulting in loosen substrate appearance. 
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Figure 3.4.35: The effect induced by NA on KCl pre-contracted coculture of ISMC and 
neurones seeded on cholesteric liquid crystal coated substrates. The profile plot was measured 
and the average intensities displayed were analysed. The combined cell population response to 
the application of KCl (6mM) induced contractile responses. The KCl pre-contracted cell 
population were consequently exposed to a single dose of NA (40μΜ), which induced clear 
relaxation responses observed at 15 (A), 30 (B), 60 sec (C). These responses were translated 
into deformations to the substrate surface displaying clear differences in the profile plot from 
the control. 
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Figure 3.4.36: Graph representing the average of all point pixels per image 
following the applications of KCl (6mM) for 1 min and consequently the 
application of noradrenaline (0.04mM) for 30 sec on cocultures of ISMC and 
neurones seeded on liquid crystal surface. The application of KCl caused cells to 
contract at a force sufficient to cause deformations to the liquid crystal surface. 
Subsequently the application of noradrenaline caused cells to relax and loosened 
the deformations induced by KCl. These displacements of the liquid crystal surface 
were measured by averaging the variation in gray scale intensities following each 
drug application. Each point represents the mean±s.e.mean. 
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3.4.16 THE EFFECTS OF SUBSTRATE STIFFNESS ON CELL 
MORPHOLOGY AND ADHESION 
 
Experiments were carried out to compare the effect of substrate stiffness on intestinal cell 
population morphology and adhesion.  When comparing the results for cell morphology 
displayed by the single ISMC isolated from segments taken from the ileum of rat neonates 
and seeded on different surfaces, the micrographs show visible differences in cell shape. 
The spreading of cells is enhanced as substrate stiffness increases. Hence, the intestinal 
cells plated on the softer substrate - shear sensitive liquid crystal coating revealed that 
although cells are clearly attached, the cell shape remains relatively round throughout the 
entire viewing period. However, a more spread morphology is observed in cells plated on 
patterned sylgard constructs and plastic surfaces (Figure3.4.34a-c).  
 
       
A C B 
Figure 3.4.36: Micrographs representing the effects of substrate stiffness on cell 
morphology. Cells isolated from segments taken from the ileum of rat neonates and seeded 
on plastic surface clearly attach and spread well (A). Cells on sylgard substrate attach 
well, however, spreads relatively less than those attached to plastic substrate (B). By 
contrast, cells plated on shear sensitive liquid crystal coating show clear attachment 
reflected by the wrinkling of the surface at the indentation points and a relative round 
shape comparing to the more rigid substrates (C). Scale bar=25μm 
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3.5 DISCUSSION 
 
 
Harrison and Carrel were the first to develop a cell culture method for studying the 
behaviour of animal cells free from systemic variation that might arise due to the 
complexity of the tissue (Harrison, 1907, Carrel, 1912). In more recent times with the 
advances in cell culture methods and the development of new dissection techniques, this 
has enabled the isolation of various cell types from the stomach, intestine, and bladder 
from both adult and neonatal animals (Bitar & Makhlouf, 1982b, Collins & Gardner, 1982, 
Seidel & Johnson, 1983, Frings et al., 2000). In the intestine, however, cell dispersion from 
neonatal source has proven challenging because of the difficulties in obtaining pure and 
functional preparations for experimental testing.  
Thus, the aim of the present studies was to develop a cell culture model of intestinal cell 
populations including ISMC, myenteric neurones, and a coculture of ISMC and myenteric 
neurones from neonates. Furthermore, to characterise the functionality of the cell culture 
models by using pharmacological active agonists and antagonists capable of activating 
specific receptor systems to induce a contraction or relaxation responses. 
The cell dissociation method reported in the present study provided evidence that the 
regions of the intestine from which cells are isolated, as well as the length of time allowed 
for trypsinisation influences the viability and growth rate of cells in culture. To support 
these studies, histological procedures also established that increase in trypsinisation times 
lead to gradual dissociation from the outer-most layers into the inner layers of the intestine. 
This suggests that this method can be used to determine the estimated time required for 
isolation of single cell types from specific intestine layers. 
Previous studies performed on the isolation of ISMC from neonatal tissue reported the use 
of dissection under sophisticated optical control.  This involved the removal of the entire 
muscularis externae layer with the support of an advanced microscope and fine forceps 
(Frings et al., 2000) or specific removal of the longitudinal muscle layer with the help of 
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stereomicroscopes (Smirnov et al., 1992). The method developed here, however, consisting 
simply of tying both ends of the intestine prior to dissociation provides an inexpensive 
technique for isolation of intestinal cells from neonatal tissues, which can be adjusted for 
isolation of specific intestinal layers. Although this may also be achieved via 
microdissection techniques, microdissection systems are expensive, unavailable to many 
researchers, and isolation of large numbers of intestinal cells such as presented here, would 
prove extremely time consuming or even impracticable in complex tissues (Kwapiszewska 
et al., 2004).  
In an attempt to separate and culture different cell types, the differential adhesion 
technique was used, which minimised the number of fibroblastic cells in culture as well as 
allowing the separation of neurones from ISMC. The differential adhesion technique has 
already been shown to be a useful method of separating fibroblasts and myogenic cells 
(Richler & Yafee, 1970, Gareth et al., 1990, Rando & Blau, 1994, Qu et al., 1998). 
Further selective purification of ISMC was achieved through treatment with scorpion 
venom maurus palmatus. According to numerous morphological (Vachon, 1952) as well as 
some biochemical (Goyffon & Kovoor, 1978) characteristics, scorpion venoms are divided 
into two groups: buthoids and chactoids. The buttoids, because of their relevant medical 
importance associated with severe envenoming and death have been widely studied and 
their toxicity has been demonstrated to target the excitation of axonal membranes by the 
modification of their ionic conductance (Romey et al., 1975, Catterall, 1980, Pelhate & 
Zlotkin, 1982). The Chactoids, including scorpio maurus palmatus were poorly 
investigated since they were thought to be medically non-significant (Goyffon & Kovoor, 
1978). On the basis of this information, scorpion venom maurus palmatus was assessed for 
purity and the most prominent characteristic present in the toxin components was the 
cooperativity between the two toxin units (paralytic fraction and the lethal factor), which 
when investigated through neurophysiological studies showed interaction with insect 
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axonal preparations and extremely low toxicity compared to other buthoid venoms. Results 
also revealed that scorpion maurus palmatus possesses cooperative interaction and 
blocking/suppressing effects on the ionic conductance for both potassium and sodium ions. 
It seems that the disturbance of the electrolyte balance in both ions affect cell membrane 
integrity and nerve transmission though interferences with the conductance of axons 
(Lazarovici et al., 1982, Possani et al., 1999). Thus, treatment in culture with this toxin 
caused selective abolition of neurones, which when compared with untreated cultures 
contained relatively higher number of ISMC but otherwise identical cultures 
(Blennerhassett & Lourenssen, 2000) and no disturbance to ISMC population was 
observed. Moreover, it has been postulated that the presence of neurones ‘in vitro’ might 
correlate with the decrease in serum availability in culture resulting in decreased 
proliferation of ISMC (Blennerhassett & Lourenssen, 2000). Hence, removal of the 
neurones may increase the availability of serum proteins and promote an increase in the 
proliferation of ISMC. 
Myenteric neurones were purified through antimitotic treatment with cytosine arabinoside. 
Pre-treatment with this drug has been primarily used to purify neurones derived from 
dorsal root or superior cervical ganglia (Blennerhassett & Lourenssen, 2000, A.Eccleston 
et al., 1989, Eccleston et al., 1989) since it inhibits DNA replication of non-neuronal cells 
(Harrington & Perrino, 1995). In the present study a single dose with cytosine arabinoside 
treatment resulted in the removal of accessory cells (ISMC and fibroblast) and rapid 
proliferation of myenteric neuronal cells bodies with extended neurites. 
To examine the purity and nature of the different population of cells in culture 
immunocytochemistry was used. These experiments on the combined cell population of 
enteric neurones and ISMC referred as cocultures confirmed the presence of both ISMC 
and neuronal cell populations.  Antibodies to α-smooth muscle actin displayed a uniform 
distribution of ISMC among positively stained myenteric neurones to antibodies raised 
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against 5-HT3 receptors. Anti-smooth muscle α-actin antibodies represent a useful tool for 
the study and characterisation of smooth muscle in culture (Skalli et al., 1986). Receptors 
to 5HT3, on the other hand, are expressed in the enteric nervous system (Johnson & 
Heinemann, 1995, Mawe et al., 1986, Richardson et al., 1985) and play important roles in 
the enteric physiology stimulating neuronal activity. Recent studies on isolated myenteric 
neurones obtained from the mouse small intestine have shown immunoreactivity to 
antibodies raised against 5HT3 receptors in neurones, labeling both neurites and cell bodies 
(Liu et al., 2002). Thus, in the present studies 5HT3 receptors antibodies were used as a 
marker for myenteric neurones. In such experiments the purified myenteric neurones 
showed uniform expression of 5HT3 receptors within the cell bodies extending to the 
processes and no immunoreactivity to α-smooth muscle actin. Furthermore, purified ISMC 
cultures showed uniform expression and distribution of α-smooth muscle actin and no 
expression of 5HT3 receptors. Additionally, purified ISMC also displayed intense diffuse 
labeling in the cytoskeleton of majority of cells following staining with antibodies raised 
against α-actinin. The distribution of α-actinin in single isolated muscle cells filaments has 
been shown in previous studies, where it displayed an high expression throughout the 
cytoplasm (Fay et al., 1983).  
 
Although this work shows that ISMC and myenteric neurones can be readily dissociated 
from the neonatal intestine, the continuous use and availability of these cells in culture is 
nonetheless limited. This is primarily attributed to ISMC and the number of phenotypic 
changes that they experience, causing impairment in their ability to contract. It has been 
reported that smooth muscle expression of actin isoforms decrease during proliferative 
phase after initial cell seeding (Halayko et al., 1996). While they may partially recover 
once cells become confluent, the actin levels do not return to those present in freshly 
isolated smooth muscle cells. There have been additional studies showing the decrease in 
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smooth muscle specific contractile proteins during proliferation and with each subsequent 
passage (Panettieri et al., 1989, Tom-Moy et al., 1987).  
This has generated an ever-increasing need to develop cryopreservation techniques, which 
would enable a constant availability of cells and enhanced ability to study their functional 
characteristics ‘in vitro'. Furthermore, limitations that are normally observed in primary 
cultures due to limited growth potential and the absence of continuous lines of healthy cells 
would be avoided. 
The basic principle of cryopreservation of cells comprises bringing cells into contact with 
the cryoprotectant agent and subsequently reducing the temperature of the cells to a 
cryopreservation temperature. However, these are thought to be often dependent on the 
type of cells being frozen (Fuller et al., 2004). Because cells differ cytologically, this also 
means that there is a cell type-related variance in the way in which solutes enters the cell 
and form ice crystals. Thus optimum freezing for each individual cell type can only be 
predicted by the rate of freezing they are exposed. On the basis of this information, we 
have developed a simple controlled rate-freezing method without the rate-controlled 
programmed freezer. Results revealed that a three-steps cooling reflecting gradual freezing 
of the cells in protocol 2 was successful for cryopreservation of ISMC with minimal DNA 
damage compared to the controls. This result suggests that the use of sophisticated and 
expensive equipments is not entirely necessary to achieve rates of cooling sufficiently 
uniform to ensure the viability of ISMC.  
To assess the DNA damage associated with freezing the comet assay was employed. This 
method detects double stranded DNA breaks in individual cells due to oxidative stress and 
it has been used for human monitoring studies looking at the DNA damage in lymphocytes 
related blood sample storage (Anderson et al., 1997) and to evaluate DNA integrity of 
frozen-thawed on cryopreserved spermatozoa (Evenson et al., 1991). This assay has proven 
effective at detecting low levels of DNA damage in the cells and there is evidence that 
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integrated measure of the tail moment is a more sensitive measure of the freezing-induced 
DNA damage comparing with the length of the comet (Olive et al., 1991).  
When looking at the long-term storage, results revealed that cells cryopreserved for up to 
1-month showed no substantial damage compared to unfrozen samples, however, 
cryopreservation of ISMC for 4 months induced a small but significant increase in the 
genomic damage to ISMC. Although the are no evidences from the present studies, the 
fluctuations in genomic damage may not to be due to cryoinjury but a possible variation of 
the physiological state at the time ISMC were acquired, essentially with regards to the cell 
dissociation procedure. When establishing cell culture models the optimisation of the 
physical dissociation, which comprises the use of proteolytic enzymes including trypsin to 
cleave cellular bonds and mechanical dissociation through which cells are dispersed are 
imperative to give a good yield of viable cells. However, this does not eliminate the 
presence of aggregates (cell clusters) in the culture. Thus, the problem rises when these 
cells are used for storage since these aggregates will allow a good diffusion of 
cryoprotectant to the cell in the periphery, but poor diffusion to the inner most cells, 
thereby making them more susceptible to oxidative stress during freezing (Zalzmann, 
1999). Therefore, although the viability of cells does not substantially differ, more 
sensitive techniques such as comet assay clearly detects the oscillations in the DNA 
damage exhibited by these cells. Additionally, there is evidence indicating that the 
cryopreservation technique applied presents the best possible maintenance of the integrity 
of cryopreserved cells, there will be no alterations at the phenotypic, biochemical, 
chromosomal and molecular level due to cryopreservation (Elgmann, 1997). These 
observations are in line with the present results since the genomic damage in unfrozen 
ISMC (control) was comparable to those of ISMC cryopreserved for 1-week using the 
slow cooling protocol. On the other hand, the linear relationship between the time length of 
cryopreservation and the genomic damage exhibited by ISMC suggests that although 
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optimised cryopreservation methods protect cells from instant genomic damage, the long-
term storage, although minimal, does interfere with genomic integrity of cryopreserved 
cells. In support of these observations, previous studies investigating the effects of short 
and long-term cryopreservation of peripheral blood monoclonal cells has shown that the 
effect of cryopreservation becomes more significant over time resulting in reduced 
responses by cytokines (Owen et al., 2007). 
Therefore, the cryopreservation technique here employed demonstrates that ISMC isolated 
from segments taken from the intestine of rat neonates can be readily stored with reduced 
genomic damage. The stability of cells in the cryo-state is adequate and this technique will 
indeed aid cell availability and phenotypic stability for experimental testing.  
 
The contractile ability of isolated ISMC was investigated through a series of 
pharmacological studies, in which single cells were exposed to selective agonists and 
antagonists. ISMC functionality was assessed on two distinct surfaces: rigid (plastic) and 
soft (silicone elastomer). ISMC responses to KCL, 5-HT, and carbachol were measured by 
microscopically assessing the changes in cell dimension on the distinct surfaces in 
response to the drug treatments. In all cases, maximum contractile responses observed on 
the soft surfaces were evoked during a shorter drug contact time and using the same or 
lower concentrations of the drugs compared to the experiments carried out on the rigid 
surface. In relation to this, several studies on the cell behaviour on different substrates have 
shown that substrate elasticity significantly modifies cell behaviour including applied 
traction forces (Pelham & Wang, 1999, Beningo & Wang, 2002). This explains the rounder 
and less spread morphology of ISMC plated on the soft surfaces. Furthermore, this 
elucidates why the contractions elicited by ISMC in response to selective drugs produced a 
more immediate response on softer materials other than plastic surfaces. This is because in 
the normal status of the mammalian tissue such as the intact intestine the most common 
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sites of attachment for a cell is another similar cell or the extracellular matrix, and these 
materials possess significant elasticity.   
According to this relationship between substrate adequate properties and contractile cell 
behaviour, the results suggest that silicone elastomer substrate could be considered as a 
relevant substrate to study contractile properties of ISMC. 
In the series of experiments that followed single ISMC were exposed to noradrenaline and 
the relaxation responses were measured. In such experiments, the changes in cell 
dimension were visibly distinct from those observed while assessing contractile responses. 
The swollen feature displayed by ISMC in response to noradrenaline treatment allowed 
isometric measurement of single cell relaxation. Previous studies have been reported on the 
measurement of smooth muscle relaxation by measuring the changes of cell length in 
suspension. In such studies computerised system permitted the direct measurement of the 
length of single cells. This was achieved by incubating cell suspension with a selective 
drug, stopping the reaction and subsequently proceeding to a computerised measurement of 
cell length (Moummi & Woodford, 1992). This technique, however, failed to provide the 
true kinetics and reversibility of the response and to identify the natural properties 
possessed by individual cells. The present study enabled the construction of time-course 
and dose-response curves on the same cell acting as its own control.  
To assess the contractility of the cells, series of experiments were carried out. In such 
experiments the effect of carbachol was investigated in the absence and presence of the 
cholinergic antagonist, atropine (0.1μM).  The results demonstrated that the non-
cumulative addition of carbachol induced contractile responses, which were antagonised 
by atropine.  This effect was surmountable and/or competitive, with no alteration of the 
maximum response induced by carbachol. Atropine is the standard muscarinic antagonist 
that has demonstrated similar effects in the inhibition of carbachol-induced contraction on 
isolated rat ileal preparations in ‘in-vitro’ organ bath experiments (Nkeh et al., 1993). 
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However, when carbachol was added cumulatively, the contractile responses were reduced. 
One possible explanation could be the development of desensitisation following repeated 
exposures to carbachol. Previous studies have demonstrated that carbachol causes non-
specific desensitisation in segments taken from the guinea pig ileum (Himpens et al., 
1991). In many smooth muscle cells it has been reported that prolonged stimulation 
initially induced contraction, but the muscle eventually relaxes in spite of the continue 
presence of the drug (Eglen et al., 1991). In line with this information, it appears that the 
decline observed in response to cumulative carbachol application is a result of to the 
repeated carbachol applications. 
The results obtained in this functionality study, together with previous studies reported by 
Bitar and Makhlouf on the characterisation of ISMC receptors (Bitar & Makhlouf, 1982a), 
suggest that isolated ISMC offer a valuable biological tool for drug screening to the 
pharmaceutical industry. This is primarily advantageous as in the single cell experiments 
the drug distribution is more evenly achieved, it allows the characterisation of receptors 
and their postsynaptic interaction, and finally this experimental approach provides a useful 
tool for investigating the mode of action of drugs at the cellular level. 
Nonetheless, limitations include the small data sampling population and cell-to-cell 
variability, which fails to outline a conclusive drug action within a particular population of 
cells.  
 
In response to the outlined limitations, attempts were made to create highly flexible 
substrates that would allow detection of mechanical forces exerted by cells in response to 
applied stimulus.  
The control of cell mechanics and shape is crucial for many cellular functions including 
cell growth, proliferation and migration (Chen et al., 1997). To better understand the 
mechanisms involved in cellular behaviour and function in the ‘in vitro’ environment, cells 
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are often attached to various micropatterned surfaces (Whitesides et al., 2001). This ability 
to spatially cell population into a complex differentiated structure has been linked to better 
stimulus sensing (Kane et al., 1999). This is particularly important in the native intestine, 
as individual cell population exist in an orientated architecture, which is crucial for the 
proper electrochemical coupling between smooth muscle and neurones to stimulate the 
transmission of directed contraction over long distances. In contrast, cultured intestinal 
cells spread to form a sheet of over-layered cells with disorganised orientation, bearing 
little similarities to the normal intestinal morphology. 
Previous attempts have been made to align cardiac myocytes ‘in vitro’. These studies have 
shown that conduction velocities and action potentials were faster in cultures of aligned 
cardiac myocytes (Lieberman et al., 1972, Thomas et al., 2000). Thus, attempts in 
organising isolated cells into more natural structures should provide new opportunities for 
studying their mechanical force. 
In order to examine the mechanical properties amenable for practical applications, an 
efficient and reliable method for fabricating cell-based actuators and controlling their 
mechanical and dynamical properties in the cellular microenvironment has to be 
developed.  
In line with this information, the motivation of the study was to develop a highly flexible 
sylgard patterned thin substrate with high mechanical properties and the ability to promote 
intestinal cell alignment. According to this experimental design, it was hypothesised that if 
cells could align in an organised manner resembling that of the intact intestine, the 
combined cell response to the drug application would produce detectable mechanical 
forces.  The generated forced in turn would be captured by microscopy imaging as the 
highly flexible substrates displayed displacement field of the surface. 
Hence, cell preparations were first assessed for the most adequate pattern size. The 
combined population of neurones and ISMC responded best to guidance cues of 
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12.5micron. In experiments that followed the 12.5micron templates were used to produce 
the thin sylgard patterned constructs onto which the combined population of neurones and 
ISMC   were plated. The organised distribution displayed by the intestinal cells resembled 
that of the intact intestine and furthermore reassured the possibility that they would equally 
respond to drug applications causing displacement of the sylgard surface. However, the 
force exerted by intestinal cells on patterned sylgard substrates in response to KCl failed to 
induce contractions that were translated into displacements in the surface.   
It is well established that most cells in multicellular organisms are attached to softer 
materials than glass or plastic surfaces. These include other similar cells or the 
extracellular matrix, both of which have elastic moduli on the order of 10-10,000 Pa (Bao 
& Suresh, 2003, Wakatsuki et al., 2000). Forces generated by the contractile cells applied 
to the membrane attachment sites can deform materials with the same range of stiffness but 
cannot move an attachment site on a rigid surface. The results of the present study implied 
that the elastic property of the patterned sylgard substrates were not within the elastic 
modulus range suitable to study mechanical forces at a cellular level. Results also indicated 
that in order to be able to study forces generated by contractile cells on artificial substrates, 
one must primarily find a material with a close elastic modulus to that of the extracellular 
matrix that surrounds these cells. However, the challenge of finding a stimulus responsive 
biomaterial with matching elastic modulus to that of the intact intestine cytoskeleton is 
indeed immense. 
In line with this evidence, the intensive search into biomaterials with known responsive 
properties for the detection of mechanical forces has led to the examination of shear 
sensitive cholesteric liquid crystals. The characteristic feature of liquid crystal is their 
exceptional responsiveness to excitations.  
Liquid crystals are organic compounds that exist in a state between a liquid and a solid 
form. They are viscous, jelly-like materials that may flow like liquids but resemble crystals 
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due to the light scattering and reflection. Their unique responsivity arises as a result of 
symmetry as geometrically they must have different optical properties in all directions 
(anisotropic) and revert to the same optical property in all directions (isotropic) via thermal 
action or the influence of solvent (Fergason, 1964).  
Liquid crystal phases can be characterised by the type of ordering they display. One can 
distinguish the liquid crystal molecules through their positional order, orientational order, 
and moreover by the short and long range ordering they may exhibit.  Most liquid crystals 
when exposed to heating will be driven into a conventional liquid phase, characterised by 
random and isotropic molecular ordering with short-range order. However, at lower 
temperatures liquid crystals might exhibit one or more phases with significant orientational 
structure and long-range orientational order while still having the ability to flow.  
One of the most common liquid crystal phases is the nematic, where molecules or 
mesogens possess a high degree of long-range orientational order, but are randomly 
distributed as in a liquid and all point in the same direction. The smectic phase is one 
where in addition to orientational order, the mesogens are grouped into layers enforcing 
long-range positional order in one direction. If chiral molecules are added to the nematic 
phase, the end product is a cholesteric phase liquid crystal in which the single directional 
order rotates around a space direction called the helical axis. These spatial variations in the 
orientation continuous symmetry are responsible for the softness of the liquid crystals and 
for their remarkable responsivity to excitations (Leslie, 1968). Cholesteric liquid crystals 
assemble into a helical molecular arrangement that selectively scatters white light in a 
three-dimensional spectrum. This feature is attributed to the helical field length, and hence 
the wavelength of the scattered light, is influenced by shear stress normal to the helical 
axis. Thus, the weakly ordered liquid crystal phase together with its unique optical 
property reflects the way in which they respond to detection of heat, light, sound, 
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mechanical pressure, and chemical environment with immense sensitivity (Fergason & 
Brown, 1968).  
 
Mesogens ordering 
in a nematic phase 
 
 
Mesogens ordering in a 
smectic phase 
 
Mesogens ordering in a chiral 
nematic or cholesteric phase 
Figure 3.5.1: Schematic illustrations of the liquid crystal mesogens ordering adapted from 
(Palffy-Muhoray, 2007). 
 
Therefore, cholesteric liquid crystals were considered for studying the contractile activity 
in isolated cell populations of the intestine. In fact, the idea that liquid crystals may be 
involved in cell structure is not recent. This idea was initially proposed by Lehmann, one 
of the first to investigate liquid crystals in 1900 (Lehmann, 1900). At the time, however, 
there seemed to be no advantage in associating liquid crystals with cell formation. The lack 
of utility and knowledge of the structure and properties of liquid crystals resulted in its 
disappearance from biological literature until recent years. 
At present the role of liquid crystals in biological systems has only began to be explored, 
especially in their role in sensory systems, in cellular shape and transmission of 
information (Fergason & Brown, 1968). 
In the present study the cellular shape and the potential use of the liquid crystals material 
as transducer to capture cell responses was analysed. The coculture of ISMC and neurones 
seeded onto the cholesteric liquid crystal coating displayed a significantly rounder shape. 
Although rounder, the cells were firmly attached to the liquid crystal coated surface. This 
was displayed by the visible indentation lines exerted by firmly attached cells on the liquid 
 163
crystal surface. When the coculture of ISMC and neurones were exposed to the application 
of KCl, a decrease in cell size was observed in response to KCl. Moreover, due to the 
softness, elasticity and responsiveness of the liquid crystal coating the combined cell 
population response resulted in shear force being applied onto the substrate, which 
translated in the displacement field of the surface. In subsequent experiments, when the 
coculture of ISMC and neurones were pre-contracted with KCl and then exposed to 
noradrenaline, an ISMC muscle relaxant, the cell population response resulted by initially 
contracting and increasing the shear force being applied onto the substrate in response to 
KCl. This was then followed by the cells relaxing and decreasing the shear force applied to 
the surface in response to noradrenaline. These changes could be closely observed by 
changes in gray scale intensities. These results suggest that the liquid crystal material may 
be a suitable choice for studies of cell contraction in response to different drugs. More 
importantly, the liquid crystal substrate may also be suitable for studies of relaxation 
responses on pre-contracted cells.   
Although, it was previously documented that most cells are attached to another cell or an 
extracellular matrix with an elastic modulus in the order of 10-10,000Pa (Bao & Suresh, 
2003, Wakatsuki et al., 2000). A more recent review has indicated that myoblasts, the 
developmental precursor of myotubes, striated and muscle cells grow on substrates with 
compliances comparable to mature muscle tissue with an elastic modulus in the range of 
0.012MPa (Engler et al., 2004). 
 In line with this information, although, the elastic modulus of the liquid crystal material is 
not documented, there are reports that when liquid crystals exist in the three-dimensional 
order, their elastic modulus is in the order of 0.5Mpa (Nozières et al., 2001). Thus, the 
literature suggests liquid crystal materials have an elasticity that is similar to that of the 
tissue. In support of the present study, the cell preparation when seeded in a compliant 
matrix of appropriate stiffness was more responsive to the drug application. This is 
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believed to occur as the artificial mechanical components of the tissue, in this case the 
cholesteric liquid crystal coating possesses the mechanical elasticity, which mostly 
resembles those surrounding mammalian cells.    
 
In conclusion, we developed a cell culture model where individual cell populations or in 
combination were successfully extracted from the different layers of the intestine, purified 
and individually characterised. The results were reproducible and reliable. The genomic 
integrity of cells remained unchanged following cryopreservation for 1-month and 
demonstrated minimal DNA damage when cryopreserved for up to 4-months. The above 
conditions would guarantee viable cell cultures with limited or minor DNA damage. 
Liquid crystals as extracellular matrices would provide a potential candidate for studying 
the contractile and relaxant properties of intestinal cells to selective drugs. 
   
The possibility of using intestinal cell populations isolated from segments of the intestine 
of rat neonates as a tool for the pharmacological characterisation of receptors capable of 
activating receptors in individual cell population or in cocultures is indeed desirable. 
Creating biological actuators from cholesteric liquid crystal materials is possible due to the 
biocompatibility and responsiveness of the liquid crystal material here investigated.  
However, it yet remains to evaluate whether full concentration-response curves can be 
performed and yield reproducible results. Furthermore, there are limitations in the 
quantitative evaluation of the data from mechanical force microscopy to make it relevant to 
the field of pharmacology. This would perhaps imply the development of computer 
modeling to convert the surface deformations induced by cells in response to drug 
application into measurable forces at a cellular level.   
 
 
 
 
 
 
 
 
 
CHAPTER FOUR 
DEVELOPMENT OF AN INTESTINAL CELL CULTURE 
MODEL OF INFLAMMATION 
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 4.1 INTRODUCTION 
 
The GI tract is unique among organ systems since it possesses autonomic function in 
isolation and is equally influenced by the central nervous system. The GI tract is organised 
in layers and has a highly complex enteric nervous systems that regulate and coordinate the 
GI absorption, secretion, motility, and sensation (Gershon & Tack, 2007). The enteric 
nervous system consists of submucosal and myenteric ganglia and an intricate network of 
intrinsic and extrinsic afferent neurones, ascending and descending interneurones, 
inhibitory and excitatory motor neurones that interact with the longitudinal and circular 
smooth muscle, mucosal, and endocrine cells (Beatie & Smith, 2008). Considering the 
complexity in regulating the GI function it is not surprising that when GI dysregulation 
occurs, the impact exerted on health is significant.  Functional GI disorders emerge from 
inflammation as a defense mechanism that the body employs to fight the constant 
challenges originated from the external environment. Because of its enormous mucosal 
surface, which is continuously exposed to antigen, mitogenic, mutagenic, toxic stimuli, the 
GI tract is clearly susceptible to such inflammatory responses. The consequences of the 
onset of the inflammatory insult is an immune response that targets potential pathogens by 
activation of mucosal immune cells including neutrophils, macrophages, and cytotoxic T 
cells that attack and destroy nearby cells either directly or indirectly through the release of 
soluble factors such as reactive oxygen and nitrogen metabolites, cytotoxic proteins, lytic 
enzymes, and cytokines (Fiocchi et al., 1994, Grisham & Yamada, 1992).  
The mounting effect of the immune response against antigens within the intestinal mucosa 
produces local tissue injury (Figure 4.1.1).  
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Figure 4.1.1: Diagram representing the mucosal surface interactions with microflora 
bacteria and infectious bacteria. In the steady state the luminal bacteria that colonises the 
gut epithelial are targeted by resident immune cells, which immune cells that keep the 
homeostasis of epithelia. State of inflammation commences with interaction of endotoxin 
with the epithelial cells, which leads to translocation of the bacteria across the intestinal 
barrier and recruitment of immune cells that release inflammatory mediators. 
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In newborn infants, the most commonly documented episode of the onset of GI 
inflammation occurs after the first feed. This results in infection that attacks predominantly 
premature infants due to the fragility of the tiny host (Anand et al., 2007).  As a result the 
continuous inflammation attacks the intestine from within inducing the development of 
necrotising enterocolitis (Anand et al., 2007). Necrotising enterocolitis is the leading cause 
of death from GI disease in preterm neonates (Anand et al., 2007, Nanthakumar et al., 
2000). The precise aetiology of the chronic intestinal inflammation, however, still remains 
elusive despite the intensive research that has been carried out over the past few years.   
More recently, intestinal cell culture models of inflammation derived from fetal epithelium 
have been developed to use as tools to examine the action of proinflammatory mediators in 
the model of necrotising enterocolitis (Nanthakumar et al., 2000). The data acquired have 
been useful in assessing the enhanced cytokine responses and may in part explain the 
factors that may contribute to the excessive inflammatory response in necrotising 
enterocolitis (Nanthakumar et al., 2000). The epithelial models of inflammation, however, 
are restricted exclusively to the investigation of epithelium responses to inflammatory 
insult (Liboni et al., 2004). Such models of inflammation were primarily developed since it 
is an established notion that when the inflammation response occurs in the intestine, the 
effector immune cells located in the epithelial lining of the gut dominate such a response 
causing destruction of other mucosal cells (Fiocchi et al., 1994). Progress in understanding 
the process of intestinal inflammation has led to further evidence of the involvement of 
epithelial, endothelial, muscle, and nerve cells as effector and regulatory elements of the 
immune response (Fiocchi, 1997).  Therefore, the development of an intestinal model of 
inflammation, representative of all intestinal cell layers would be desirable to assess the 
complex interplay between conventional immune cells and newly proposed non-immune 
cell interactions. It is hypothesised that the information derived from such an‘in-vitro’ 
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approach will provide evidence of the pro-inflammatory mediators and cytokines 
implicated in the process of GI inflammation in neonates.  
 
 
4.2 AIM 
 
 
The aim of the present study was to first develop an intestinal cell culture model of 
inflammation including all cellular components representative of the intact intestine. The 
inflammation status was achieved by lipopolysaccharide (LPS)-induced inflammation ‘in 
vitro’.    
Secondly, following confirmation of the stimulation of pro-inflammatory cytokines and 
mediators, the model was used to investigate the effects of granisetron, a 5-HT3 receptor 
antagonist, L-NAME, a nitric oxide (NO) synthase inhibitor, and Chaga mushroom extract, 
a wood-rotting fungus with reported anti-inflammatory properties on inflammation induced 
by LPS. 
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4.3 METHODS 
 
 
4.3.1 CELL CULTURE AND LPS STIMULATION 
 
 
The animal housing and conditions were followed as described in section 2.3.1. Rat 
neonates were killed by dislocation of the neck.  The whole intestine was subsequently 
removed and emptied of its contents by gently flushing with HBSS. The length of the 
intestine was approximately 15cm in its contracted form. One segment (2cm) was taken 
12-14 cm distal to the pyloric region, that was considered as the ileum as explained in 
section 3.3.1. The segments were then enzymatically dissociated in 1ml of 0.25% 
trypsin/EDTA for 30 min at 37ºC. The preparations were then triturated by gently pipetting 
the contents up and down for approximately 5 min until a homogenous mixture was 
achieved. The mixture was then transferred to a clean centrifuge tube and 1ml media 
added: Dulbecco modified eagle’s medium (DMEM) with HEPES modification (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) and supplemented with 10% fetal calf 
serum (FCS), 100U ml-1 penicillin and 100μg ml-1 streptomycin solution, 2mM L-
glutamine, and 0.2% amphotericin B.  
The cell suspensions were centrifuged for 5 min at 450xg. Supernatant was discarded and 
5ml media was added. The cell suspensions were triturated so as to obtain a suspension of 
single cells and then transferred to 25cm2 cell culture flask and incubated at 37°C. Cells 
were routinely monitored and medium was changed at 48h intervals. On day 7 as cells 
reached confluence, the cell culture media was replaced by FCS-free media supplemented 
with 2Mm glutamine. In separate experiments investigating the effect of low glutamine 
supplementation on intestinal inflammation, the cell culture media was replaced by FCS-
free media supplemented with 0.5mM glutamine. After 24h, intestinal cell culture 
preparations were treated with 0, 10, 50, and 100μg/ml of LPS. Following incubation for 
24h with the varying treatments with LPS, cell culture supernatant were collected, 
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centrifuged at 450xg, and stored at -20°C for subsequent analysis of IL-8 and nitric oxide 
(NO) production. 
 
4.3.2 DETERMINATION OF NITRATE AND IL-8 CONCENTRATION IN 
CELL SUPERNATANT  
 
The ability of LPS to stimulate IL-8 secretion was quantified by an ELISA assay and 
expressed as pg/mg of total cellular protein. IL-8 was quantified in each supernatant in 
triplicate. Colorimetric results were read on a Titertek Multiscan II 96-well plate reader at 
a wavelength of 450nm.  
The biological activities of NO were measured as its end product, nitrite using the Griess 
reagent. Since NO is a gaseous free radical with a short half-life ‘in vivo’ of a few seconds, 
the levels of their metabolites (nitrate and nitrite) are more stable for the measurement of 
NO in biological fluids (Marletta et al., 1993).  The Griess assay determines NO 
concentration based on the enzymatic conversion of nitrate to nitrite by nitrate reductase. 
The Griess Reaction is based on the two-step diazotization reaction in which acidified 
nitrite produces a nitrosating agent, which reacts with sulfanilic acid to produce the 
diazonium ion. This ion is then coupled to N- (1-naphthyl) ethylenediamine to form the 
chromophoric azo-derivative, which absorbs light at 540 - 570nm. Briefly, the cell culture 
supernatant (100μl) was mixed with 100μl Griess reagent and incubated for 10 min before 
absorbance was read at 570nm using the plate reader. The concentration of nitrite in the 
samples was determined with reference to a sodium nitrite standard curve. NO was 
quantified in each treatment in triplicates.  
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4.3.3 CELL VIABILITY, PROLIFERATION AND ADHESION STUDIES 
 
To assess cell dynamics following exposure to varying LPS treatments cell viability, cell 
proliferation, and cell adhesion studies were carried out. Following cell dispersion from 
segments taken from the ileum of rat neonates, cells were seeded onto cell culture flasks 
and allowed to reach confluence before they were exposed to the varying LPS treatments. 
As cell culture supernatants were collected for IL-8 and NO measurements, the intestinal 
cell monolayer in the cell culture flaks were subsequently used for cell viability, 
proliferation and adhesion studies. Cell viability and cell proliferation were performed as 
described in section 3.3.3. The only exception being that unlike cell viability studies, in 
cell proliferation studies the cell counting involved count of both stained and unstained 
cells hence enabling the determination of the total cell number in the cultures. In the cell 
adhesion studies, media was removed from the cell culture preparations and the cell culture 
surface washed with HBSS. HBSS was removed and replaced by 1ml of 0.25% 
trypsin/EDTA and microscope images were taken every 30 sec until cells were completely 
detached from the cell culture surface.  
 
4.3.4 IMMUNOCYTOCHEMISTRY 
 
To assess the phenotypic properties of ISMC exposed to the LPS treatment, 
immunocytochemistry was carried out. This technique was used to qualitatively assess the 
amount of α-smooth muscle actin fibers between LPS-treated and untreated preparations. 
Cells dispersed from segments taken from the ileum of rat neonates, seeded on cell culture 
flasks and treated with LPS (50μg/ml) were subsequently purified for ISMC as described 
in section 3.3.6. The LPS concentration of 50μg/ml was selected, as it was the lowest LPS 
concentration necessary to induce the release of pro-inflammatory mediators. The ISMC 
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were subsequently grown on glass cover slides overnight, fixed in 2% formaldehyde for 5 
min and kept in PBS until used for immunostaining experiments. 
Immunocytochemistry on purified ISMC was carried out with mouse anti-α-smooth 
muscle actin antibody. Briefly, cells were made permeable by incubating in PBS 
containing 0.1% Triton X-100 for 15 min. Slides were then bathed in PBS containing 2% 
goat serum for 30 min before incubation for 60 min with α-smooth muscle actin (1:100 in 
PBS-1%BSA) at room temperature. This was followed by incubation with mouse TRITC-
labeled secondary antibody (1:30 in PBS-1%BSA) for 60 min at room temperature. Both 
incubations were preceded by 3 washes with PBS.  Negative controls were carried out, in 
which primary antibodies were replaced with PBS. Preparations were mounted using 
DAPI. Stained samples were observed with a Nikon Eclipse 80i Fluorescence, and images 
were digitally captured with SOP (ACT-2U) software. Digital recombination of images 
using Adobe Photoshop was applied for the combined display of cytoplasmic and nucleus 
staining. 
 
4.3.5 PHARMACOLOGICAL ASSAYS 
 
Following confirmation that LPS stimulation promotes pro-inflammatory responses on the 
entire intestinal cell population isolated from segments taken from the ileum of rat 
neonates, experiments were carried out using this intestinal cell culture model to examine 
the role of 5-HT in the inflammatory process using granisetron (0.01, 0.1, 1μM) a 5-HT3 
receptor antagonist. In separate experiments the anti-inflammatory potential of L-NAME 
(0.1μM) a partial NO synthase inhibitor was also investigated. Intestinal cell culture 
preparations were pre-treated for 1h with media containing granisetron, L-NAME, or 
vehicle. Subsequently, media was replaced by FCS-free media supplemented with 2mM 
glutamine and containing 50μg/ml of LPS for 24h. This approach was sought to assess the 
potential anti-inflammatory action of granisetron and L-NAME in the management of 
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intestinal inflammation in neonates.  In separate experiments, intestinal cell culture 
preparations were pre-treated primarily for 1h with media containing granisetron, L-
NAME, or vehicle, after which LPS (50μg/ml) was concurrently added to the media and 
incubated for additional 24h. This continual drug treatment for 25h was sought to assess 
the effect of sustained anti-inflammatory drug management. The supernatant was collected 
and centrifuged for 5 min at 450xg and subsequently assayed for NO production as 
described in section 4.3.2. In separate experiments cell culture preparations were treated 
solely with granisetron (1μM) or L-NAME (1μM). The culture supernatant was then 
assayed for NO production. 
In another series of experiments the anti-inflammatory potential of the Chaga mushroom 
extract was investigated. Chaga mushroom extract was obtained from Fungi Perfecti’s 
Mycomedicinals, Chicago USA. According to the manufacturer’s description, 30 drops of 
this alcohol-based extract are equivalent to 1g, which was further diluted in water to yield a 
concentration of 180μg/ml.  Intestinal cell culture preparations were pre-treated for 1h with 
media containing Chaga mushroom extract (180μg/ml) or vehicle. Subsequently, media 
was replaced by FCS-free media supplemented with 2mM glutamine and containing 
50μg/ml of LPS for 24h. The culture supernatant was then assayed for NO production. 
 
4.3.6 STATISTICAL ANALYSIS 
 
Comparative results were presented as means ± standard error of the mean. Following 
normality tests, the significance of the differences was tested by one-way ANOVA 
followed by Bonferroni adjustment test.  
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Table 4.1: Chemicals/drugs used in the present study, their solvent and suppliers. 
Chemicals/drugs 
 
 
Solvents Suppliers 
Chaga mushroom ethanolic extract Distilled water Fungi Perfecti’s 
Myocomedicinals 
Lipopolysaccharide (LPS) 
 
HBSS Sigma 
Griess Reagent 
 
Distilled water Sigma 
Scorpion venom (maurus palmatus) 
 
Distilled water Sigma 
Granisetron HCL 2H20 Distilled water Sigma 
 
Trypan blue Distilled water Sigma 
 
L-NAME (L-Nitro-Arginine Methyl Ester) Distilled water Sigma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 176
4.4 RESULTS 
 
 
4.4.1 THE EFFECTS OF LPS AND GLUTAMINE TREATMENTS ON IL-8 
AND NO PRODUCTION IN INTESTINAL CELL CULTURE 
 
The extracted cells showed a basal level of NO of 12.5μM±0.5 and a basal level of IL-8 of 
7.5pg/ml±1.5 in the absence of any inflammatory promoter.  
The intestinal cell cultures treated with varying concentrations of LPS (10, 50, 100μg/ml) 
and supplemented with 0.5mM or 2mM glutamine were assessed for the levels of pro-
inflammatory cytokines and mediators by measuring IL-8 and NO levels in the cell culture 
supernatants. 
Pre-treatments with LPS plus 2mM glutamine induced the release of NO in the intestinal 
cell preparations, which achieved significance at 50 and 100μg/ml of LPS (p<0.001). 
However, when cells were treated with LPS plus 0.5 mM glutamine, NO production was 
only significantly (p<0.001) elevated at 100μg/ml (Figure 4.4.1a).  
Pre-treatments with LPS (10, 50, 100μg/ml) plus 2mM glutamine induced the production 
of IL-8 in a concentration–dependent manner, which achieved significance (P<0.05) at 
100μg/ml. The intestinal cell culture pre-treatment with LPS (10, 50, 100μg/ml) plus 0.5 
mM glutamine also induced the release of IL-8, however, the levels of IL-8 were 
comparable to those in the control cell preparations (Figure 4.4.1b). 
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 Figure 4.4.1: The effect of increasing concentrations of LPS (0, 10, 50, 100 μg/ml) plus 
glutamine 2 mM or 0.5mM treatments on the production of pro-inflammatory agents NO 
(A) and cytokine IL-8 (B) in intestinal cell preparations. Each point represents the 
mean±s.e.mean; n=4. *p<0.05, **p<0.01, ***p<0.001 taken as a significant difference 
compared to the control values. 
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 4.4.2 THE EFFECT OF LPS TREATMENTS ON CELL VIABILITY, CELL 
ADHESION AND CELL PROLIFERATION 
 
 
To address the effects LPS-induced inflammation on the cellular dynamics of intestinal cell 
preparations, cell viability, adhesion and proliferation were examined. The intestinal cell 
culture preparations treated with LPS at the varying concentrations of 10, 50, 100μg/ml 
showed no significant differences in the cell viability when compared with untreated cell 
culture preparations (Figure 4.4.2a). 
The cell proliferation analysis showed that LPS treatments enhanced cell numbers. 
Intestinal cells isolated from segments of the ileum produce cell yields of 2x105.   
Following cell seeding for 7 days until cultures reached confluence, treatments with LPS at 
concentrations of 10, 50, 100μg/ml produced cell numbers of 4x105, 5.5x105, 6x105, 
respectively. Although, increased cell proliferation was observed in LPS treated cell 
preparations, these were not significantly different compared to the untreated cell cultures 
(3x105) (Figure 4.4.2b).  
In separate studies assessing the cell adhesion properties of intestinal cell preparations 
following LPS treatments, results revealed that LPS challenge at any given concentration 
had no effect on the rate of intestinal cell detachment (Figure 4.4.3). Time-lapse 
micrographs demonstrated progressive cell detachment that was completed following 180 
sec incubation with trypsin/EDTA.  These were observed in untreated and LPS-treated 
intestinal cell cultures (Figure 4.4.4). 
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Figure 4.4.2: Intestinal cell viability following treatment with increasing concentrations of 
LPS (10, 50, 100μg/ml). LPS treatments had no effect on intestinal cell viability when 
compared to untreated intestinal cell preparations (A).Intestinal cell proliferation following 
treatment with increasing concentrations of LPS (10, 50, 100μg/ml). LPS treatments 
demonstrated dose dependent increase in intestinal cell proliferation (B).Each point 
represents the mean±s.e.mean; n=3. *p<0.05, **p<0.01, ***p<0.001 taken as a significant 
difference compared to the control values. 
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 Figure 4.4.3: The effect of LPS treatment on the cell adhesion ability of intestinal cells. 
Intestinal cell culture preparations were exposed to increasing concentrations of LPS (0, 
10, 50, 100 um/ml) and once cells reached confluence, proteolytic enzyme trypsin was 
used to cleave the bound between cells and the surface promoting cell detachment. This 
was monitored for each LPS treatment and the percentage of cell detachment rate 
calculated at 0, 30, 60, 120, and 180 sec. 
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Figure 4.4.4: Micrographs illustrating the rate of cell detachment on LPS-treated at 
50μg/ml (A) and untreated (B) intestinal cell culture preparations at 0 (1), 60 (2), 120 (3), 
180 sec (4). Following exposure to proteolytic enzyme trypsin, intestinal cell preparations 
demonstrated gradual and coordinated rate of cell detachment between the differently 
treated cell cultures. Scale bar=50 μm. 
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4.3.3 IMMUNOCYTOCHEMISTRY 
 
 
Immunocytochemistry was carried out to investigate the phenotypic changes induced by 
LPS (50μg/ml) treatment on ISMC. Antibody to α-smooth muscle actin indicated that LPS 
treatment caused a decrease in the expression of actin fibers compared to untreated 
intestinal cell preparations. Moreover, the actin fibers of ISMC from LPS-treated 
preparations displayed an impaired distribution compared to ISMC of untreated intestinal 
cell preparations (Figure 4.4.5).  
 
   
   
A1 B1 
    
 
Figure 4.4.5: Representative micrographs showing a comparison of the α-actin fibers 
expression and distribution between purified ISMC from LPS-treated (B1-2) and untreated 
(A1-2) intestinal cell preparations. ISMC isolated from segments taken from the intestinal 
rat ileum stained with α-smooth muscle actin antibody (green) for confirmation of the 
nature of the purified ISMC. DAPI mount was used for labeling of cell nucleus (blue). 
Scale bar=25μm. 
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A2 
4.4.4 THE EFFECT OF GRANISETRON AND L-NAME ON LPS-INDUCED 
INFLAMMATION IN THE INTESTINAL CELL CULTURE 
PREPARATIONS 
 
The extracted cells from the intestine showed a basal level of NO of 10μM±0.5 in the 
absence of any inflammatory promoter (Figure 4.4.6a). The cell preparations treated with 
LPS (50μg/ml) alone induced a significant (p<0.05) increase in the level of NO production 
compared to controls. The level of NO was still significantly (p<0.05) high when cells 
were treated for 1h with the 5-HT3 receptor antagonists, granisetron at a concentration of 
0.01μM prior to the application of LPS as compared to the level of NO in non-treated cells. 
Pre-treatment for 1h with granisetron at concentrations of 0.1μM and 1μM showed an 
increase in the level of NO, however, these were not significant as compared to control cell 
preparations (Fig. 4.4.6a). In addition, the level of NO was significantly (p<0.05-p<0.001) 
high when cells were treated for 1h with granisetron (0.01, 0.1, and 1μM) and concurrently 
with LPS (50μg/ml) for 24h (Figure 4.4.6a). 
Pre-treatment for 1h or 25h with the NO synthase inhibitor, L-NAME, prior to the 
application of LPS caused a significant (p<0.05-p<0.01) increase in the level of NO 
production compared to non-treated cells (control) (Figure 4.4.6a).  
In separate studies the effect of 1h treatment with granisetron (1μM) or L-NAME (1μM) 
was investigated on intestinal cell preparations in the absence of LPS. Following 1h 
treatments with granisetron or L-NAME (1μM), results revealed no influence of these 
drugs on the levels of NO production in the intestinal cell preparations as compared to the 
basal level of NO in control cells. However, longer incubation times of 25h with 
granisetron or L-NAME caused a significant (p<0.001) increase in the levels of NO 
production compared to controls (Figure 4.4.6b). 
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Figure 4.4.6: The effects of 1h and 25h pre-treatment with granisetron (0.01, 0.1, 1μM) or 
L-NAME (0.1μM) on LPS (50μg/ml)-treated intestinal cell cultures (A). The effects of 1h 
and 25h treatment with granisetron (1μM) or L-NAME (0.1μM) on intestinal cell 
preparations (B). Each point represents the mean±s.e.mean; n=3. *p<0.05, **p<0.01, 
***p<0.001 taken as a significant difference compared to the control. 
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 4.4.5 THE EFFECT OF CHAGA MUSHROOM EXTRACT ON LPS-
INDUCED INFLAMMATION IN THE INTESTINAL CELL CULTURE 
PREPARATIONS 
 
The extracted cells from the intestine showed a basal level of NO of 9.5μM±0.5 in the 
absence of LPS stimulation (Figure 4.4.7). The cell preparations treated with LPS 
(50μg/ml) alone induced a significant (p<0.05) increase in the level of NO production 
compared to controls. Pre-treatment for 1h with Chaga mushroom extract at a 
concentration of 180μg/ml prior to the application of LPS (50μg/ml) did not significantly 
change the level of NO production in comparison to the controls. Thus, there were no 
significant differences in NO production between LPS plus Chaga-treated preparations and 
controls.  Moreover, the intestinal cell preparations pre-treated for 1h with Chaga 
mushroom extract prior to the application of LPS (50μg/ml) caused a significant (p<0.05) 
reduction in the level of NO production when compared to the LPS-treated preparations 
(Figure 4.4.7). 
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Figure 4.4.7: The effects of Chaga mushroom extract (180μg/ml) treatments on LPS 
(50μg/ml)-treated intestinal cell cultures. Each point represents the mean±s.e.mean; n=4. 
*p<0.05  taken as a significant differences compared to the control. 
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4.5 DISCUSSION 
 
Respiratory distress syndrome has been over many years the major medical challenge in 
premature newborns. With the development of surfactant to reduce the incidence of 
respiratory disease, necrotising enterocolitis has become the leading case of death in these 
patients. Necrotising enterocolitis is diagnosed in between 0.19 to 2.4 per 1000 live births 
(Feng et al., 2005, Henry & Lawrence, 2005). The disease is characterised initially by 
intestinal inflammation, which may progress into intestinal necrosis. Several theories have 
been proposed to explain the development of necrotising enterocolitis and they are all 
centered on the role of stressed premature intestine in association with bacteria. It is 
thought that the presence of gas within the walls of the intestine from enteric bacteria is the 
pathogenic cause of necrotising enterocolitis (Foglia, 1995, Anand et al., 2007). The study 
of inflammatory response ‘in vitro’ is limited as the commercially available cell lines only 
represent one cell type. However, the progression of local intestinal injury to a diffused 
multisystem process suggests the involvement of circulating pro-inflammatory cytokines in 
different layers of the intestine and the involvement of different cell types in the 
pathogenesis of necrotising enterocolitis (Anand et al., 2007).  
In the present study attempts were made to develop an intestinal cell culture model of 
inflammation with cells isolated from the neonatal rat ileum. The developed model 
consisted of cells extracted from different layers of intestine and was used to investigate 
the effects of LPS in the absence and presence of some pharmacologically active 
compounds such as granisetron, a 5-HT3 receptor antagonist, L-NAME, a NO synthase 
inhibitor. Additionally, the model was used to investigate the potential anti-inflammatory 
properties of the Chaga mushroom extract.  
The extracted cells when assayed for NO and IL-8 showed a basal levels of 12.9μM±0.5 
and 6.75pg/ml±1.7, respectively. The application of LPS (10, 50, and 100μg/ml) induced 
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an increase in the levels of NO production (19.15±1.8, 30.55±2.4, and 26.8±1.6 
respectively). The application of LPS (10, 50, and 100μg/ml) also induced an increase in 
the levels of IL-8 production (8.0±0.7, 8.25±0.9, and 19.1±4.5 respectively). NO and IL-8 
have been shown to be markers of GI inflammation in epithelial cell models (Eckmann et 
al., 1993) and animal models (Jourd'Hevil et al., 1997).  
Recent research studies have suggested that pathologic microorganisms, particularly Gram-
negative bacteria, communicate with the intestinal epithelium. Through this 
communication, these pathologic microorganisms interact with the epithelial cells to 
stimulate the activation of pro-inflammatory cytokines (Ulevitch & Tobias, 1995). During 
this period of antigen insult, the bacteria may cross the intestinal epithelium resulting in the 
widespread activation of the mucosal immune system.  This is initiated by the activation of 
T cells (Ford et al., 1996) producing pro-inflammatory cytokines that may cause direct 
epithelial damage (Homan et al., 1989). This results in the stimulated release of 
inflammatory mediators by neighboring recruited cells (Rowe et al., 1994) or recruitment 
of additional blood-borne inflammatory cells, which in turn activate additional cytokines. 
This continuous status of inflammation may become established resulting in further tissue 
invasion by bacteria and the onset of necrotising enterocolitis (Ford, 2006). 
To examine this, previous models of intestinal inflammation have been achieved through 
exposure to cell wall Gram-negative bacteria, namely endotoxin LPS. Studies have shown 
that treatments with LPS stimulates cellular inflammatory insult and releases immune 
related factors such as NO (Chen et al., 2001), and cytokines including tumour necrosis 
factor (TNF-α) (Tracey & Ceremi, 1994), interleukin 6 (IL-6) and IL-8 (Ulevitch & 
Tobias, 1995, DeFranco et al., 1998) that promote inflammatory responses. 
Some of the studies reported on cell models of GI inflammation include RAW 264.7 
macrophage cell line (Ohgami et al., 2003), H2 primary crypt-like human fetal enterocytes 
cell line (Nanthakumar et al., 2000), Caco-2 a widely studied human adult intestinal 
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epithelial cell line (Nanthakumar et al., 2000, Liboni et al., 2004), and H4 a recently 
developed human fetal non transformed primary small intestine epithelial cell model 
(Liboni et al., 2004). Data obtained from such studies have contributed enormously to our 
understanding the mechanisms of activation of the immune system. These studies also 
provide supporting evidence on the role of various cytokines and immune mediators in 
onset of GI inflammation and demonstrate their potential use as a tool for pharmacological 
analysis of candidate drug therapeutics in GI inflammation (Ohgami et al., 2003). 
Although, the aforementioned models of GI inflammation are representative of cell 
populations with well-documented involvement in the mechanisms inflammatory injury, 
however as indicated before, results obtained from such models following the onset of 
inflammatory insult are limited to the individual cell population being analysed and not to 
the overall host responses. These unidirectional models are based on the traditional 
understanding that intestinal inflammation is a process in which the mucosal immune 
compartments, namely the epithelium lining, chooses the appropriate effector functions 
necessary to deal with each encountered antigen. This decision-making process represents 
the coordinated response of several cell types present in the epithelial mucosa, which 
mediate the immune response (Laroux et al., 2001).  However, emerging evidence showing 
that all cell types populating the mucosa have an active role in the intestinal immunity and 
inflammation has increasingly challenged this unidirectional model (Fiocchi, 1997). Apart 
from epithelial cells, it has been reported that endothelium, mesenchymal, nerve cells, 
muscle cells and even acellular components of the extracellular matrix appear to be 
involved in the immunoregulatory activity under normal and inflammation conditions 
(Fiocchi, 1997, Raghow, 1994).  
Therefore, in the present study it was hypothesised that by creating a model of intestinal 
inflammation, which was representative of all cellular and acellular components of the 
intestine, would produce a model of the intestine where overall host responses could be 
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assessed. Such a model was sought to investigate the scale of inflammatory challenges 
encountered by neonates and furthermore contribute to the pathophysiology of necrotising 
enterocolitis.   
The experiments were carried out by exposing the intestinal cell preparations with 
increasing concentrations of LPS (10, 50, 100 μg/ml) and the cell culture supernatants 
were measured for the levels of NO and IL-8 production in response to inflammatory 
challenge. The results demonstrated that inflammatory stimuli by LPS on intestinal 
preparations caused a significant increase in NO levels at concentrations of 50 and 100 
μg/ml compared to untreated intestinal cells. The IL-8 production was also significantly 
increased in response to LPS treatment at 100μg/ml. These results correlate with studies by 
Nanthakumar et al, who observed a significant increase in the level of IL-8 after following 
the exposure to LPS in the fetal enterocytes cell line (Nanthakumar et al., 2000). This was 
confirmed by Liboni et al, who reported increased level of IL-8 after treatment with LPS in 
human fetal non-transformed primary small intestine epithelial cell model (Liboni et al., 
2004). Increased NO production in response to LPS exposure was also reported in RAW 
264.7 macrophage cell line (Ohgami et al., 2003).  
In recent studies by Haung et al, and Liboni et al, it was reported that reduction in the level 
of glutamine in cells treated with LPS led to an increase in the level of IL-8 production 
(Huang et al., 2003, Liboni et al., 2004). However, results in the present study showed that 
reduction in the level of glutamine from 2mM to 0.5mM in cells treated with LPS did not 
have any significant effect on the level of IL-8 production. Although, the level of NO 
production was significantly higher in preparations treated with low glutamine compared 
to controls, this was only observed in intestinal preparations exposed to 100μg/ml LPS. 
The NO levels observed at each given concentration of LPS failed to produce excessive 
release of NO comparable to those observed under commonly used ‘in vitro’ glutamine 
supplementation of 2mM. Data derived from the present study show discrepancies from 
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those presented by Liboni et al, in which glutamine deprivation upregulated pro-
inflammatory mediators in fetal non transformed primary small intestine epithelial cell 
model (Liboni et al., 2004). However, findings from the present study are in line with ‘in 
vitro’ observations of increasing IL-8 production in macrophages and monocytes 
inflammation models with increased glutamine concentration (Wallace & Keast, 1992, 
Murphy & Newsholme, 1999). The models of inflammation derived from macrophages, 
monocytes, and epithelial cells are unidirectional models consisting of cell cultures of a 
single immune effector cell type that are still challenged by evidence that other cells from 
the mucosa may be implicated in intestinal immune response to inflammation (Fiocchi, 
1997). However, the intestinal cell culture model of inflammation developed in the present 
study offers a multidirectional model comprising the various cell populations harvested 
from segments taken from the ileum of rat neonates. Such model combines the interaction 
between effector cells promoting the release of the pro-inflammatory mediators and cells 
affected by these mediators in normal and inflamed mucosa, which makes practical sense 
and possibly more closely reflects reality.  
To elucidate the effects of LPS treatments on intestinal cell function, preparations were 
assessed for cell viability, proliferation, and adhesion. Treatments with varying LPS 
concentrations did not influence cell viability significantly compared to the untreated cell 
preparations. These were in line with reports by Mochida et al, while investigating the 
inflammatory responses to LPS in murine macrophages (Mochida et al., 2007). Similarly, 
treatments with varying LPS concentrations did not alter cell adhesion properties compared 
to the untreated cell preparations. Mucosal damage is a characteristic feature during 
inflammatory injury, which requires efficient wound healing action. The response of the 
epithelial cells to injury is a complex process, where cell-matrix interactions play 
important roles in the wound healing process (Kolachala et al., 2007).  Studies 
investigating the levels of expression of the binding protein, fibronectin in the regulation of 
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intestinal inflammation has revealed that fibronectin was abundantly expressed and 
synthesised by intestinal epithelial cells. Fibronectin was also demonstrated to be 
transcriptionally upregulated in epithelial cells during the onset of inflammatory response 
and during recovery phase. The epithelial derived fibronectin appeared to potentiate cell 
attachment through epithelial-matrix interactions and fibronectin expression. This 
observation suggests that during the onset of intestinal inflammation, fibronectin 
expression is upregulated in the epithelial cells to support the inflammatory injury tolerated 
by cells and maintain normal epithelial integrity including epithelial-matrix interactions 
(Kolachala et al., 2007). Thus, this explains why the rate of cell detachment remains the 
same between LPS treated and untreated cell preparations. 
In separate experiments investigating the effect of LPS treatments on intestinal cell 
proliferation, results revealed an increase in the intestinal cell number with increasing 
concentrations of LPS. Although the onset of inflammation insult through LPS exposure 
increased cell numbers in culture, this was not significantly different as compared to 
control preparations. Nonetheless, the results correlate with characteristic morphology of 
the inflamed intestine, where inflammation results in thickening of the tissue layers with 
excessive deposition of extracellular matrix including collagen (Graham et al., 1988) and 
thickening of the tissue layers that have been associated with the expansion of all intestinal 
layers and enhanced ISMC proliferation (Graham et al., 1988). The extensive literature 
shows that the onset of smooth muscle division is associated with the modulation of 
cellular phenotype towards reduced expression of contractile proteins (Owens et al., 2004). 
In line with this information, the experiments that followed focused on the investigation of 
ISMC contractile proteins expression in the LPS treated and untreated preparations. The 
immunocytochemistry procedure using antibodies directed to α-smooth muscle actin 
revealed that ISMC from LPS treated cell preparations displayed a downregulated 
expression of actin filaments, with a disorganised orientation and rough appearance. 
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Whereas ISMC from untreated cell preparations displayed a high expression of actin 
filaments that aligned across the cytoskeleton and produced a smooth appearance. These 
results correlated with previous studies, where phenotype modulation of smooth muscle 
through reduction in actin expression was associated with various pathological conditions 
including inflammation (Johansson & Persson, 2004, Owens et al., 2004). However, the 
factors that may be involved in the increased cell proliferation through stimulation of 
smooth muscle growth and modulation of smooth muscle phenotype through reduction in 
actin expression remain to be identified.  
One important factor that has been related to regulatory role of ISMC proliferation is the 
intestinal innervations. In the animal model of colitis where ISMC hyperplasia was 
described, there was a 40% loss in intrinsic neurones, which occurred early in the time 
course following the induction of colitis (Sanovic et al., 1999). Related studies showed that 
innervations of ISMC by myenteric neurones in vitro maintained the high expression of α-
smooth muscle specific actin and reduced the sensitivity to growth stimuli (Blennerhassett 
& Lourenssen, 2000). Thus, there seems to be a correlation between the effect of 
inflammation on the enteric nervous system and the extent of ISMC hyperplasia in affected 
tissues.  
Another factor that may play a regulatory role in ISMC proliferation ‘in vitro’ is the 
production of pro-inflammatory cytokines. These include the inducible nitric oxide 
synthase (iNOS), which is induced in response to pro-inflammatory stimulus (Marlow & 
Blennerhassett, 2006). In other studies, the smooth muscle phenotype was investigated in 
correlation to iNOS expression in the vasculature. The intimal smooth muscle exhibited a 
different morphological phenotype from normal cells in the media and showed higher 
activity of the iNOS promoter in response to inflammatory response (Yan & Hansson, 
1998). Interestingly, iNOS expression has also been associated with ISMC cytoskeleton 
changes through disruption of actin polymerization (Zeng & Morrison, 2001). Such 
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findings in the impairment of the actin cytoskeleton formation are believed to be 
potentiated by cytokine formation in response to inflammatory stimulus through increase 
of NO production during bladder inflammation (Johansson & Persson, 2004). This was 
subsequently confirmed in observation where bladder smooth muscle were stimulated with 
various cytokines including TNF-α and IL-1β and stained for iNOS and α-actin production. 
The bladder smooth muscle cells that expressed iNOS displayed low actin expression 
(Johansson & Persson, 2004).  
Therefore, the increase in the cell proliferation would affect the ISMC phenotype, which in 
turn would lead to impairment of the actin fibers. Furthermore, the excessive production of 
pro-inflammatory cytokines and mediators are characteristic occurrences during intestinal 
inflammation. Such occurrences were efficiently reproduced in the present ‘in vitro’ model 
of intestinal inflammation. This study is the first to report the development of a coherent 
model of inflammation, which may be used for pharmacological screening of potential 
compounds in the treatment of intestinal inflammation. 
 
Various inflammatory mediators, including TNF-α, IL-1, IL-6, IL-8, and IL-8 have been 
implicated in the pathogenesis of necrotising enterocolitis (Ford et al., 1996). Ford et al, 
have also shown that cytokine activation can lead to persistent, local production of NO 
through activation of inducible iNOS, which leads to damage to the intestine (Ford et al., 
1996). During the last decade, it became increasingly clear that NO can be produced by 
almost all mammalian cells, including endothelium lining and vasculature, neurones of the 
central and enteric nervous system, and cells of the immune system (Moncada, 1992, 
Nathan & Xie, 1994). NO is produced by distinct a enzyme systems: a constitutive enzyme 
that is observed primarily in endothelium lining the vasculature (eNOS), a neural 
associated constitutive NO found in neurones of the brain and ENS (nNOS) and the 
inducible enzyme (iNOS) whose expression in endothelium, epithelium, and inflammatory 
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cells requires protein synthesis that is induced by cytokines as a response inflammatory 
conditions (Nathan & Xie, 1994). In the gut, NO synthase activity has been found within 
the intestinal wall in the enteric neurones (Aimi et al., 1993), enteric blood vessels 
(Nichols et al., 1993), and enterocytes (M'Rabet-Touil et al., 1993). Such localisation of 
NO releasing sites are associated with constitutive NO production (eNOS and nNOS) and 
have been deemed beneficial, contributing to enhanced mucosal blood flow and sustained 
vascular integrity (Kubes, 2000). However, intestinal NO produced by neutrophils (McCall 
et al., 1989), macrophages (Hibbs et al., 1988) and mast cells (Salvemini et al., 1990) are 
associated with inducible NO production (iNOS) and are deleterious to the intestine 
(Hogaboam et al., 1995). Sustained overproduction of NO resulting from iNOS 
upregulation can have profound effects on the gut epithelium (Ford, 2006). Since NO is 
produced in large quantities by enterocytes in the intestinal walls of patients with 
necrotising enterocolitis transforming the intestinal villi into necrotic tissue, one could 
argue that any selective NO inhibitor could be used to reduce such effect. However, this 
would lead to a reduction in the production of both inducible iNOS and constitutive enteric 
nNOS. Such deficiency in constitutive nNOS may in turn also predispose the intestines to 
necrotising enterocolitis. Thus, maintaining the homeostasis of the internal GI tract, 
especially with regards to NO, is essential. The selective inhibition of iNOS, which does 
not affect the constitutive types is desirable and could have therapeutic values in treating 
intestinal inflammation, particularly with regards to necrotising enterocolitis. 
In the present study, pre-treatment of intestinal cell preparations for 1h with L-NAME 
(1μM), a NO synthase inhibitor, prior to exposure to LPS (50μg/ml) for 24h caused a slight 
reduction of the NO levels, however, these were still significantly high when compared to 
cell preparations with no LPS treatment.  Surprisingly, treatment with L-NAME (1μM), for 
1h followed by concurrent application of LPS (50μg/ml) for 24h caused a significant 
increase in NO production compared to controls. 
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The findings from the present study demonstrated that the time of treatment with NO 
synthase inhibitor has a critical bearing on its action on intestinal injury following 
challenge with the endotoxin LPS. Thus, L-NAME may either increase or decrease the 
intestinal injury. These divergences may reflect the dual function of NO with beneficial 
and detrimental effects in the intestine. The reduced NO production observed over a 
shorter contact time with L-NAME may possibly reflect the beneficial effects of NOS 
inhibitor in the present experimental inflammatory model. The reduction of NO production 
by L-NAME suggests that L-NAME is able to reduce the exacerbated NO levels following 
LPS challenge (Miller et al, 1993). L-NAME, although potent is not a selective inhibitor of 
the INOS isoforms (Vallance and Leiper, 2002). Thus, the effects of inhibiting iNOS as 
well as the constitutive isoforms (nNOS and eNOS) for a longer duration may lead to the 
detrimental effects as observed in the present study, when longer incubation with L-NAME 
caused an increase in NO production.   
The anti-inflammatory and immune modulatory properties of 5-HT3 receptor antagonists 
have also been demonstrated ‘in vitro’ and ‘in vivo’ (Fiebich et al., 2004, Vega et al., 2005, 
Seide et al., 2004). Tropisetron, a selective 5-HT3 receptor antagonist was found to inhibit 
LPS-stimulated secretion of TNF-α and IL-1β in monocytes (Fiebich et al., 2004).  
The beneficial effects the 5-HT3 receptor antagonist granisetron have also been reported in 
the treatment of diarrhoea-predominant irritable bowel syndrome (DePonti & Tonini, 2001, 
Camilleri et al., 2007). The important role attributed to 5-HT3 in intestinal 
immunomodulation prompted the investigation of the anti-inflammatory effects of 
granisetron, a 5-HT3 receptor antagonist (Tamura et al., 1996) on NO production in the 
present ‘in vitro’ model of intestinal inflammation.   
Results revealed that treatments with granisetron at 0.01μM for 1h contact time followed 
by application of LPS (50μg/ml) for 24h did not modify the increased level of NO induced 
by LPS, thus showing no differences between LPS-treated preparations and granisetron 
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plus LPS treated preparations. The level of NO was significantly high when compared to 
cell preparations with no LPS treatment. In addition, treatments with granisetron at 0.1μM 
and 1μM showed an increase in the level of NO, however, these were not significant. Pre-
treatment with granisetron was also able to increase the basal level of NO indicating the 
involvement of endogenous 5-HT in the production of NO. The 5-HT3 receptor activation 
might inhibit the increase in the level of NO as in the present experiments antagonism of 
these receptors increased the level of NO. 
Further support for the involvement of 5-HT and its receptors in inflammation come from 
studies by Cloez-Tayarani et al, where the pre-treatment of LPS- stimulated blood 
monoclonal cells with 5-HT and its associated antagonists such as ketanserin, a 5-HT2 
receptor antagonist inhibited TNF-α production and increased IL-1β production (Cloez-
Tayarani et al., 2003).     
The study also demonstrated that there were no differences observed when blood 
mononuclear cells were incubated with the testing agent for a shorter or longer contact 
times or when the testing agent and LPS were added concurrently (Cloez-Tayarani et al., 
2003). Thus, in the present study attempts were made to investigate the effect of a short 
pre-treatment time with the anti-inflammatory drugs in the management of intestinal 
inflammation. This was achieved by incubating cells for 1h with the test agent such as 
granisetron prior to the exposure to LPS. Whereas in separate experiments the concurrent 
incubation with the test agent plus the stimulant was the approach adopted to investigate 
the effect of sustained anti-inflammatory drug treatment in the management of intestinal 
inflammation. The ability of the short-term treatment with granisetron to reduce the levels 
of NO production during the inflammation challenge induced by LPS and to separately 
induce a significant increase in the level of NO production during sustained treatment 
suggests the possible involvement of 5-HT in inflammation response through 5-HT3 
receptors. 
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Further experiments are required to investigate if activation of 5-HT3 receptors would 
result in a reduction in the level of NO.  
 
 In line with this finding, results have revealed an interesting correlation between the 5-
HT3 receptor antagonist granisetron and NOS inhibitor L-NAME treatments on NO 
production. Such findings showing similar profile to the drug treatments following LPS 
challenge, suggests that like NO, 5-HT appears to participate in mucosal function 
associated with intestinal inflammation. (Sanders & Ward, 1992, Briejer et al., 1992). 
In addition, studies investigating the effect of 5-HT on NO production in human vascular 
endothelial cells revealed that treatments with 5-HT increased the production of 
constitutive eNOS (Fukatsua et al., 2006).  
It is well documented that complex interactions of the immune system, nervous, and 
epithelial systems occur to provide integrated responses to physiological and 
pathophysiological stimuli. Although the pathways by which these interactions occur are 
not clear, intensive research is beginning to unravel these interactions. The enteric nervous 
circuit has been reported to regulate the concentration of luminal antigen or bacterial 
products by evoking protective events including the initiation of mast cell degranulation or 
activation phagocytes and other auxiliary immune cells. On the other hand, antigenic 
challenge sensitised by the tissue during mucosal injury leads to release of inflammatory 
mediators that act locally to influence neural and epithelial functions while simultaneously 
recruiting additional auxiliary immune cells.  Most of the regulatory molecules released 
from immune cells include histamine, 5-HT and prostaglandins that influence local enteric 
circuits while concurrently exciting submucosal neurones (Cooke, 1994). Furthermore, in 
infectious disease caused by endotoxin LPS, the inflammatory response may also activate 
the 5-HT containing platelets (Timmons & Hawiger, 1986). In this direct mechanism, LPS 
action also leads in the translocation of platelets to the inflamed tissue and a consequent 
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increase in the local concentration of 5-HT (Endo et al., 1997). Such observations possibly 
indicate that 5-HT may interact with the inflamed tissue macrophages and contribute to the 
activation of various cytokines mediating infections and inflammatory disease (Devoino et 
al., 1988). Thus, the presence of 5-HT at inflammatory sites suggests its possible 
involvement in the control of inflammatory modulation. The effect of 5-HT on production 
of cytokines has been the subject of a few studies. It has been shown that 5-HT promotes 
IL-16 (Laberge et al., 1996) IL-1β (Cloez-Tayarani et al., 2003). Moreover, because 5-HT3 
receptors have been implicated in the treatment of women suffering from IBS with 
diarrhoea (Humphrey et al., 1999), it was postulated that a 5-HT3 receptors antagonist such 
as granisetron might be a desirable candidate in the reduction of excessive 5-HT activation 
that it is believed to contribute to the augmentation inflammatory response. 
In the present study, when assessing the effect of granisetron or L-NAME on the ‘in vitro’ 
intestinal models in the absence of LPS challenge, non-significant changes in NO 
production were observed over 1h treatment compared to the control. However, the 25h 
treatment caused a significant increase in NO production. Treatments with NOS inhibitors 
have been reported to cause increased neutrophil recruitment, increased stress, increased 
microvascular and epithelial permeability (Kubes & Granger, 1994, Suematsu et al., 1994). 
Additionally, chronic treatments with such inhibitors have been associated with intestinal 
inflammation (Miller et al., 1993, Miller et al., 1994). 
 
Further experiments were carried out looking at the anti-inflammatory properties of the 
Chaga extract. The Chaga mushroom, Inonotus obliquus, is a wood-rotting fungus that has 
been reported to have natural beneficial properties in humans including anti-bacterial, anti-
allergic, anti-inflammatory and anti-oxidant activities protecting the tissues against free 
radicals such as NO (Naba, 1994). The Chaga mushroom is used in East-European 
countries to treat gastritis and cancers and traditionally used in some Asian countries as an 
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herbal extract for the treatment of inflammatory diseases. The pharmacological importance 
of the Chaga mushroom extract as been ascribed with a number of biologically active 
immunomodulatory properties, which seem to protect against free radicals such as NO 
(Allgaher, 1991).  
In the present study the pre-treatment of intestinal preparations with ethanolic Chaga 
mushroom extract (180μg/ml) significantly reduced the levels of NO production following 
the exposure to LPS.  
The activity of NO synthase has been reported to be the main factor for NO production 
during functional GI disorders such as Crohn’s disease and Ulcerative Colitis (Boughton-
Smith et al., 1993). The result suggests that Chaga mushroom extract may possess anti-
inflammatory properties, which appear to protect cells by inhibiting the release of free 
radicals such as NO. In line with the present findings, studies investigating the anti-
inflammatory properties of the Chaga mushroom extract have revealed that it inhibits 
iNOS expression via the down-regulation of nuclear factor (NF)-kappa B binding activity 
(Park et al., 2005). At the molecular levels the stimuli of inflammatory molecules, such as 
LPS have been reported to act through receptors initiating a cascade of NF-kappa B-
dependent events that culminate with the transcription of and translation of pro-
inflammatory cytokines and other mediators (Nanthakumar et al., 2000). Further 
experiments are needed to investigate the effect of the Chaga mushroom extract on 
cytokines and perhaps using longer contact times and varying concentrations.  
 
In the present study a multidirectional model of intestinal inflammation was developed to 
investigate key aspects of intestinal inflammation ‘in vitro’. These include aspects related 
to tissue hyperplasia and enteric innervations, which were demonstrated through the 
investigation of intestinal cell proliferation and immunocytochemistry. In line with 
previous studies, the present studies on the onset of inflammation showed an increase in 
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cell proliferation and a decrease in the contractile protein expression in the smooth muscle 
cells, which have been associated with loss of intestinal innervations (Blennerhassett & 
Lourenssen, 2000). Nutrients supplementation was another aspect that was explored by 
assessing the effect of glutamine supplementation on the model of intestinal inflammation. 
It was observed that commonly used glutamine supplementation in the cell culture 
environment was more suitable for stimulation of inflammatory responses and the release 
of pro-inflammatory mediators compared to lower glutamine supplementation. The level of 
IL-8 production and NO production were significantly elevated in the present model of 
intestinal inflammation confirming that LPS treatment is effective in inducing intestinal 
inflammation ‘in vitro’. Finally, attempts were made to reduce the levels of pro-
inflammatory mediators NO using granisetron, L-NAME and the Chaga mushroom extract. 
The results revealed that short-term treatment with granisetron (0.1μM and 1μM) induces 
reduction of NO production, which showed no significant differences compared to the 
controls. This suggests the possible role of 5-HT3 receptors during the inflammation 
response.  The treatments with the Chaga extract induced a significant reduction of the 
level of NO production suggesting that such compounds might also be valuable in 
management of intestinal inflammation since it significantly reduced the level of NO 
production. 
 
Thus, the model of intestinal inflammation may contribute greatly in future work 
examining more selective drugs, namely iNOS inhibitors. It would also be interesting to 
further investigate the anti-inflammatory properties of the Chaga mushroom extract at 
higher concentrations and perhaps at longer contact times. The model may also be a 
valuable tool for the investigation of other pro-inflammatory mediators and cytokines that 
may be involved in the pathology of intestinal inflammation in neonates. This may offer 
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potential therapeutic benefits in the management of inflammation contributing to the 
pathogenesis of necrotising enterocolitis.  
 
 
 
 
 
 
 
CONCLUSION 
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The aims of this study were first to investigate the role of 5-HT receptors mediating 
contractile responses in the intact intestinal segments taken from the ileum of rat neonates. 
This investigation focused on the ‘in vitro’ measurement of changes in the tension of the 
intact intestinal segments to exogenously added ACh, atropine, a cholinergic antagonist, 5-
HT and 5-HT receptor agonists and antagonists. 
Secondly, the study focused on the development of an intestinal cell culture model to 
obtain purified ISMC, myenteric neurones, and a coculture of ISMC and myenteric 
neurones. This was achieved by various purification procedures and characterised by 
immunocytochemistry. A method for the long-term storage of ISMC was developed 
through cryopreservation. The functionality of isolated cells from segments taken from the 
ileum of rat neonates was assessed by isometric measurements of single cell contraction 
and relaxation responses to specific agonists. Cell functionality was further assessed in 
large cell populations of ISMC and myenteric neurones using substrates of different tensile 
strength. 
Thirdly, attempts were made to develop an intestinal cell culture model of inflammation 
from segments taken from the ileum of rat neonates. Inflammation was induced by 
treatments with the endotoxin LPS and the mounting inflammatory response were assessed 
by measuring the levels of the pro-inflammatory mediators such as IL-8 and NO, cell 
proliferation and the profile of ISMC contractile proteins. Furthermore, the effects of 
granisetron, a 5-HT3 receptor antagonist, L-NAME, a NO synthase inhibitor, and the 
Chaga mushroom extract, a wood-rooting fungus with reported anti-inflammatory 
properties, were assessed for their ability to reduce the augmentation of the NO production 
in response to the induced inflammation by LPS. 
 
The results of the experiments reported in the thesis have revealed that ‘in vitro’ organ bath 
experiments are suitable for the investigation of the role of 5-HT receptors mediating 
 205
contractile responses in the rat neonatal ileum. 5-HT induced contractile responses in the 
neonatal and adult intact rat ileum. These contractile responses were significantly reduced 
by atropine in the neonatal rat ileum but not in the adult rat ileum. Such observations 
highlighted the differences related to the expression of 5-HT receptors during GI tract 
postnatal maturation. Therefore, the studies that followed were focused on the 
characterisation of 5-HT receptors that may be involved in mediating contractile responses 
to 5-HT in the segments taken from the neonatal rat ileum. Pre-treatments with 
methysergide (5-HT1/2/5-7 receptor antagonists), ritanserin (5-HT2 receptor antagonist), or 
RS 23597 190 (5-HT4 receptor antagonist) at 1μM significantly reduced contractile 
responses induced by 5-HT at concentrations lower than 3μM. The application of 
granisetron (5-HT3 receptor antagonist) at 1μM significantly reduced contractile responses 
induced by 5-HT at concentrations higher than 30μM. Furthermore, the combined 
treatments with ritanserin, granisetron, plus RS 23597 190 at 1μM reduced or abolished 
contractile responses induced by 5-HT. This indicated the involvement of 5-HT2, 5-HT3, 
and 5-HT4 receptors mediating 5-HT-iduced contractions in the neonatal rat ileum. 
However, pre-treatments with WAY 100635 (5-HT1A receptors antagonist) or SB 267790A 
(5-HT7 receptor antagonist) at 1μM had no influence on the contractile responses induced 
by exogenously applied 5-HT. Pre-treatments with WAY 100635 and SB 267790A also 
had no influence on the contractile responses induced by 5-HT1A/7 receptor agonists, 5-CT 
(0.3nM-0.1mM) and 5-HT1A receptor agonists, 8-OH-DPAT (0.3nM-0.1mM), which itself 
failed to induce a measurable response. These observations indicated the unlikely 
involvement of 5-HT1A and 5-HT7 in mediating 5-HT contractile responses in the segments 
taken from the neonatal rat ileum.  
Further experiments are required to explore the role of 5-HT receptors mediating 5-HT 
relaxation responses in the neonatal rat ileum. For example, it would be interesting to 
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investigate if 8-OH-DPAT applications would induce a relaxation response in pre-
contracted tissues.  
 
In an attempt to reduce the number of animal usage in pharmacological research, efforts 
were made to extract cells from the intestine, which were viable following storage to be 
used for subsequent experiments. In such studies the ligation of both ends of a segment 
taken from the neonatal intestine allowed gradual separation of the intestinal layers 
following the exposure to trypsin. This was confirmed through histological procedures that 
demonstrated that increased incubation times with the proteolytic enzyme, trypsin causes 
gradual cell dissociation from the outer most layers towards the deepest layers of the 
intestine. The combination of histological procedure with viability and confluence studies 
support that isolation of cells from segments taken from the ileum and a trypsinisation time 
of 30 min provided the most adequate parameters for the isolation of a mixed population of 
fibroblasts, ISMC and myenteric neurones from the neonatal (1-4 days old) intestine. Cell 
mixtures were purified using differential adhesion technique and selective cytotoxicity. 
The purified ISMC, myenteric neurones and co-culture of ISMC and myenteric neurones 
were characterised by immunocytochemistry using antibodies to α-smooth muscle actin, 
labeling ISMC cytoskeleton and 5-HT3 receptor antibody labeling myenteric neurones. A 
cryopreservation technique for the long-term storage of ISMC was established through a 
gradual cooling process, which led to minimal genomic damage. Functionality of single 
ISMC in culture was assessed in plastic and silicone elastomer surfaces using specific 
agonists known to induce contraction and relaxation responses in the ISMC. The 
application of KCl, 5-HT, carbachol, induced contractile responses on ISMC plated on 
plastic and silicone elastomer substrates. As cells displayed changes in dimension in 
response to the drug application, this caused a variation in gray scale intensities, which 
were captured by the peripherally located pixel points. The application of noradrenaline 
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induced relaxation responses in the silicone elastomer substrate. Atropine significantly 
reduced contractile responses induced by carbachol in the silicone elastomer substrate. 
Silicone elastomer provided a more suitable substrate for the single cell functionality 
studies compared to the plastic substrate and revealed contraction and relaxation patterns 
comparable to ‘in vitro’ organ bath set up. Thus, as an attempt to produce a suitable 
substrate for functionality studies of large population large cell populations, cocultures of 
ISMC and myenteric neurones were seeded onto patterned silicone elastomer substrate and 
cholesteric liquid crystal substrate, and single dose application of KCl analysed. Results 
revealed that cholesteric liquid crystal materials provide a more suitable substrate for cell 
functionality studies as responses induced by cells following drug application was 
translated into deformation in the surface of the liquid crystal. In the pattern silicone 
substrate, however, cell responses to KCl were not translated into surface deformation. 
This may suggest that the elastic modulus of liquid crystal material is more closely related 
to that of the extracellular matrix that surrounds these cells in the intact intestine. In 
subsequent experiments the cholesteric liquid crystal material was used to investigate the 
effect of noradrenaline on KCl pre-contracted cells. The ability of the coculture of 
neurones and ISMC to produce relaxation responses following the application 
noradrenaline suggests that the liquid crystal material is suitable in studies investigating 
contraction and relaxation responses induced by cells following the application of 
pharmacologically active compounds.   
Although cholesteric liquid crystal materials display the biocompatibility and the elastic 
properties necessary to promote substrate displacement as a result of contractile responses 
induced by the cells following drug application, it remains to determine if full 
concentration response curves could be performed and yield reproducible results. 
Additionally, it remains to evaluate if data derived from time-lapse miscroscopy may be 
relevant to the field of pharmacology.  
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Stimulation of ileal cells with increasing concentration of the endotoxin LPS (10, 50, 
100μg/ml) induced inflammation responses. This was confirmed through the measurement 
of pro-inflammatory mediators such as IL-8 and NO, which caused a significant increase in 
the level of IL-8 production following LPS challenge at 100μg/ml, and NO following LPS 
challenge at 50μg/ml and 100μg/ml. The use of normal glutamine supplementation during 
cell culture (2mM) enhanced the intestinal inflammation response compared to low 
glutamine supplementation (0.5Mm). The supplementation of cell cultures with the normal 
glutamine levels (2mM) induced higher level of NO and IL-8 production. In the presence 
of LPS the cell viability and cell adhesion remained unchanged, indicating the possible 
modulatory role of extracellular matrix proteins in maintaining homeostasis in normal and 
inflamed intestine. Cell proliferation was increased in response to LPS stimulation, 
suggesting that during intestinal inflammation the enteric innervations are partially affected 
and this leads to decreased ability of nerves to efficiently coordinate intestinal cell growth 
resulting in increased cell proliferation.  This observation concurred with 
immunocytochemistry analysis assessing the α-smooth muscle actin expression in the 
ISMC cytoskeleton during normal and diseased conditions. The significant reduction in the 
expression of actin fibers indicated an increase in the cell proliferation through reduced 
nerve coordination.  
The effect of pre-treatments with granisetron and L-NAME on the level of NO production 
was investigated during intestinal inflammation induced by LPS. A 1h treatment with L-
NAME (0.1μM) showed an increase in NO production. An increase in the level of NO was 
also observed following 1h treatment with granisetron (0.01μM). The treatments with 
granisetron at 0.1μM and 1μM showed an increase in the NO production, however these 
were not significant. The prolonged treatments for 25h caused an increase in the level of 
NO production. This may be related to the fact that although the level of NO production 
increases during the activation of the inflammatory response, this consists of only the 
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inducible isoform of NO, namely iNOS. However, other constitutive isoforms are also 
present in the intestine and may play a vital role in the GI tract physiology. Thus, sustained 
treatment with L-NAME, which is not specific to the NO isoforms may inhibit all 
isorforms leading to further augmentation of the inflammatory response. The increase in 
the level of NO induced by pre-treatments with granisetron indicates the involvement of 
endogenous 5-HT in the inflammatory responses via 5HT3 receptors. The endogenous 5-
HT might reduce the inflammatory response by activating the 5-HT3 receptors. 
In separate experiments the effect of the Chaga mushroom extract, a wood-rotting fungus 
that has been reported to have natural anti-inflammatory properties in protecting the tissues 
against free radicals such as NO was investigated. Pre-treatment of intestinal preparations 
with ethanolic Chaga mushroom extract (180μg.ml) significantly reduced the levels of NO 
production following the exposure to LPS.  
The present study indicates that the developed cell culture model of intestine offers a 
useful tool for ‘in vitro’ analysis of potential therapeutics in the treatment of intestinal 
inflammation. 
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